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Foreword 
The present report has been developed within the NANoREG project: "A common 
European approach to the regulatory testing of nanomaterials", funded by the European 
Union's 7th Framework Programme, under grant agreement no. 310584 
(http://cordis.europa.eu/project/rcn/107159_en.html, www.nanoreg.eu).  
It represents the project attempt at bringing common understanding and consistency in 
the use of key terms important in the field of environmental health and safety (EHS) 
assessment of nanomaterials. It is at the same time a contribution to the on-going 
(global) debate on the meaning of some of those words in this field. The NANoREG 
partners, including JRC, believe in the usefulness of this terminology review for scientific 
experts and stakeholders, such as regulatory authorities, industry and consumers. 
This report has been shared with the participants to the OECD Expert Meeting on 
'Grouping and read-across for the hazard assessment of manufactured nanomaterials' 
hosted by the European Commission's Directorate-General for the Environment (DG 
ENV) and scientifically organised by JRC in Brussels on 13-14 April 2016. 
The content of the report has been considered in the development of a scientific 
document on Usage of (eco)toxicological data for bridging data gaps between and 
grouping of nanoforms of the same substance. Elements to consider, jointly prepared by 
RIVM, ECHA and JRC. It is available for download from the ECHA website 
(https://echa.europa.eu/documents/10162/13630/eco_toxicological_for_bridging_groupi
ng_nanoforms_en.pdf).  
For a direct access to the 'NANoREG Harmonised Terminology', go to Section 3. 
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Abstract 
Several terms in the field of environmental health and safety (EHS) assessment of 
chemicals and nanomaterials (hereinafter NMs) have been defined or used by the 
scientific community and different organisations, including international bodies, 
European authorities, and industry associations. This is also true for multidisciplinary 
projects such as NANoREG, which aims at supporting regulatory authorities and industry 
in dealing with EHS issues of manufactured NMs. 
The objective of the present JRC technical report is to publish the harmonised 
terminology that has been developed and used within NANoREG. It has been agreed 
upon and adopted by all project partners in their activities and related documents. The 
report specifically includes: i) the methodology used to select key terms that form the 
harmonised terminology and to develop harmonised definitions; ii) the existing literature 
definitions that have been used as a starting point to develop for each key term a 
harmonised definition; and iii) the reason(s) behind the choices that have been made in 
drafting a definition. As far as possible, the harmonised definition is reproducing (an) 
already existing definition text(s), thus avoiding the creation of new and unwelcome 
information. 
The discussion on the key terms to be considered for the harmonised terminology led to 
the selection of 43 key terms. The list includes terms with international regulatory 
relevance, such as those defined at OECD level, as well as terms that have a specific 
meaning and use under REACH. 
The 'NANoREG Harmonised Terminology' has already proven very useful in the context 
of the OECD work, as support document to the April 2016 OECD Expert Meeting on 
'Grouping and read-across for the hazard assessment of manufactured nanomaterials', 
and in a regulatory context, as support document to the work recently released by RIVM, 
ECHA and JRC on using (eco)toxicological data for bridging data gaps between 
nanoforms of the same substance (March 2016). 
For quick access, the 'NANoREG Harmonised Terminology' is reported in Section 3. 
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1. Introduction 
Consistent use of terminology is important in any field of science and technology to 
ensure common understanding of concepts and tools among experts and different 
stakeholders, such as regulatory authorities, industry and consumers. 
Several terms in the field of environmental health and safety (EHS) assessment of 
nanomaterials (hereinafter NMs) have been indeed defined or used by the scientific 
community and various organisations, including international bodies, European 
authorities, and industry associations. 
This is true for multidisciplinary projects such as NANoREG, which aims at supporting 
regulatory authorities, and industry, in dealing with EHS issues of manufactured NMs 
('nanoEHS') (http://cordis.europa.eu/project/rcn/107159_en.html, www.nanoreg.eu).  
Terminology thus plays an important role in NANoREG's internal process of producing 
diverse types of output with regulatory relevance (e.g. physicochemical characterisation 
and test protocols, grouping and read-across approaches, exposure models, a framework 
for safety assessment of NMs, etc.). The process takes place in a collaborative effort 
across several NANoREG work packages or tasks, involving quite a few partners. 
Moreover, the different types of NANoREG output ('deliverables') are addressed to a 
large audience of scientists, industry and regulatory bodies, extending beyond Europe. 
Hence, a coordinated initiative has been undertaken by the Joint Research Centre (JRC) 
to harmonise the use of specific wording within NANoREG. 
The objective of this JRC report is to disseminate the harmonised terminology that has 
been developed and used within NANoREG. This collection of key terms has been agreed 
upon by all project partners and adopted in their activities and related documents, as 
recommended by the NANoREG internal Guidance Document.  
Accordingly, Section 2 of the report illustrates the methodology used i) to select key 
terms that form the 'NANoREG Terminology', ii) to develop harmonised 'NANoREG 
Definitions', and iii) it also explains the thinking that led to the choices made in drafting 
a definition. In Section 3, those definitions, adopted by the project Consortium, are 
reported in a table format and constitute the 'NANoREG Harmonised Terminology'. 
Section 4 summarises the existing literature definitions that have been used as starting 
point to elaborate, for each key term, a NANoREG Definition. It also shortly discusses the 
reason(s) behind the choices that have been made in drafting a definition. 
 
2. Methodology 
The NANoREG Harmonised Terminology illustrated in this report is not a 'dictionary' that 
collects a long list of well-known, well-defined scientific and/or regulatory terms relevant 
to the field of nanoEHS. Rather, the NANoREG Harmonised Terminology focuses on a 
relatively short list of key terms that may be interpreted in various ways, depending on 
where the reader is located on the globe or on the reader's scientific area of expertise. 
Moreover, it focuses on few terms that are specifically relevant in a REACH context, 
which represents the regulatory framework of reference for NANoREG. 
The first step was therefore to agree with all project partners on a relatively short list of 
key terms that are considered relevant to the nanoEHS field and, more specifically, to 
the various tasks performed within NANoREG (Section 3). 
The second step was to retrieve from different types of information sources existing 
definitions for each of those key terms (Section 4). Highest priority was given to 
guidelines and standards from international organisations (e.g. OECD, ISO) and official 
documents from European bodies, including text from relevant legislation (e.g. REACH) 
and guidance/opinions from agencies and committees (e.g. ECHA, SCCS). Official 
documents from US and Canadian bodies were also considered to discern possible 
definition differences in comparing with the European perspective. Then, publicly 
available documents that are widely used and cited were consulted. This includes reports 
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from European national authorities, reports from industrial associations (e.g. ECETOC) 
and, with the lowest priority, peer-reviewed/non peer-reviewed scientific literature.  
The relevant sources that have been accessed for each key term do not represent an 
exhaustive list. Due to time and resources constraints, the sources of existing definitions 
were not selected through an extensive literature search, but rather by using the 
available knowledge within NANoREG's Task 1.4 1 . The Task 1.4 partners include 
scientists of varying expertise (e.g. physicochemical characterisation, ecotoxicity, 
exposure, regulatory risk assessment, safe-by-design, grouping and read-across, life 
cycle assessment and data management). This has guaranteed that the most relevant 
sources per key term could be reviewed in a relatively short time period (about 5 
months). It is therefore recognised that some sources may have been neglected in the 
process. Nevertheless, this is seen as a minor gap, hence not influencing the overall 
elaboration of the harmonised definitions. The existing definitions that have been 
collected in this second step are reported as quotations of original text (Section 4). 
The third step was to elaborate and reach consensus on a proposal of a harmonised 
NANoREG Definition for each key term (Section 3 and 4). A NANoREG Definition is, as 
often as possible, a copy-paste from an existing definition reported in a high-priority 
source with regulatory relevance and/or broad consensus at international level (e.g. 
OECD, ISO), thus avoiding the creation of new and unwelcome information. However, in 
some cases, it is a compromise between existing definitions from various relevant 
sources, for instance if the existing definitions are conflicting or complementary). 
The whole 3-steps process was coordinated by JRC. The Task 1.4 partners were involved 
in each step. They were periodically informed on the progress of the document and 
asked to contribute at each step, from the selection of the key terms to the collection of 
the existing definitions, up to the discussion on how to formulate the harmonised 
NANoREG Definitions. In the last step of the process, the document was circulated 
among all NANoREG partners to reach the widest possible consensus within the 
Consortium.  
In chronological order, JRC has gathered the existing definitions for a preliminary list of 
43 key terms. It circulated a first draft version of the document among T1.4 partners on 
24 June 2015. T1.4 partners were asked to provide input to the document and, more 
specifically, i) to indicate if there were key terms that needed to be added to or removed 
from the list and ii) if there were additional definitions that should have been studied. 
An updated draft version of the terminology was circulated on 13 July 2015 for further 
comments by the T1.4 partners. JRC coordinated the collection of additional input, 
received from ENEA, ECAMRICERT (at that time VenetoNanotech, Italy), RIVM, NILU, 
ISQ, and NRCWE. JRC then drafted a proposal of a 'NANoREG Definition' for each key 
term in a third draft version of the terminology that was circulated in Task 1.4 on 31 
August 2015. The partners were asked to comment in order to find consensus on the 
most suitable definition for each key term. JRC revised and consolidated the proposed 
definitions according to the received feedback (AIT, ENEA, and ECHA). The final draft 
version of the terminology, still proposing NANoREG Definitions, was sent to the 
NANoREG Project Officer on 29 September 2015 and, through him, to all project 
partners, with 23 October 2015 as deadline for comments. The document was reviewed 
by some partners (BIONANONET, ENVICAT, KI, and SINTEF) and the final version was 
released for 'internal to NANoREG use' by JRC on 30 October 2015. 
On 11 November 2015 the NANoREG Management Committee adopted the 'NANoREG 
Harmonised Terminology' as new deliverable of the project. It agreed to its public 
dissemination in the form of a JRC Report, upon JRC's proposal. The expected date of 
publication of the report by JRC was March 2016. 
 
                                          
1 Task 1.4: 'Framework Development' 
 10 
 
3. NANoREG Harmonised Terminology and Definitions 
In Table 3.1, the 43 terms identified by the NANoREG partners as 'key' in the field of 
nanoEHS and relevant to the project tasks are listed in alphabetical order. 
This list constitutes the 'NANoREG Harmonised Terminology'. For each key term, a 
harmonised definition, adopted by consensus within the whole Consortium is reported. 
This is the 'NANoREG Definition' of the term. 
 
Table 3.1 NANoREG Harmonised Terminology and Definitions in the field of 
environmental health and safety assessment of nanomaterials with focus on the 
European REACH regulatory context. 
KEY TERM NANoREG DEFINITION 
ADAPTATION The term 'adaptation' is used in the context of REACH (EP and EC 2006; EC 2009) to 
indicate all types of deviation from the standard information requirements at the 
actual tonnage level to avoid unnecessary animal testing. Adaptation types mostly 
include testing omission, triggering, and replacement (ECHA 2011a). The rules for 
adaptation are laid down in Annex XI to REACH (EC 2009) and include: 1) testing 
does not appear scientifically necessary and is substituted by use of existing data, 
weight of evidence, QSARs, in vitro methods, grouping and/or read-across; 2) testing 
is technically not possible as a consequence of the properties of the substance; 3) 
substance-tailored exposure-driven testing (see 'Adaptation based on exposure').  
More specifically, the term 'omission' or 'waiving' is used when testing can be avoided 
and no other information needs to be supplied (e.g. when there is no significant 
exposure to the substance in any scenario). The term 'replacement' is used when 
alternative test methods rather than animal testing may be used for fulfilling the 
information requirements (e.g. read-across if one or more analogues exist, in vitro 
studies). The term 'triggering' is used when additional animal testing is needed to 
investigate further the effects on humans or the environment. 
ADAPTATION BASED 
ON EXPOSURE 
The term 'adaptation based on exposure' is used in the context of REACH (EP and EC 
2006; EC 2009) to indicate a deviation from the standard information requirements at 
the actual tonnage level based on exposure arguments (ECHA 2011a).  
According to REACH Annex XI (EC 2009) and ECHA guidance (ECHA 2011a), exposure 
based adaptations may be appropriate under the following conditions: 
− Exposure is absent (i.e. exposure is excluded) or not significant throughout the 
whole life cycle of the substance for manufacture and all identified uses; or 
− When strictly controlled conditions apply throughout the life cycle of the 
substance for manufacture and all identified uses; and 
− No releases from the article life cycle stage (and subsequent waste life stage) 
are to be expected and consequently there is a negligible likelihood of exposure 
(this situation only applies to substances incorporated into articles). 
The same principles apply to nanomaterials as long as the 'no release' or 'no leaching 
out' during the life cycle statement is supported by analytical/experimental data and 
documentation (ECHA 2012a; 2014a). 
ADVERSE OUTCOME 
PATHWAY (AOP) 
OECD defines an Adverse Outcome Pathway (AOP) as a linear sequence of key events 
(or pathway) from the exposure of an individual or population to a chemical 
substance through to a final adverse (toxic) effect (or adverse outcome) at the 
individual level (for human health) or population level (for ecotoxicological endpoints) 
(OECD 2013a). An AOP can therefore be seen as a conceptual way to assemble the 
existing knowledge on the link between a molecular initiating event caused by a 
chemical reaching an initial key target and a series of subsequent processes that are 
triggered at the subcellular, cellular, tissue, organ, whole animal, and population 
level, which result in an adverse effect (OECD 2013a). The key events/processes in 
an AOP should be definable and make sense from a physiological and biochemical 
point of view (OECD 2013a). An AOP should be built upon all documented, plausible 
and testable existing knowledge (OECD 2014a).  
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Table 3.1 (cont.) 
KEY TERM NANoREG DEFINITION 
 Different pathways can result in the same adverse outcome, and each constitutes an 
individual AOP (OECD 2014a). 
Although initially developed for use in ecotoxicology (Ankley et al 2010), the AOP 
concept is also applicable to human health effects (Schultz 2010). 
ALTERNATIVE TEST 
METHOD 
OECD defines an 'alternative test method' as a test that reduces the number of 
animals required; refines procedures to lessen or eliminate pain or distress to 
animals, or enhance animal well-being; or fully replaces animals with non-animal 
systems or with non-sentient species (OECD 2005). This definition follows the 
principle of the 3Rs, i.e. to Replace, Reduce and Refine the use of animals in 
(eco)toxicity testing. 
In the EU, the development and validation of alternative approaches to animal testing 
is explicitly encouraged in Directive 2010/63/EU (EP and EC 2010) and REACH (EP 
and EC 2006). In Directive 2010/63/EU it is also specified that alternative test 
methods should provide the same or higher levels of information as those obtained in 
procedures using animals (EP and EC 2010).  
Alternative test methods are typically based on either in vitro systems or computer-
based models.  
In vitro systems are experimental methods that use (reconstructed) tissues, whole 
cells or parts of cells.  
Computer-based models (often termed 'in silico' or 'non-testing methods') refer to 
any non-experimental methods that can be used to predict data for the assessment of 
chemicals based on their intrinsic properties. The development and application of 
these approaches is based on the similarity principle, i.e. the hypothesis that similar 
compounds should have similar biological activities (ECHA 2008a). According to OECD 
(2014a) and ECHA (2008a), non-testing data can be generated by three main 
approaches:  
− Grouping and read-across; 
− Trend analysis and use of computational methods based on internal models; 
− Use of computational models based on external models. 
In more general terms, non-testing methods can be divided into comprehensive 
(global) methods (also called 'expert systems') and specific (local) ones (including 
(Q)SARs) (ECHA 2008a; Raunio 2011). 
ANALOGUE(S) OECD considers two techniques for grouping of chemicals: the formation of a 
'chemical category' (referred to as 'category approach') and the identification of 
'analogues' (referred to as 'analogue approach') (OECD 2014a). More specifically, 
OECD defines an 'analogue' as a chemical whose intrinsic physicochemical, 
environmental or toxicological properties are likely to be similar to those of another 
chemical based upon a number of potential properties including structural and 
physicochemical properties (OECD 2014a). The term 'analogue approach' is used 
when the grouping involves a very limited number of chemicals and trends or regular 
patterns in properties are not apparent. In this case, the focus of the assessment is 
on filling data gaps for one or few more individual chemical(s) using data from one or 
few more similar individual chemical(s) that are considered as analogues. 
The OECD terminology is reflected in ECHA guidance for the implementation of REACH 
(ECHA 2008a) and in guidance by industry (ECETOC 2012). 
As far as nanomaterials are concerned, OECD states that it is premature to develop 
guidance on grouping for nanomaterials, as research first needs to pave the way for it 
(OECD 2014a), and has not developed any recommendation on how the grouping 
concepts and approaches previously developed for chemicals need to be adapted to 
take MNs' specificities into account. At European level, ECHA has not yet developed 
official guidance on how to implement grouping concepts and approaches for 
nanomaterials in the context of REACH. Until now, the existing guidance (ECHA 
2008a) has been considered in principle applicable to nanomaterials. The use of data 
between analogues in registration dossiers is supported for nanomaterials and should 
be performed in line with the similarity rules in Annex XI to REACH (ECHA 2013a). 
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Table 3.1 (cont.) 
KEY TERM NANoREG DEFINITION 
 In the US, no specific recommendation has been developed for nanomaterials. 
However, given that for many nanomaterials the available information is insufficient, 
US EPA has made use of analogues from existing chemical categories to assess the 
potential hazard of some nanomaterials, e.g. carbon nanotubes (US EPA 2014a). 
Despite the lack of official guidance at international and European level, experts seem 
to agree that identifying analogues for nanomaterials introduces additional 
challenges, compared to traditional chemicals: similarity cannot be based on 
structural or chemical composition only, but needs to consider a wider spectrum of 
physicochemical properties determining identity and behaviour of nanomaterials, 
including e.g. impurities, surface treatment, surface area, surface charge and shape 
(RIVM 2015; OECD 2014b; ECHA 2013b). Moreover, some researchers underline that 
physicochemical properties are not sufficient for categorization of nanomaterials, and 
that indicators of both hazard and exposure potential need to be included (Godwin et 
al 2015). Arts and colleagues suggest that all aspects of the nanomaterials life cycle 
need to be considered in a grouping approach, i.e. physicochemical properties, 
biophysical interactions, intended use, external exposure, uptake and internal 
exposure, biokinetics and early biological and apical effects (Arts et al 2014). 
ASSESSMENT 
FACTOR (AF) 
International organisations, such as IPSC and OECD, define an ‘assessment actor’ as 
a numerical adjustment used to extrapolate from experimentally determined (dose-
response) relationships to estimate the agent exposure below which an adverse effect 
unlikely to occur (IPSC 2004; OECD 2003).  
In the REACH context (EP and EC 2006), the exposure level to a substance below 
which an adverse effect unlikely to occur is called Derived No Effect Level (DNEL) for 
human health and Predicted No Effect Level (PNEC) for the environment (ECHA 
2008b; 2012b). The biological starting points to derive these levels are the dose 
descriptors obtained from long-term or short-term animal experiments (e.g. NOEC, 
EC10, BMD, EC50). To account for the uncertainty and variability associated with 
extrapolation from individual test animals to human population or whole ecosystems, 
a set of assessment factors is applied to the initial dose descriptors.  
In establishing the size of the assessment factors to be applied a number of aspects 
need to be considered. Both ECHA (2012b) and US EPA (2002) identify the following 
sources of uncertainty and variability: 
− Interspecies differences; 
− Intraspecies differences; 
− Differences in duration of exposure; 
− Issues related to dose-response; 
− Quality of the whole database. 
Preferably, the value for each individual assessment factor is based on substance-
specific information, i.e. a 'substance-specific assessment factor' is derived. However, 
'default assessment factors', usually 10-fold, need most often to be used to 
compensate for lack of data (e.g. human data) and information (e.g. on 
toxicodynamics) (ECHA 2012b). 
CATEGORISATION The term 'categorisation' is used in the scientific literature to indicate the organisation 
of nanomaterials into 'groups' or 'categories' based on criteria that could either 
consider their structural and physicochemical similarities (e.g. Godwin et al 2015) or 
their similarities in terms of exposure route, physicochemical properties and/or mode 
of action (e.g. Gebel et al 2014). In both cases, the term 'categorisation' seems to 
resemble the concept of 'grouping' and 'chemical category', which are terms well-
defined at OECD level, and in both US and EU legislation on chemicals. 
In the Canadian legislation on chemicals, the term 'categorisation' refers to the 
identification of substances that i) may present the greatest potential for human 
exposure or ii) are persistent, bioaccumulative and inherently toxic to human beings 
or non-human organisms (CEPA 1999). This process resembles the 'hazard 
classification' required by UN (2003) and EU (EP and EC 2008) for chemicals (see 
'classification') and the 'PBT assessment' required by EU under REACH. In all cases, 
substances tend to be evaluated and grouped based on their hazard or exposure 
potency without consideration of their structural/physicochemical similarities. 
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Table 3.1 (cont.) 
KEY TERM NANoREG DEFINITION 
CHEMICAL 
CATEGORY 
OECD considers two techniques for grouping of chemicals: the formation of a 
'chemical category' (referred to as 'category approach') and the identification of 
'analogues' (referred to as 'analogue approach') (OECD 2014a). More specifically, 
OECD defines a 'chemical category' as a group of chemicals for which 
physicochemical, toxicological and ecotoxicological properties are likely to be similar 
or follow a regular pattern as a result of structural similarity (OECD 2014a). This 
definition was initially proposed by US EPA (1999), which has so far developed 56 
chemical categories to be used to assess new chemicals under the Toxic Substances 
Control Act (US EPA 2010). The same definition is also used by ISO (2014). 
At EU level, a similar definition is included in Annex XI to REACH, where the use of 
categories is considered among the rules for adaptation of the standard testing 
regime (EP and EC 2006; EC 2009). The OECD terminology is reflected in ECHA 
guidance for the implementation of REACH (ECHA 2008a) and in guidance by industry 
(ECETOC 2012). 
A 'chemical category' usually encompasses a large number of chemicals, which are 
often related by a trend in a property for a given endpoint (OECD 2014a). As the 
number of chemicals in a category increases, the potential for developing hypotheses 
and generalisations about the trends within the category also increases (ECHA 
2008a). If the available test results show that the chemicals in a category behave in a 
similar or predictable manner, then interpolation and/or extrapolation may be used to 
assess the chemicals instead of conducting additional testing (US EPA 1999) (see 
'interpolation' and 'extrapolation'). This allows the properties of the individual 
chemicals in the category to be assessed on the basis of the evaluation of the 
category as a whole, rather than based on measured data for each individual chemical 
(OECD 2014a). 
As far as nanomaterials are concerned, OECD states that it is premature to develop 
specific guidance on this subject for nanomaterials as research first needs to pay the 
way for it (OECD 2014a). At European level, ECHA has not developed any official 
guidance on the development and use of the category approach for nanomaterials in 
the context of REACH. Until now, the existing guidance for chemicals (ECHA 2008a) 
has been considered in principle applicable to nanomaterials. However, the ECHA 
Group Assessing Already Registered Nanomaterials (GAARN) has clarified that the use 
of data from chemical categories in REACH registration dossiers is supported for 
nanomaterials and should be performed in line with the similarity rules specified in 
Annex XI to REACH (ECHA 2013a). In the US, no specific category has been 
developed for nanomaterials. However, given that for many nanomaterials the 
available information is insufficient, US EPA has made use of data from existing 
chemical categories to assess the potential hazard of some nanomaterials, e.g. carbon 
nanotubes (US EPA 2014a). 
Despite the lack of official guidance at international and European level, experts seem 
to agree that developing categories for nanomaterials introduce additional challenges 
compared to traditional chemicals: similarity cannot be based on structural or 
chemical composition only, but a wider spectrum of physicochemical properties 
determining identity and behaviour of nanomaterials including e.g. impurities, surface 
treatment, surface area, surface charge and shape (RIVM 2015; OECD 2014b; ECHA 
2013a) needs to be considered. Some experts underline that physicochemical 
properties are not sufficient for categorization of nanomaterials and indicators of both 
hazard and exposure potential needs to be included (Godwin et al 2015). Arts and 
colleagues suggest that all aspects of the nanomaterials' life cycle need to be 
considered in a grouping approach, i.e. physicochemical properties, biophysical 
interactions, intended use, external exposure, uptake and internal exposure, 
biokinetics and early biological and apical effects (Arts et al 2014). 
CHEMICAL SAFETY 
ASSESSMENT (CSA) 
The term Chemical Safety Assessment (CSA) has a specific meaning in the context of 
the REACH (EP and EC 2006). It indicates the process that identifies and describes 
the conditions under which the manufacturing and use of a substance is considered to 
be safe (ECHA 2009). There are three major steps in the CSA process under REACH 
and are:  
− Hazard assessment, 
− Exposure assessment, 
− Risk characterisation. 
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KEY TERM NANoREG DEFINITION 
 The goal of the assessment is not to establish whether or not there is a risk, but to 
identify and describe the conditions under which the risks are controlled (ECHA 
2011b). Risks are regarded as controlled when the estimated exposure levels do not 
exceed the predicted no effect levels (DNEL or PNEC). For substances for which such 
no-effect levels cannot be determined, the risk characterisation may consist of semi-
quantitative or qualitative assessment of the likelihood that adverse effects are 
avoided (ECHA 2011b). 
CLASS OF 
SUBSTANCES 
At UN level and in the EU legislation on chemicals, substances are assigned to the 
same 'hazard class' when they share the same physicochemical (e.g. explosiveness), 
health (e.g. carcinogenicity) or environmental (e.g. aquatic acute toxicity) hazard 
potential (UN 2003, EP and EC 2008), without the condition of structural similarity. 
The assignation is based on the results of a standard test method for a specific 
endpoint and is most commonly used for classification and labelling purposes (NIEHS 
1997). 
As far as nanomaterials are concerned, the US and Canada have developed the 'Joint 
Nanomaterials Classification Scheme' for regulatory purposes (RCC 2013). The scope 
is not to assign nanomaterials to hazard classes for labelling purposes but to group 
them based on similarities in chemical composition for read-across (RCC 2013). The 
concept of 'class' in this document is therefore different from the one in UN/EU 
documents and more similar to the concept of 'grouping' and 'chemical category' used 
at OECD and EU level. The document indeed specifies that the term 'classification' is 
not intended to be similar to its use in other regulatory/policy documents in Canada, 
the US or internationally (RCC 2013).  
Since a clear and unique definition of the term 'class of substances' at international 
and/or European level could not be found, in NANoREG both terms 'class of 
substances' and 'classification' are used in line with UN/EU documents and practices 
(UN 2003, EP and EC 2008). 
CONTROL BANDING 
(CB) 
ISO defines Control Banding (CB) as a pragmatic approach that can be used for the 
control of workplace exposure to possibly hazardous agents with unknown or 
uncertain toxicological properties and for which quantitative exposure estimations are 
lacking (ISO 2014). It may complement the traditional quantitative methods based on 
air sampling and analysis with reference to Occupational Exposure Levels (OELs) 
when they exist (ISO 2014).  
CB is a risk assessment approach in a context of uncertainty using the generally 
accepted risk paradigm, where risk is a function of severity of impact (hazard) and 
the anticipated probability of that impact (exposure) (Brouwer 2012). It is a 
qualitative approach where both hazard and exposure are graded into two to five 
different levels, usually referred to as 'bands'. It is based on expert judgment and 
combined, most often in a matrix, resulting into control or risk bands (Brouwer 2012). 
A range of control techniques (e.g. general ventilation, containment) is associated to 
each control or risk band. 
CB has frequently been used in risk management guidance for particles and chemicals 
(ISO 2012) and its possible application to nanomaterials has been recently debated 
(Brouwer 2012). 
DATA GAP OECD defines a 'data gap' as a physical-chemical, environmental fate, 
ecotoxicological, or mammalian toxicological/human health endpoint for which data is 
not available when required for an assessment (OECD 2014a).  
A data gap can be related to either a regulatory requirement that is not fulfilled (and 
may be fulfilled via animal testing or alternative test methods) or a need for some 
specific information that is deemed crucial for a certain type of assessment. 
DATA GAP FILLING OECD defines 'data gap filling' as the process of providing data to inform upon a 
particular endpoint by whatever means is scientifically justified, including direct 
animal testing and alternative test methods (OECD 2014a). 
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KEY TERM NANoREG DEFINITION 
ENDPOINT OECD defines an ‘endpoint’ as a broad description of a specific environmental or 
toxicological property of a chemical, e.g. acute oral toxicity or water solubility, which 
can be assessed though any type of test method (OECD 2005; 2014a). 
EXPOSURE 
SCENARIO (ES) 
In risk assessment, an ‘exposure scenario’ can be defined as a set of facts, 
assumptions and inferences that describe how exposure to a chemical may occur 
under certain conditions (US EPA 1992, OECD 2003, IPSC 2004). According to US EPA 
(1992), these conditions include: 
− The physical setting where exposure takes place (exposure setting);  
− The exposure pathway(s) from source(s) to exposed individual(s) (exposure 
pathways); 
− The characterization of the chemical, i.e., amounts, locations, time variation of 
concentrations, source strength, environmental pathways from source to 
exposed individuals, fate of the chemical in the environment, etc. 
(characterization of the chemical); 
− Identification of the individual(s) or population(s) exposed, and the profile of 
contact with the chemical based on behaviour, location as a function of time, 
characteristics of the individuals, etc. (characterization of the exposed 
population); and 
− If the dose is to be estimated, assumptions about the transfer of the chemical 
across the boundary, i.e., ingestion rates, respiration rates, absorption rates, 
etc. (intake and uptake rates). 
In risk assessment, the exposure scenario is the basis for quantification and 
evaluation of exposure levels of an individual (for human health) or population (for 
the environment) to a chemical (OECD 2003, IPSC 2004). 
Under REACH, an ‘exposure scenario’ not only characterises the set of conditions that 
describes how the substance is manufactured or used during its life cycle and how 
exposures of humans and the environment may occur, but also those actions by 
which the manufacturer or importer controls – or recommends downstream users to 
control – exposures (EP and EC 2006). Thus, an 'exposure scenario' under REACH 
specifies those operational conditions and risk management measures that need to be 
implemented to ensure that the use of the substance is safe (ECHA 2011b). 
EXTRAPOLATION OECD defines ‘extrapolation’ as the estimation of a value for a member of a chemical 
category that is near or at the boundary of the chemical category using measured 
values from members that are internal to that chemical category (OECD 2014a). 
In general, confidence in the prediction is enhanced when available experimental data 
from members of the chemical category allows for interpolation rather than 
extrapolation, as extrapolation is perceived to be more uncertain and therefore less 
reliable (OECD 2014a) (see 'interpolation'). 
FRAMEWORK A set of elements (e.g. ideas, best practices, regulatory provisions) organised in a 
conceptual manner, which constitute a frame of reference for a certain topic or issue. 
GROUPING OECD (2014a) defines 'grouping' as the general approach for considering more than 
one chemical at the same time.  
The rationale underpinning grouping may be based on the following: 
− Common functional group(s); 
− Common constituents or chemical classes, similar carbon range numbers; 
− A common mode or mechanism of action or adverse outcome pathway; 
− The likelihood of common precursors and/or breakdown products via physical or 
biological processes that result in structurally similar chemicals; 
− An incremental and constant change across the category. 
According to OECD, grouping may include formation of a 'chemical category' or 
identification of (a) 'chemical analogue(s)' (OECD 2014a). The terms 'category 
approach' and 'analogue approach' are therefore used to describe techniques for 
grouping of chemicals, whilst the term 'read-across' is reserved for a technique of 
data gaps filling in either approach.  
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KEY TERM NANoREG DEFINITION 
 The OECD terminology is reflected in guidance for the implementation of REACH by 
ECHA (2008a) and industry (ECETOC 2012). Structural similarity is a prerequisite for 
any grouping approach under REACH (EC 2009, ECHA 2015a).  
In the US and Canada, the term 'categorization' is more often used to indicate the 
organisation of chemicals into 'groups' or 'categories' based on structural similarities 
for regulatory purposes (Godwin et al 2015).  
As far as nanomaterials are concerned, OECD states that it is premature to develop 
guidance on grouping for nanomaterials, as research first needs to pave the way for it 
(OECD 2014a), and has not developed any recommendation on how the grouping and 
read-across concepts and approaches previously developed for chemicals need to be 
adapted to take NMs' specificities into account. At European level, ECHA has not 
developed yet any official guidance on how to implement grouping and read-across 
for nanomaterials in the context of REACH. Until now, the existing guidance (ECHA 
2008a) has been considered in principle applicable to nanomaterials. However, the 
ECHA Group Assessing Already Registered Nanomaterials (GAARN) has clarified that 
the use of grouping and read-across in REACH registration dossiers is supported for 
nanomaterials and should be performed in line with the similarity rules specified in 
Annex XI to REACH (ECHA 2013a). However, while read-across commonly involves 
substances with different chemical composition but structural similarity, read-across 
of nanomaterials largely involves different nanoscale materials of the same chemical 
composition, i.e. different nanoforms of a certain substance addressed within the 
same REACH registration dossier (ECHA 2013a) (see 'nanoform').  
Despite the lack of official guidance at international and European level, experts seem 
to agree that grouping and read-across of nanomaterials introduce additional 
challenges compared to traditional chemicals: similarity cannot be based on structural 
or chemical composition only, but needs to consider a wider spectrum of 
physicochemical properties determining identity and behaviour of nanomaterials 
including e.g. impurities, surface treatment, surface area, surface charge and shape 
(RIVM 2015; OECD 2014b; ECHA 2013a). Physicochemical characterisation is 
therefore a prerequisite of any grouping and read-across approach for nanomaterials 
(ECHA 2013a). Some experts underline that physicochemical properties are not 
sufficient for categorization of nanomaterials and that indicators of both hazard and 
exposure potential need to be included (Godwin et al 2015). Arts and colleagues 
suggest that all aspects of the nanomaterials' life cycle need to be considered in a 
grouping approach, i.e. physicochemical properties, biophysical interactions, intended 
use, external exposure, uptake and internal exposure, biokinetics and early biological 
and apical effects (Arts et al 2014). 
The RCC Nanotechnology Initiative has developed a Canada-US 'Joint Classification 
Scheme for nanomaterials', where the term 'classification' is used in place of 
'grouping' but with the same meaning (RCC 2013). The scheme has been developed 
for regulatory purposes and its rationale is based only on similarity of chemical 
composition. For each class, the scheme provides a list of physicochemical properties 
to be considered at a subsequent step for identification of analogues that could be 
used for read-across. 
HARMONISATION The term 'harmonisation' can be defined as the establishment of a common and 
coherent basis in a certain field/activity or for a certain scope.  
At OECD level, 'harmonisation' means establishing a common and coherent basis for 
chemical testing in safety assessment. OECD focuses on harmonisation of Test 
Guidelines for chemicals in order to ensure the generation of reliable and reproducible 
data, which can be shared among OECD countries under the Mutual Acceptance of 
Data (MAD) agreement. 
At UN level, 'harmonisation' means establishing a common and coherent basis for 
chemical hazard classification and communication (UN 2003). 
INFORMATION 
REQUIREMENT 
The term 'information requirement' can be defined as the entry in a legal text 
requiring information on e.g. physicochemical properties, (eco)toxicological effects, 
fate and behaviour of a chemical (Danish EPA 2013). 
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KEY TERM NANoREG DEFINITION 
INTERPOLATION OECD defines 'interpolation' as the estimation of a value for a member of a chemical 
category using measured values from members that are on both sides of that 
member within the spectrum of that chemical category (OECD 2014a). 
In general confidence in the prediction is enhanced when available experimental data 
from members of the chemical category allows for interpolation rather than 
extrapolation, as extrapolation is perceived to be more uncertain and therefore less 
reliable (OECD 2014a) (see 'extrapolation'). 
Annex XI to REACH explicitly requires interpolation (EC 2009). 
LIFE CYCLE ISO defines the 'life cycle' of a product system as the consecutive and interlinked 
stages of a product system, from raw material acquisition or generation from natural 
resources to final disposal (i.e. cradle-to-grave) (ISO 2006). 
Under EU REACH Regulation (EP and EC 2006) the safe use of a substance during the 
whole life cycle needs to be ensured. ECHA identifies different stages during the life 
cycle of a substance, including manufacture, formulation, use by industrial workers, 
professional workers and consumers and end-use or service life (ECHA 2010a; ECHA 
2011b). 
LIFE CYCLE 
ASSESSMENT (LCA) 
ISO defines Life Cycle Assessment (LCA) as the compilation and evaluation of the 
inputs, outputs and the potential environmental impacts (e.g. use of resources and 
the environmental consequences of releases) of a product system throughout its life 
cycle, from raw material acquisition through production, use, end-of-life treatment, 
recycling and final disposal (i.e. cradle-to-grave) (ISO 2006). 
LCA is therefore a comprehensive tool for environmental sustainability assessment 
that evaluates the overall impacts of a product system on human health and natural 
resources (Som et al 2010). 
With regard to nanomaterials, LCA can be used for comparing a product that includes 
nanomaterials with similar products without nanomaterials and, thus, to assess the 
relative environmental performance of products containing nanomaterials in 
comparison with their conventional equivalents (Som et al 2010). 
MODE OF ACTION OECD defines ‘mode of action’ as the functional or anatomical change at cellular level 
resulting from the exposure of a living organism to a chemical (OECD 2014a). In 
comparison, ‘mechanism of action’ is defined as the change at molecular level (OECD 
2014a). 
NANOFORM For the term 'nanoform', there is no internationally agreed definition. At European 
level, the term is not officially defined. However, in the context of REACH (EP and EC 
2006), the term appears in several documents (EC 2008a; JRC and ECHA 2012) and 
refers to a form of a substance that meets the criteria of the EC Recommendation for 
the definition of a nanomaterial 2011/696/EU (EC 2011), here subsequently referred 
to as the EC Definition, as opposed to a 'bulk form' or 'non-nanoform' of the same 
substance, i.e. a form of the same substance not meeting the criteria of the EC 
Definition. 
(QUANTITATIVE) 
STRUCTURE-
ACTIVITY 
RELATIONSHIP 
((Q)SAR) 
OECD defines a Structure-Activity Relationship (SAR) as a qualitative relationship that 
relates a chemical (sub)structure to the presence or absence of a property or activity 
of interest (OECD 2014a). The chemical substructure may consist of adjacently 
bonded atoms, or an arrangement of non-bonded atoms that are collectively 
associated with the property or activity (OECD 2014a). 
A Quantitative Structure-Activity Relationship (QSAR) is a mathematical model (often 
a statistical correlation) relating one or more quantitative parameters derived from 
chemical structure to a quantitative measure of a property or activity (e.g. a 
(eco)toxicological endpoint) (OECD 2014a). QSARs are quantitative models yielding a 
continuous or categorical result (OECD 2014a). 
(Q)SAR is an expression used to consider, simultaneously, SARs and QSARs (OECD 
2005). 
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KEY TERM NANoREG DEFINITION 
(Q)SAR MODEL 
VALIDATION 
The conventional use of the terms 'reliability' and 'relevance' for test methods can be 
extended to the validation process for (Q)SAR models (see 'Test method validation' 
and 'Validation'). However, because (Q)SAR models are derived from experimental 
data, the concepts of reliability and relevance for test guideline purposes are 
necessary but not necessarily sufficient for validation of (Q)SAR models and need to 
be expanded (OECD 2007). 
OECD (2007) specifies that for a (Q)SAR model to be accepted for regulatory 
purposes, it should be associated with the following information: 
− A defined endpoint; 
− An unambiguous algorithm; 
− A defined domain of applicability; 
− Appropriate measures of goodness-of-fit, robustness and predictivity; 
− A mechanistic interpretation, if possible. 
'Goodness-of-fit' and 'robustness' indicate the internal performance of a (Q)SAR 
model, determined by using a training set (OECD 2007). 
The 'predictivity' of a (Q)SAR model is determined by using an appropriate test set 
(OECD 2007). 
A 'validated' (Q)SAR is a model considered to be reliable for a particular purpose 
based on the results of the validation process in which the domain of application and 
the level of uncertainty required is defined (OECD 2007). 
A 'valid' (Q)SAR is a model considered to be adequate for the intended purpose 
because either reliability has been demonstrated by historical use, or by a validation 
process (OECD 2007). 
READ-ACROSS OECD defines 'read-across' as a technique to fill in data gaps where the test 
information concerning a certain endpoint for one chemical, referred to as source 
chemical, is used to predicted the test information concerning the same endpoint for 
another chemical, referred to as target chemical, which is considered to be similar 
based on a scientific justification (OECD 2014a). 
Theoretically, read-across can be applied to retrieve test information concerning any 
type of endpoint i.e. physicochemical properties, environmental fate, human health 
effects, and ecotoxicity (OECD 2014a). For any of them, read-across can be 
performed in a qualitative or quantitative manner (OECD 2014a). The aim of any 
read-across approach is to provide a prediction that is (more or less) equivalent to 
the omitted standard animal study and hence be acceptable for regulatory purposes 
(Schultz et al 2015). 
Read-across is mentioned in Annex XI to REACH as one of the rules for adaptation of 
the standard testing regime (EC 2009). The OECD terminology is reflected in ECHA 
guidance for the implementation of REACH (ECHA 2008a) and in guidance by industry 
(ECETOC 2012). 
As far as nanomaterials are concerned, OECD states that it is premature to develop 
guidance on grouping and read-across for nanomaterials, as research first needs to 
pave the way for it (OECD 2014a), and has not developed yet any recommendation 
on how the grouping and read-across concepts and approaches previously developed 
for chemicals need to be adapted to take MNs' specificities into account. At European 
level, ECHA has not developed any official guidance on how to implement grouping 
and read-across approaches for nanomaterials in the context of REACH. Until now, the 
existing guidance (ECHA 2008a) and the Read-Across Assessment Framework (RAAF) 
(ECHA 2015a) have been considered in principle applicable to nanomaterials. 
However, the ECHA Group Assessing Already Registered Nanomaterials (GAARN) has 
clarified that the use of data from grouping and read-across in REACH registration 
dossiers is supported for nanomaterials and should be performed in line with the 
similarity rules specified in Annex XI to REACH (ECHA 2013a). ECHA GAARN has also 
clarified that while read-across commonly involves substances with different chemical 
composition but of structural similarity, read-across of nanomaterials largely involves 
different nanoscale materials of the same chemical composition, i.e. different 
nanoforms of a certain substance addressed in the same REACH registration dossier 
(ECHA 2013a) (see 'nanoform'). 
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KEY TERM NANoREG DEFINITION 
 Despite the lack of official guidance at international and European level, experts seem 
to agree that grouping and read-across of nanomaterials introduce additional 
challenges, compared to traditional chemicals: similarity cannot be based on 
structural or chemical composition only, but a wider spectrum of physicochemical 
properties determining identity and behaviour of nanomaterials, including e.g. 
impurities, surface treatment, surface area, surface charge and shape (RIVM 2015; 
OECD 2014a; ECHA 2013a) needs to be considered. Physicochemical characterisation 
is therefore a prerequisite of any grouping and read-across approach for 
nanomaterials (ECHA 2013a). 
READ-ACROSS 
ASSESSMENT 
FRAMEWORK 
(RAAF) 
The Read-Across Assessment Framework (RAAF) is a structured tool developed by 
ECHA to facilitate the assessment of read-across cases in REACH registration dossiers 
by ECHA evaluators (ECHA 2012c). The RAAF provides a framework and guidance for 
consistent evaluation of the scientific aspects of a proposed read-across case, 
resulting in an output which is suitable for subsequent regulatory consideration of the 
read-across case (ECHA 2015a). It is thus not meant to serve as guidance for 
registrants (ECHA 2012c). 
REGULATORY 
ACCEPTANCE 
The 'regulatory acceptance' of a test method is its formal acceptance by regulatory 
authorities indicating that the test method may be used to provide information to 
meet a specific regulatory requirement (OECD 2005). This includes, but is not limited 
to, a formal adoption of a test method by EU and/or OECD and included in the EU 
Test Methods Regulation (EC 2008b) and/or as an OECD Test Guideline, respectively 
(EURL ECVAM 2015).  
In general, regulatory acceptance depends upon the outcome of the validation 
process. The process has generally been on a case-by-case basis. Regulatory 
authorities have the option to accept results generated using a test method that has 
not undergone what today would be considered formal validation (e.g., methods used 
in mechanistic studies that could help underpin or explain results derived from other 
tests). However, the regulatory acceptance of tests that have not been subjected to 
prevailing validation processes is discouraged. In cases in which validation is not 
considered necessary or appropriate, a written justification should be available (OECD 
2005). 
SAFE-BY-DESIGN The 'safe by design' concept aims at reducing potential health and environmental 
risks at an early phase of the innovation process. Such concept aims at creating an 
integrated research strategy. This enables the consideration of safety aspects for 
humans and the environment in the design process of a product/material, to eliminate 
or minimise the risk of adverse effects during its life cycle including construction, use, 
maintenance and deconstruction. 
Within the safe-by-design concept the functionality of a nanomaterial and its 
toxicity/safety are therefore considered in an integrated way. Such an approach 
maximises resources use and expedites the development of products containing 
nanomaterials and new nanomaterials that are safer by design. 
STANDARDISATION ISO defines 'standardisation' as the activity of establishing provisions for common and 
repeated use of a certain tool aimed at achievement of the optimum degree of order 
in a given context (ISO 2015a). 
An ISO/CEN 'standard' is a document that provides requirements, specifications, 
guidelines or characteristics that can be used consistently to ensure that materials, 
products, processes and services are fit for their purpose (ISO 2015b; CEN 2015). 
STANDARD 
OPERATING 
PROCEDURE (SOP) 
OECD defines a Standard Operating Procedure (SOP) for a laboratory as a formal, 
written procedure that describes in detail how to perform specific routine and test-
specific laboratory operations (e.g. a specific measurement or sampling operation) 
(OECD 2005). The purpose of a SOP is to carry out the operations correctly and 
always in the same manner (FAO 1998).  
A SOP should be available at the place where the work is done (FAO 1998). 
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KEY TERM NANoREG DEFINITION 
 A SOP is a compulsory instruction; if deviations from this instruction are allowed, then 
the conditions for these deviations should be documented (including who can give 
permission and what exactly the complete procedure will be) (FAO 1998). 
SOPs are required by Good Laboratory Practice (OECD 2005). 
SUBSTANCE At EU level, the term 'substance' is defined as a chemical element and its compounds 
in the natural state or obtained by any manufacturing process, including any additive 
necessary to preserve its stability and any impurity deriving from the process used, 
but excluding any solvent which may be separated without affecting the stability of 
the substance or changing its composition (EP and EC 2006; EP and EC 2008). The 
same definition is included in the Globally Harmonised System (UN 2003). 
TEST METHOD OECD defines a 'test method' as an experimental system that can be used to obtain a 
range of information about a certain chemical, from intrinsic properties to adverse 
effects in a living organism or population (OECD 2005). The term 'test method' may 
be used interchangeably with 'assay' for both ecotoxicity and human health studies 
(OECD 2005).  
OECD defines 'testing' as applying a test method (OECD 2005). 
TEST METHOD 
VALIDATION 
OECD defines 'test method validation' as a process based on scientifically sound 
principles by which the reliability and relevance of a particular test method are 
established for a specific purpose (OECD 2005).  
The 'reliability' of a test method is defined as the extent of reproducibility of results 
from a test method within and among laboratories over time, when performed using 
the same standardised protocol (OECD 2005).  
The 'relevance' of a test method describes the relationship between the test and the 
effect in the target species and whether the test method is meaningful and useful for 
a defined purpose, with the limitations identified (OECD 2005). Regulatory need, 
usefulness and limitations of the test method are aspects of its relevance (OECD 
2005). 
New and updated test methods need to be both reliable and relevant i.e. validated 
(OECD 2005). 
TIERED TESTING 
STRATEGY 
OECD defines a 'tiered testing strategy' as a stepwise testing strategy where all 
existing information on a test substance is reviewed, in a specified order, using a 
weight of evidence process at each tier to determine if sufficient information is 
available for a hazard classification decision, prior to progression to the next tier 
(OECD 2013b). A tiered approach usually progresses from a review of existing 
literature and data to a review of data for related chemicals or formulations, to 
perhaps a (Q)SAR analysis, to simple in vitro screening assays, to the use of more 
complex in vitro three-dimensional models, to testing in lower species, to the 
traditional animal test (Ferrario et al 2014). 
TOOL  A 'tool' is an experimental or computerised procedure used to generate, collect and/or 
store a certain type of output. 
TREND ANALYSIS OECD defines 'trend analysis' as a data gap filling method for quantitative endpoints. 
Trend analysis can be applied to fill data gaps in a chemical category when the 
members are related by a trend such that the properties of the category members 
change in a predictable manner and there is a pattern in the changing potency of the 
properties across the category (e.g. increasing, decreasing, or constant) (OECD 
2014a). 
VALIDATION At international level, the term 'validation' is defined as a process by which the 
reliability and relevance of a particular approach, method, procedure, or assessment 
is established for a defined purpose (IPSC 2004; OECD 2005).  
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KEY TERM NANoREG DEFINITION 
 Different parties define ‘reliability’ as establishing the reproducibility of the outcome of 
the approach, method, procedure, or assessment over time, and ‘relevance’ as 
establishing the meaningfulness and usefulness of the approach, method, procedure, 
or assessment for the defined purpose (IPSC 2004). 
A 'validated method' is therefore a test method for which the reliability and relevance 
for a specific purpose have been established in one or more validation studies (NIEHS 
1997). 
A 'valid method' is a test method determined to be acceptable for a specific use and 
application (NIEHS 1997). 
VALUE CHAIN The 'value chain' describes the full range of activities which are required to bring a 
product or service from conception, through the different phases of production 
(involving a combination of physical transformation and the input of various producer 
services), delivery to final consumers and final disposal after use (Kaplinsky and 
Morris 2001). 
While the 'life cycle' is a series of ordered phases through which an object and its 
different forms passes, the 'value chain' begins with an intellectual process and 
focuses on the activities to bring that object from conception to use and disposal 
(including e.g. design, production, marketing, distribution).  
Within NANoREG, 'safety value chain case studies' for some nanomaterials are 
performed. These case studies add value to the normal linear process of describing 
the fate of a material/product and how its value increases or decreases along the 
value chain by integrating aspects related to safety and performing risk assessment 
when appropriate. 
WAIVING See 'adaptation'. 
WEIGHT OF 
EVIDENCE (WoE) 
The term 'weight of evidence' is not a scientifically well-defined term or an agreed 
formalised concept (ECHA 2011c). 
In the context of hazard assessment, several international and European bodies 
define 'weight of evidence' as the process of considering the strengths and 
weaknesses of various pieces of information in reaching and supporting a conclusion 
concerning the hazard potential of a substance (ECHA 2010b, SCENHIR 2012, OECD 
2012a, OECD 2013b, Ferrario et al 2014). In this process, relevance and reliability of 
each piece of available information is assessed and weighed using expert judgment 
(ECHA 2011c). All pieces of information and related weights are then compared to 
each other and integrated to draw a conclusion (ECHA 2011d). 
 
4. Literature definitions collected for the key terms 
In this section, the original definitions that have been collected from the literature and 
used to develop the NANoREG Definitions are reported and discussed. Each key term is 
addressed by a dedicated sub-section where a table summarises the literature definitions 
that have been considered, in chronological order and starting from the most recent one. 
Moreover, the text briefly discusses the sources and types of definitions that are 
available, what has been or not been taken into account for the NANoREG Definition 
elaboration and gives the reasons for these choices. As far as possible, the NANoREG 
Definition is reproducing (an) already existing definition text(s), thus avoiding the 
creation of new and unwelcome information. 
 
4.1 Adaptation  
Table 4.1 shows the original definitions of the term 'adaptation', which have been 
collected from the literature and used to develop the NANoREG Definition. The term 
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'adaptation' is mainly used in REACH legal text (EP and EC 2006) and in principle applies 
to all substances including NMs. Definitions could only be found in ECHA official guidance 
documents for implementation of REACH (ECHA 2010c, 2011a). Accordingly, the 
harmonised definition adopted in NANoREG reflects the definitions provided by ECHA. 
 
Table 4.1 Literature definitions collected for the key term 'adaptation' and considered 
to develop the NANoREG Definition. 
Source Original definition of the term 'adaptation' 
EU BODIES 
ECHA 2011a 
Adaptations to 
information 
requirements 
The terminology ‘adaptation’ comprises all types of modifications of the standard 
information requirements, including omissions, triggering, replacement or other 
adaptations. 
The term ‘omission’ (=waiving) is used when on the basis of specific rules in Annex XI, 
section 3, or the sections in column 2 of Annex VII-X testing may be omitted. 
Contrary to adaptation, additional testing can be triggered if the chemical safety 
assessment indicates the need to investigate further the effects on humans or the 
environment […] 
ECHA 2010c 
How to report 
data waiving 
[…] the adaptation of the standard information requirements means the use of non-
standard methods for fulfilling the information requirements. This includes the adaptation 
options outlined in Annex XI sections 1.1-1.5: the use of existing data, including historical 
human data, the use of a Weight of Evidence (WoE) approach, information generated 
using Quantitative Structure Activity Relationships (QSAR), in vitro tests methods, and 
grouping of substances and read-across. These adaptation options can be used either 
individually or combined together (e.g. use of (Q)SAR and information from read-across). 
In all cases the data used must be adequate, reliable and relevant for the particular 
endpoint(s), and must follow the criteria set out in Annex XI for each method of 
adaptation. 
EP and EC 2006; 
EC 2009  
REACH Annex XI 
[…] a registrant may adapt the standard testing regime in accordance with the general 
rules set out in Section 1 of this Annex. […] 
1. TESTING DOES NOT APPEAR SCIENTIFICALLY NECESSARY 
2. TESTING IS TECHNICALLY NOT POSSIBLE 
3. SUBSTANCE-TAILORED EXPOSURE-DRIVEN TESTING 
 
4.2 Adaptation based on exposure 
Table 4.2 shows the original definitions of the term 'adaptation based on exposure', 
which have been collected from the literature and used to develop the NANoREG 
Definition. The term 'adaptation based on exposure' is mainly used in REACH legal text 
(EP and EC 2006) and in principle applies to all substances including NMs. Definitions 
could only be found in ECHA official guidance documents for implementation of REACH 
(ECHA 2011a). Accordingly, the harmonised definition adopted in NANoREG reflects the 
definitions provided by ECHA. The NANoREG Definition also includes those considerations 
made by ECHA Group Assessing Already Registered Nanomaterials (GAARN) with regard 
to the application of this concept to NMs (ECHA 2012a; 2014a). 
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Table 4.2 Literature definitions collected for the key term 'adaptation based on 
exposure' and considered to develop the NANoREG Definition. 
Source Original definition of the term 'adaptation based on exposure' 
EU BODIES 
ECHA 2014a 
Third GAARN 
meeting 
Best practice for 
REACH 
registrants 
[…] they have to provide analytical and/or experimental data to demonstrate and support 
their "no release" statement. 
ECHA 2012a 
First GAARN 
meeting 
Best practice for 
REACH 
registrants 
If registrants are able to show (by measurement and documentation) that particles form 
strong aggregates that will not leach out nanoparticles during the lifecycle of the 
substance, then this may be an exposure-based argument that no further testing (beyond 
size) is necessary. 
ECHA 2011a 
Adaptations to 
information 
requirements 
REACH provides for the option that information requirements may be adapted based on 
the justification 
− that exposure is absent or not significant (Annex XI, section 3.2(a) (i); Annex VIII 
column 2 section 8.6.1 and 8.7.1) or unlikely (Annex IX column 2 section 9.4) or, 
− that strictly controlled conditions (Annex XI section 3.2 (b)) apply for the whole life 
cycle1 of the substance (including the waste stage), 
− and for substances incorporated into an article that the substance is not released 
during the whole life cycle and that the likelihood of exposure of man or the 
environment is negligible (Annex XI section 3.2 (c ) (i) and 3.2 (c ) (ii)). 
These provisions were included to avoid unnecessary animal testing. Based on adequate 
information on exposure, release and fulfilment of strictly controlled conditions, a decision 
can be taken whether it is possible to omit certain testing, or if further testing should be 
proposed, or if more stringent risk management measures (RMMs)/operational conditions 
(OCs) need to be introduced. Exposure based adaptation (EBA) in this context is defined 
as a deviation from the standard information requirement at the actual tonnage level 
based on exposure arguments. 
Exposure based adaptations may be appropriate under the following conditions: 
− exposure is absent (= exposure excluded) or not significant throughout the whole life 
cycle of the substance for manufacture and all identified uses or 
− when strictly controlled conditions apply throughout the life cycle of the substance for 
manufacture and all uses and 
− no releases from the article life cycle stage (and subsequent waste life stage) is to be 
expected and consequently there is a negligible likelihood of exposure. Situation iii) 
only applies to substances incorporated into articles. 
Annex XI section 3.2 (a) requires that the absence or insignificance of exposure is 
underpinned by the derivation of a risk characterisation ratio (quantitative assessment). 
If the justification is based on Annex XI section 3.2 (b) or (c) a qualitative assessment is 
expected to include three elements: the description of operational conditions and risk 
management measures in all related exposure scenarios; the quantification of the 
resulting release/exposure for all routes; and a qualitative statement why the release is 
low enough. 
[…] a high level of confidence is needed to demonstrate no or no significant exposure or 
no release. 
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Table 4.2 (cont.) 
Source Original definition of the term 'adaptation based on exposure' 
EP and EC 2006; 
EC 2009  
REACH Annex XI 
Testing in accordance with Sections 8.6 and 8.7 of Annex VIII and in accordance with 
Annex IX and Annex X may be omitted, based on the exposure scenario(s) developed in 
the Chemical Safety Report.  
[…] The justification shall be based on a through and rigorous exposure assessment in 
accordance with section 5 of Annex I and shall meet one of the following criteria: 
(a) […]  
(i). the results of the exposure assessment covering all relevant exposures 
throughout the life cycle of the substance demonstrate the absence of or no 
significant exposure in all scenarios of the manufacture and all identified uses as 
referred to in Annex VI section 3.5; 
(ii). a DNEL or a PNEC can be derived from results of available test data for the 
substance concerned taking full account of the increased uncertainty resulting 
from the omission of the information requirement, and that DNEL or PNEC is 
relevant and appropriate both to the information requirement to be omitted and 
for risk assessment purposes (*); 
(iii). the comparison of the derived DNEL or PNEC with the results of the exposure 
assessment shows that exposures are always well below the derived DNEL or 
PNEC; 
(b) where the substance is not incorporated in an article the manufacturer or importer 
demonstrates and documents for all relevant scenarios that throughout the life cycle 
strictly controlled conditions as set out in Article 18(4)(a) to (f) apply; 
(c) where the substance is incorporated in an article in which it is permanently embedded 
in a matrix or otherwise rigorously contained by technical means, it is demonstrated 
and documented that all of the following conditions are fulfilled: 
(i). the substance is not released during its life cycle; 
(ii). the likelihood that workers or the general public or the environment are exposed 
to the substance under normal or reasonably foreseeable conditions of use is 
negligible; and 
(iii). the substance is handled according to the conditions set out in Article 18(4)(a) to 
(f) during all manufacturing and production stages including the waste 
management of the substance during these stages. 
 
4.3 Adverse Outcome Pathway (AOP) 
Table 4.3 shows the original definitions of the term 'Adverse Outcome Pathway (AOP)', 
which have been collected and used to develop the NANoREG Definition. Definitions 
could be found in documents from international organisations such as OECD (2011, 
2013a, 2014a) and peer-reviewed scientific literature (Ankley et al 2010, Schultz 2010, 
Watanabe et al 2011, Villeneuve and Garcia-Reyero 2011). The definitions that are 
reported in OECD official guidance documents are given higher priority as they have 
regulatory relevance and are the result of a broad consultation at international level. 
Accordingly, the harmonised definition adopted in NANoREG reflects the definitions 
provided by OECD. 
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Table 4.3 Literature definitions collected for the key term 'Adverse Outcome Pathway 
(AOP)' and considered to develop the NANoREG Definition. 
Source Original definition of the term 'Adverse Outcome Pathway (AOP)' 
INTERNATIONAL BODIES 
OECD 2014a 
Guidance on 
grouping of 
chemicals 
[…] the documented, plausible, and testable processes by which a chemical induces 
molecular and the associated biological responses that describe how the molecular 
perturbations cause effects at the subcellular, cellular, tissue, organ, whole animal, and 
population levels of observation. The pathway approach is based on the concept that 
toxicity results from a chemical first reaching and then interacting with an initial key target 
(e.g., membrane, receptor) in the organism; this is defined as the primary molecular 
initiating event. Subsequent to this primary interaction begins a series of events that can 
individually be documented and tested, resulting in an adverse outcome (e.g., reproductive 
failure, neurotoxicity). 
[…] several pathways can result in the same adverse outcome, and each constitutes an 
individual AOP. 
OECD 2013a 
Developing and 
assessing AOPs 
An AOP can be defined in the context of Figure 1. An AOP is a sequence of events from the 
exposure of an individual or population to a chemical substance through a final adverse 
(toxic) effect at the individual level (for human health) or population level (for 
ecotoxicological endpoints). The key events in an AOP should be definable and make sense 
from a physiological and biochemical perspective. AOPs incorporate the toxicity pathway 
and mode of action for an adverse effect. AOPs may be related to other mechanisms and 
pathways as well as to detoxification routes. 
[…] an AOP may describe a pathway initiated via non-specific interactions (e.g. a toxicant 
physically residing in a bio-membrane), as well as more specific ligand-receptor 
interactions leading to adverse effects. Although developed for use in ecotoxicology, the 
AOP concept is also applicable to human health effects (Schultz, 2010). In an AOP, it is 
important to integrate all of the known information. The approach is based on the concept 
that toxicity results from the chemical first reaching and then interacting with an initial 
target or targets in the organism. As such, an AOP is the sequential progression of events 
from the molecular initiating event (MIE) to the in vivo outcome of interest (Fig. 1). 
Generally, it refers to a broader set of pathways that would: 1) proceed from the MIEs, in 
which a chemical interacts with a biological target (e.g. DNA binding, protein oxidation 
etc.), 2) continue on through a sequential series of biological activities (e.g. gene 
activation, or altered tissue development etc.), and 3) ultimately culminate in the final 
adverse effect relevance to human or ecological risk assessors (e.g. mortality, disrupted 
reproduction, cancer, or extinction, etc.) (OECD 2011) […] 
OECD 2012b 
Collection of 
working 
definitions 
[…] it relates to a linear sequence of events from the exposure of an individual to a 
chemical substance through to an understanding of the adverse (toxic) effect at the 
individual level (for human health) or population level (for ecotoxicological endpoints). The 
key events in an AOP should be definable and make sense from a physiological and 
biochemical perspective. AOPs incorporate the toxicity pathway and mode of action. AOPs 
may be related to other mechanisms and pathways as well as detoxification routes. 
OECD 2011 
Mechanistic 
information in 
forming 
chemical 
categories 
[…] existing knowledge concerning the linkage between at the molecular initiating event 
and an adverse outcome at the individual or population levels (Ankley, Bennett et al. 
2009). As such, AOPs by definition span multiple levels of biological organization. AOPs 
often start out being depicted as linear processes, however, the amount of detail and 
linearity characterizing the pathway between a molecular initiating event and an adverse 
outcome within an AOP can vary substantially, both as a function of existing knowledge and 
risk assessment needs. 
[…] Linking molecular initiating events to the in vivo outcomes […] 
Qualitative means of establishing causal linkages. 
Conceptual framework for organising information at different levels of biological 
organisations, characterising the weight of evidence. 
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Table 4.3 (cont.) 
Source Original definition of the term 'Adverse Outcome Pathway (AOP)' 
PEER-REVIEWED SCIENTIFIC LITERATURE 
Villeneuve and 
Garcia-Reyero 
2011 
Predictive 
ecotoxicology 
testing in the 
21st century 
A conceptual framework that links a molecular-level initiating event with adverse effects 
relevant for risk assessment. 
Watanabe et al 
2011 
Defining and 
modelling known 
adverse 
outcome 
pathways 
The sequence of events between cellular response and adverse outcome on an individual 
organism or population of organisms is an AOP. 
Schultz 2010 
Adverse 
outcome 
pathways 
Each adverse outcome pathway is a set of chemical, biochemical, cellular, physiological, 
behavioural, etc. responses which characterise the biological effects cascade resulting from 
a particular MIE. The term "adverse outcome pathway" has been selected so not to cause 
confusion with the term "Toxicity Pathway", which is used by the US National Research 
Council in its document, Toxicity Testing in the Twenty-first Century: A Vision and a 
Strategy, where the focus is on omics and high throughput in vitro data (Schultz 2010). 
Ankley et al 
2010 
Adverse 
outcome 
pathways: a 
conceptual 
framework 
Representation of existing knowledge concerning the linkage between the molecular 
initiating event and an adverse outcome at the individual or population levels. 
 
4.4 Alternative test method 
Table 4.4 shows the original definitions of the term 'alternative test method', which have 
been collected from the literature and used to develop the NANoREG Definition. 
Definitions could be found in documents from international organisations such as OECD 
(2005; 2014a), in documents from European bodies including REACH legal text (EP and 
EC 2006), ECHA official guidance for implementation of REACH (ECHA 2008a, 2012d, 
2014b), in legal text of Directive on protection of animals used for scientific purposes (EP 
and EC 2010), and EURL ECVAM webpage (EURL ECVAM 2015), as well as in peer-
reviewed scientific literature (Raunio 2011). The definitions that are reported in OECD 
official guidance documents are given higher priority as they have regulatory relevance 
and are the result of a broad consultation at international level. Accordingly, the 
harmonised definition adopted in NANoREG reflects the definitions provided by OECD. 
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Table 4.4 Literature definitions collected for the key term 'alternative test method' and 
considered to develop the NANoREG Definition. 
Source Original definition of the term 'alternative test method' 
INTERNATIONAL BODIES 
OECD 2014a 
Guidance on 
grouping of 
chemicals 
[…] non-testing methods for filling data gaps: 
− Read-across; 
− Trend analysis and use of computational methods based on internal models; 
− Use of computational methods based on external models. 
In principle the above-listed non-testing techniques can be used to indicate either the 
presence or the absence of an effect or an estimated value (e.g., a relevant toxicity value 
such as a LOAEL) for an analogue or a group of substances. However, this is highly 
dependent on the substance under consideration, the endpoint, the level of information 
already available, the regulatory purpose, and the confidence that can be derived from its 
interpretation. 
OECD 2005 
Test methods for 
hazard 
assessment 
A test that: reduces the numbers of animals required; refines procedures to lessen or 
eliminate pain or distress to animals, or enhance animal well-being; or replaces animals 
with non-animal systems or with non-sentient species. 
EUROPEAN BODIES 
EURL ECVAM 
2015 
Glossary 
Alternative test methods  
The term "alternative" is generally associated with the Principles of the 3Rs, - Replacement, 
Reduction and Refinement - of animal testing. In this context an alternative method serves 
to fully replace an animal test, to reduce the number of animals needed in a test, or to 
refine an animal testing procedure in order to reduce pain and suffering. 
Alternative test methods that are developed to reduce or replace animal experiments are 
typically based on either in vitro systems or on computer-based models. 
In vitro test methods use (reconstructed) tissues, whole cells or parts of cells. Recent 
advances in cell-based research include the development of two-dimensional and three-
dimensional cell (co)-cultures which mimic very closely cells and tissues in the human 
body. 
The growing use of 'omics' technologies (e.g. transcriptomics, proteomics and 
metabonomics) in combination with in vitro test systems allows a comprehensive analysis 
of the impact of a chemical at the molecular level and can indicate potential toxicity 
pathways that may lead to adverse health effects. 
Computer-based approaches (often termed in silico or non-testing methods) are becoming 
increasingly powerful and can be used effectively to predict the toxicity of a chemical from 
its basic properties. Computer models are also an important tool for efficiently integrating 
toxicological information derived from complimentary in vitro and in silico methods. 
A non-testing approach frequently used in the safety assessment of industrial chemicals, 
for example, is called 'read-across' technique where toxicological effects for one chemical 
are predicted using data for the same toxicological effect from another chemical, which is 
considered to be similar in terms of chemical structural, physico-chemical properties, or 
bioactivity. 
ECHA 2014b 
Use of 
alternatives to 
testing on 
animals for 
REACH 
By contrast to animal test methods; in the context of REACH this mainly relates to the use 
of in vitro methods, (Q)SAR, grouping and read-across (Article 13(1)): “Information on 
intrinsic properties of substances may be generated by means other than tests, provided 
that the conditions set out in Annex XI are met. In particular for human toxicity, 
information shall be generated whenever possible by means other than vertebrate animal 
tests, through the use of alternative methods, for example, in vitro methods or qualitative 
or quantitative structure-activity relationship models or from information from structurally 
related substances (grouping or read-across).” Alternative test methods can also be in vivo 
tests, but which use fewer animals and/or causes less suffering. 
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Table 4.4 (cont.) 
Source Original definition of the term 'alternative test method' 
ECHA 2012d 
Non-testing 
methods under 
REACH 
[…] “non-test method” refers to any non-experimental method or approach that can be 
used to provide data for the assessment of chemicals. Data, produced by a non-test 
method, are called “non-test data”. Non-test methods include QSAR models and read-
across/grouping approaches and can be used to predict in a quantitative or a qualitative 
manner the physicochemical, biological, i.e. (eco)toxicological, and environmental fate 
properties of substances from knowledge of their chemical structure and other properties. 
Both QSARs and read-across/grouping approaches are based on the principle that the 
properties of substances, including their biological activities, depend on their chemical 
structure and hence can be predicted from it (similar substances have similar properties). 
ECHA 2008a 
QSARs and 
grouping of 
chemicals 
Non-testing data can be generated by three main approaches: a) grouping approaches, 
which include read-across and chemical category formation; (quantitative) structure-
activity relationships ((Q)SARs); and c) expert systems. The development and application 
of all kinds of non-testing methods is based on the similarity principle, i.e. hypothesis that 
similar compounds should have similar biological activities. 
[…] non-testing techniques for filling data gaps: 
− read-across, 
− trend analysis and use of computational methods based on internal models, 
− use of computational methods based on external models. 
EP and EC 2010 
Directive 
2010/63/EU 
Protection of 
animals used for 
scientific 
purposes 
The Commission and the Member States shall contribute to the development and validation 
of alternative approaches which could provide the same or higher levels of information as 
those obtained in procedures using animals, but which do not involve the use of animals or 
use fewer animals or which entail less painful procedures, and they shall take such other 
steps as they consider appropriate to encourage research in this field. 
EP and EC 2006 
REACH 
The Commission, Member States, industry and other stakeholders should continue to 
contribute to the promotion of alternative test methods on an international and national 
level including computer supported methodologies, in vitro methodologies, as appropriate, 
those based on toxicogenomics, and other relevant methodologies. 
PEER-REVIEWED SCIENTIFIC LITERATURE 
Raunio 2011 
In silico 
toxicology, non-
testing methods 
In more general terms, non-testing methods can be divided into two main classes, i.e., 
comprehensive (global) and specific (local) ones. Comprehensive methods, also called 
expert systems, mimic human reasoning and formalise existing knowledge. Expert systems 
have an advantage over QSAR methods in that prediction is related to specific 
mechanisms. Specific systems generally apply to a narrow range of targets, e.g., specific 
receptors or enzymes. 
Specific methods can be divided into ligand-based and target-based techniques. Ligand-
based modelling such as QSAR involves active ligands without considering the 3-
dimensional (3D) structure of the protein and the possible sites of interaction.  
Target-based methods calculate atomic interactions between ligands and their target 
macromolecules. They require 3D structures of both ligands and macromolecules and need 
more computational power. 
 
4.5 Analogue(s) 
Table 4.5 shows the original definitions of the term 'analogue(s)', which have been 
collected from the literature and used to develop the NANoREG Definition. Definitions 
could be found in documents from international organisations such as OECD (2014a) and 
ISO (2014), documents from European bodies such as ECHA official guidance for 
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implementation of REACH (ECHA 2008a, 2012c, 2013b, 2015a), documents from US 
bodies (US EPA 2014a), reports from industry associations (CEFIC-LRI 2012, ECETOC 
2012), and in peer-reviewed scientific literature (van Leeuwen et al 2007, 2009, 
Patlewicz et al 2014). The definitions that are reported in OECD official guidance 
documents are given higher priority as they have regulatory relevance and are the result 
of a broad consultation at international level. These definitions are reflected in ECHA 
official guidance documents for implementation of REACH and in reports by industry, and 
in principle apply to all chemicals including NMs. Accordingly, the harmonised definition 
adopted in NANoREG reflects the definitions provided by OECD. The NANoREG Definition 
also includes those considerations made by several organisations (OECD, ECHA GAARN, 
RIVM) and authors in the peer-reviewed scientific literature with regard to the 
application of this concept to NMs (ECHA 2013b, OECD 2014a, Arts et al 2014, Godwin 
et al 2015, RIVM 2015). 
 
Table 4.5 Literature definitions collected for the key term 'analogue(s)' and considered 
to develop the NANoREG Definition. 
Source Original definition of the term 'analogue(s)' 
INTERNATIONAL BODIES 
OECD 2014a 
Guidance on 
grouping of 
chemicals 
In the analogue approach where comparisons are made between a very limited number of 
chemicals, endpoint information for one chemical is used to predict the same endpoint for 
another chemical, which is considered to be “similar” in some way (usually on the basis of 
structural similarity and similar properties and/or activities). 
When the focus of the assessment is on filling data gaps for one specific chemical, empirical 
data from one or more similar chemical(s) (“the analogue(s)”) or “source” chemical can be 
used to predict the same endpoint for the “target” chemical, which is considered to be 
“similar”. This analogue approach is useful when the target and source chemicals share a 
known common mode (and/or mechanism) of action, and the adverse effects resulting from 
this mode (and/or mechanism) of action is evaluated. The analogue approach could also be 
used in the absence of effects or when no specific mode (and/or mechanism) of action is 
expected and toxicokinetic behaviour is not expected to differ significantly. In such case, 
more evidence, or more lines of evidence, should support the assessment. 
[…] comparisons are made between a very limited number of chemicals, endpoint 
information for one chemical is used to predict the same endpoint for another chemical, 
which is considered to be “similar” in some way (usually on the basis of structural similarity 
and similar properties and/or activities). 
An analogue is a chemical whose intrinsic physical-chemical, environmental or toxicological 
properties are likely to be similar to another chemical based upon a number of potential 
properties, including structural, physical-chemical and toxicological. 
[…] in addition to structural similarity and similar physical-chemical properties between the 
source chemical(s) and the target chemical, criteria such as common functional group, 
biochemical processes and mode (and/or mechanism) of action, or environmental fate 
come into play for judging the suitability of source chemical(s). 
In principle the above-listed non-testing techniques can be used to indicate either the 
presence or the absence of an effect or an estimated value (e.g., a relevant toxicity value 
such as a LOAEL) for an analogue or a group of substances. However, this is highly 
dependent on the substance under consideration, the endpoint, the level of information 
already available, the regulatory purpose, and the confidence that can be derived from its 
interpretation. 
NB. Figure 2 (p. 65) Stepwise approach to an analogue approach 
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Table 4.5 (cont.) 
Source Original definition of the term 'analogue(s)' 
INTERNATIONAL BODIES 
ISO 2014 
Use of the 
control banding 
approach 
analogous material 
material of the same chemical category, with a similar composition and/or crystalline phase 
and documented similar physicochemical properties (metal oxides, graphite, ceramics, etc.) 
EUROPEAN BODIES 
ECHA 2015a 
Read-Across 
Assessment 
Framework 
The term ‘analogue approach’ is used when read-across is employed between a small 
number of structurally similar substances; there is no trend or regular pattern on the 
properties. As a result of the structural similarity, a given toxicological property of one 
substance (the source) is used to predict the same property for another substance (the 
target) to fulfil a REACH information requirement. The outcome of a study conducted with 
the source substance is read-across for all investigated parameters to the target substance. 
A worst-case approach may also be used. In the context of the RAAF as describe in this 
document, the simplest case of an analogue approach is considered: read-across from a 
single source substance to a target substance. If an analogue approach uses more than 
one source or target substance, the assessment of the read-across approach has to be 
repeated for each source and/or target substance. 
ECHA 2013b 
Grouping of 
substances and 
read-across 
approach 
The term analogue approach is used when read-across is employed within a group of a 
very limited number of substances for which trends are not apparent: i.e. the simplest case 
is read-across from a single source substance to a target substance. 
ECHA 2012c 
An introduction 
to the 
assessment of 
read-across in 
ECHA 
[…] is concerned with read-across between two or among a few analogues. 
ECHA 2008a 
QSARs and 
grouping of 
chemicals 
The term analogue approach is used when the grouping is based on a very limited number 
of chemicals, where trends in properties are not apparent. 
The simplest example of the category approach is a comparison between two chemicals. 
This form of evaluation is often called a read-across approach, and this is the term used in 
Annex XI of REACH. […] In order to avoid confusion, evaluations of a very limited number 
of chemicals using largely read-across to fill data gaps is described in this guidance as the 
analogue approach. The term read-across is therefore limited to the technique for filling 
data gaps. 
NB. Figure R.6-5 (p. 95) Stepwise procedure to the analogue approach 
US BODIES 
US EPA 2014a 
Nanomaterials 
under TSCA 
Presentation at 
ECHA workshop  
Given the lack of data, EPA uses analogs to make determinations. 
For many nanoscale materials where there are insufficient data, EPA uses data for the 
category "Respirable, Poorly Soluble Particulates" to assess potential hazard. 
Category is limited to effects on the lung as a result of inhaling particles < 10 um in 
diameter. 
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Table 4.5 (cont.) 
Source Original definition of the term 'analogue(s)' 
INDUSTRY ASSOCIATIONS 
CEFIC-LRI 2012 
Experts 
Workshop on 
Read-across 
assessment 
[…] comparisons are made between a very limited number of substances. Endpoint 
information on the source substance(s) is used to predict the same endpoint for the target 
substance, which is considered to be ‘similar’ in some way (usually on the basis of 
structural similarity and similar properties and/or activities). Potential source substances 
need to be reasonably data-rich from which comparisons can be made. 
ECETOC 2012 
Category 
approaches, 
read-across, 
(Q)SAR 
In this report, the term 'category approach' and 'analogue approach' are used to describe 
techniques for grouping chemicals, whilst the term 'read-across' is reserved for a technique 
of filling data gaps in either approach. […] Analogue approach is often used when the 
grouping is based on a very limited number of chemicals, typically two substances. 
PEER-REVIEWED SCIENTIFIC LITERATURE 
Patlewicz et al 
2014 
Read-across 
approaches 
[…] the analogue approach, which is based on a chemical group with a very limited number 
of structurally similar substances (usually a target and source substance), […] 
Van Leeuwen et 
al 2009 
Using chemical 
categories to fill 
data gaps in 
hazard 
assessment 
Read-across has been proposed to estimate missing data from a single or restricted 
number of compounds using the analogue approach […]. 
Van Leeuwen et 
al 2007 
Intelligent 
Testing 
Strategies 
[…] the identification of a chemical substructure that is common to the two substances 
(which are therefore analogues). 
 
4.6 Assessment Factor (AF) 
Table 4.6 shows the original definitions of the term 'Assessment Factor (AF)', which have 
been collected from the literature and used to develop the NANoREG Definition. 
Definitions could be found in documents from international organisations such as OECD 
(2003), IPSC (2004), and IUPAC (Duffus et al 2007), in documents from European 
bodies such as ECHA official guidance for implementation of REACH (ECHA 2008b; 
2012d), in documents from US bodies such as US EPA (1998, 2002, 2014b), in reports 
from industry associations (ECETOC 2010), and in peer-reviewed scientific publications 
(Ferrario et al 2004). The definitions that are reported in official guidance documents by 
OECD and IPSC are given higher priority as they have regulatory relevance and are the 
result of a broad consultation at international level. Accordingly, the harmonised 
definition adopted in NANoREG reflects the definitions provided by OECD and IPSC and 
complements them with elements provided by ECHA and US EPA. 
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Table 4.6 Literature definitions collected for the key term 'Assessment Factor (AF)' and 
considered to develop the NANoREG Definition. 
Source Original definition of the term 'Assessment Factor (AF)' 
INTERNATIONAL BODIES 
Duffus et al 2007 
IUPAC 
Recommandations 
Uncertainty factor (UF): 
1. In assay methodology, confidence interval or fiducial limit used to assess the probable 
precision of an estimate. 
2. In toxicology, value used in extrapolation from experimental animals to man (assuming 
that man may be more sensitive) or from selected individuals to the general population. 
For example, a value applied to the no-observed-effect-level (NOEL) or no-observed-
adverse-effect-level (NOAEL) to derive an acceptable daily intake (ADI) or tolerable daily 
intake (TDI). Note: The NOEL or NOAEL is divided by the value to calculate the ADI or 
TDI. 
See also Modifying factor, Safety factor. 
IPSC 2004 
Risk Assessment 
Terminology 
Assessment factor: 
Numerical adjustment used to extrapolate from experimentally determined (dose–
response) relationships to estimate the agent exposure below which an adverse effect is 
not likely to occur.  
Related terms: Safety factor, Uncertainty factor. 
OECD 2003 
Key generic terms 
Assessment factor: 
Numerical adjustment used to extrapolate from experimentally determined (dose-
response) relationships to estimate the agent exposure below which an adverse effect is 
not likely to occur. 
Related terms: Safety Factor, Uncertainty Factor. 
EUROPEAN BODIES 
ECHA 2012b 
Characterisation 
of dose-response 
for human health 
The term assessment factor is used because of it being a neutral term. However, these 
factors can in the DMEL approach also be viewed as ‘correction factors’ and ‘uncertainty 
factors’. 
The next step in the calculation of a DNEL is to address uncertainties in the extrapolation 
of experimental data to the real human exposure situation, taking into account variability 
and uncertainty. These uncertainties concern, e.g., differences between animals and 
humans in anticipated sensitivity towards the toxicity of the substance. All these 
uncertainties/differences are individually addressed by so-called assessment factors (AFs), 
that together result in an overall AF that is applied to the corrected dose descriptor to 
account for all these uncertainties. Preferably, the value for each individual assessment 
factor is based on substance-specific information. However, although sound in principle, in 
practice the approach has limitations (data are often scarce, especially toxicodynamic 
data, and human data) and, therefore, default assessment factors most often need to be 
used. Each step in the process, including any choice for an assessment factor value, 
whether substance-specific or default should be explained as transparently as possible, 
with a qualitative narrative in the chemical safety report (CSR). 
Assessment factors are numerical values. They are used to address the differences 
between the experimental data and the human situation, taking into account the 
uncertainties in the extrapolation procedure and in the available data set. In principle, all 
data on a specific substance need to be reviewed thoroughly in order to use, as far as 
possible, substance-specific information for the establishment of appropriate values for 
the various assessment factors. When substance-specific information is not available, data 
on analogues, which act with the same mode of action as the chemical under 
consideration, should be taken into account. However, when the available data do not 
allow the derivation of substance-specific or analogue-specific assessment factors, default 
assessment factors should be applied. Although very often necessary to rely upon, the 
default assessment factors represent a fall-back position rather than the starting point. 
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Table 4.6 (cont.) 
Source Original definition of the term 'Assessment Factor (AF)' 
 Several aspects are involved in the extrapolation of experimental data to the human 
situation, inter alia, from the variability in the experimental data and from intra- and 
inter-species variation, the nature and severity of the effect, and the sensitivity of the 
human (sub-)population (REACH Annex I, Section 1.4.1). These aspects will be discussed 
under the following headings; 
− Interspecies differences; 
− Intraspecies differences; 
− Differences in duration of exposure; 
− Issues related to dose-response; 
− Quality of whole database. 
ECHA 2008b 
Characterisation 
of dose-response 
for environment 
The general principle of these methods is that the result from a laboratory test is divided 
by an appropriate assessment factor. The sparser the available data, the higher is the 
assessment factor which is applied. PNECs are estimated by division of the lowest value 
for the toxicity with the relevant assessment factor. Results of long-term tests (expressed 
as EC10 or NOEC for a sublethal parameter) are preferred to those of short-term tests 
(EC/LC50), because such results give a more realistic picture of effects on the organisms 
during their entire life cycle. 
In establishing the size of these assessment factors, a number of uncertainties have been 
addressed to extrapolate from single-species laboratory data to a multi-species 
ecosystem. These areas comprise: 
− Intra- and inter-laboratory variation of toxicity data; 
− Intra- and inter-species variations (biological variance); 
− Short-term to long-term toxicity extrapolation; 
− Laboratory data to field impact extrapolation. 
US BODIES 
US EPA 2014b 
Guidance for 
applying 
quantitative data 
to develop data-
derived 
extrapolation 
factors 
In deriving reference concentrations (RfCs) and reference doses (RfDs), the Agency has 
historically used default uncertainty factors (UFs) to compensate for a lack of information 
(U.S. EPA, 2002b). As science has advanced, however, there has been a growing effort to 
increase reliance on available data to modify the values for these UFs (IPCS, 2005). The 
default UFs were developed to address data gaps in the development of RfDs and RfCs, 
but when appropriate data are available for an assessment, those data are given 
precedence over standard default values (U.S. EPA, 2004a). This guidance describes an 
approach for identifying and using pertinent information for developing data-derived 
extrapolation factors (DDEFs) for the purposes of developing RfDs, RfCs, or related 
metrics/approaches (e.g., hazard index, margin of exposure). 
US EPA 2002 
Review of 
reference dose 
and reference 
concentration 
processes 
Reference values are derived in a way that attempts to account for both the uncertainty 
and the variability in the data available […] 
Uncertainty/Variability Factor:  
One of several, generally 10-fold, default factors used in operationally deriving the RfD 
and the RfC from experimental data. The factors are intended to account for (1) the 
variation in sensitivity among the members of the human population (i.e., inter-individual 
variability); (2) the uncertainty in extrapolating animal data to humans (i.e., interspecies 
uncertainty); (3) the uncertainty in extrapolating from data obtained in a study with less-
than-lifetime exposure to lifetime exposure (i.e., extrapolating from subchronic to chronic 
exposure); (4) the uncertainty in extrapolating from a LOAEL rather than from a NOAEL; 
and (5) the uncertainty associated with extrapolation when the database is incomplete. 
Modifying Factor (MF):  
A factor used in derivation of a reference dose or reference concentration. The magnitude 
of the MF reflects the scientific uncertainties of the study and database not explicitly 
treated with standard uncertainty factors (e.g., the completeness of the overall database). 
A MF is greater than zero and less than or equal to 10, and the default value for the MF 
is1. [Current definition in IRIS; this report recommends that its use be discontinued.] 
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Table 4.6 (cont.) 
Source Original definition of the term 'Assessment Factor (AF)' 
US EPA 1998 
Guidelines for 
ecological risk 
assessment 
Uncertainty factors are used to ensure that measures of effects are sufficiently protective 
of assessment endpoints. Uncertainty factors are empirically derived numbers that are 
divided into measure of effects values to give an estimated stressor level that should not 
cause adverse effects to the assessment endpoint. Uncertainty factors have been 
developed most frequently for chemicals because extensive ecotoxicologic databases are 
available, especially for aquatic organisms. Uncertainty factors are useful when decisions 
must be made about stressors in a short time and with little information. Uncertainty 
factors have been used to compensate for assessment endpoint/effect measures 
differences between endpoints (acute to chronic effects), between species, and between 
test situations (e.g., laboratory to field). Typically, they vary inversely with the quantity 
and type of measures of effects data available (Zeeman, 1995). […] 
Despite their usefulness, uncertainty factors can also be misused, especially when used in 
an overly conservative fashion, as when chains of factors are multiplied together without 
sufficient justification. Like other approaches to bridging data gaps, uncertainty factors 
are often based on a combination of scientific analysis, scientific judgment, and policy 
judgment (see section 4.1.3). It is important to differentiate these three elements when 
documenting the basis for the uncertainty factors used. Empirical data can be used to 
facilitate extrapolations between species, genera, families, or orders or functional groups 
(e.g., feeding guilds) (Suter, 1993a). 
INDUSTRY ASSOCIATIONS 
ECETOC 2010 
Guidance on 
assessment 
factors to derive 
DNEL 
The biological starting point for DNEL are dose descriptors such as the no observed 
adverse effect levels (NOAEL) or benchmark doses (BMD) that are expected to be mostly 
obtained from animal experiments. The dose descriptors are adapted to human exposure 
periods and life time (in relation to the experimental setting), and extrapolated to human 
populations by means of physiological scaling factors and a number of assumptions which 
are considered into a system of standardised assessment factors (AF). 
Both the REACH TGD and ECETOC recognise that when substance- or category-specific 
information is available there may be a scientific justification for deviating from default 
guidance. ECETOC has introduced the term 'informed' AF to address these alternative AF. 
The term 'default' AF is, in contrast, conceived for those cases where little else other than 
the experimental dose descriptor is known about a compound (or category) and other 
aspects of the toxicological profile, mode of action (MOA), toxicokinetics and species 
variability are unknown. 
PEER-REVIEWED SCIENTIFIC LITERATURE 
Ferrario et al 
2004 
Glossary of 
reference terms 
Assessment factor (safety factor, uncertainty factor):  
Numerical adjustment used to extrapolate from experimentally determined 
(dose/concentration-response) relationships to estimate the agent exposure below which 
an adverse effect is not likely to occur (OECD, 2004b). 
 
4.7 Categorisation 
Table 4.7 shows the original definitions of the term 'categorisation', which have been 
collected from the literature and used to develop the NANoREG Definition. Definitions 
could be found in documents from Canadian bodies such as CEPA legal text (CEPA 1999) 
and in peer-reviewed scientific literature (Gebel et al 2014, Godwin et al 2015). The 
term 'categorisation' is not defined in European legal acts and not used by European 
bodies. One definition with regulatory relevance is present in CEPA legal text for 
chemicals (CEPA 1999) and applies to the Canadian regulatory context. The definitions 
reported in the peer-reviewed literature seems to be quite general: Godwin and 
colleagues (2015) defines 'categorisation' as a synonymous of 'grouping' for both 
chemicals and NMs whereas Gebel and colleagues (2014) uses the term 'categorisation' 
 35 
 
of NMs in a way that is similar to the concept of 'chemical category' and 'category 
approach' as defined by OECD. Accordingly, no harmonised definition of the term 
'categorisation' has been adopted in NANoREG and project partners have concluded that 
the terms 'chemical category' and 'category approach' are preferred (see 'chemical 
category'). 
 
Table 4.7 Literature definitions collected for the key term 'categorisation' and 
considered to develop the NANoREG Definition. 
Source Original definition of the term 'categorisation' 
CANADIAN BODIES 
CEPA 1999 
Canadian 
Environmental 
Protection Act 
PRIORITY SUBSTANCES AND OTHER SUBSTANCES 
Categorization of substances on Domestic Substances List 
73. (1) The Ministers shall, within seven years from the giving of Royal Assent to this Act, 
categorize the substances that are on the Domestic Substances List by virtue of section 
66, for the purpose of identifying the substances on the List that, in their opinion and on 
the basis of available information, (a) may present, to individuals in Canada, the greatest 
potential for exposure; or (b) are persistent or bioaccumulative in accordance with the 
regulations, and inherently toxic to human beings or to non-human organisms, as 
determined by laboratory or other studies. 
PEER-REVIEWED SCIENTIFIC LITERATURE 
Godwin et al 2015 
Nanomaterial 
Categorization 
Categorization refers to the grouping of chemicals. […] Categorization strategies may 
include grouping, ranking, and read-across as examples of types of categorization. […] In 
the context of nanomaterials, additional factors could be considered such as grouping by 
mechanisms of action at the nano/biointerface. 
Categorization strategies are needed to enable regulators and industry either to predict 
ENM risk better or to allow prioritization of the testing (hazard, exposure, 
physicochemical) needed to estimate their potential risk while minimizing time-consuming 
and costly in vivo studies or traditional risk assessments. 
The "holy grail" of this field is to be able to categorise the risk potential of ENMs based on 
their physicochemical properties because such as approach would allow manufacturers 
and regulators to make rapid decisions without requiring costly and time-consuming in 
vivo and/or in vitro data. 
[…] constructive guidance on how to improve and to expedite categorization of ENMs 
according to risk potential: 
− Physicochemical properties are not currently sufficient for ENM categorization for 
regulatory purposes. 
− Categorisation methods for regulatory purposes should include indicators of both 
hazard and exposure potential. 
− Alternative testing strategies (ATS) may provide a useful means for expedited 
hazard screening for ENMs. 
− Decision-tree approaches for categorizing CNTs according to their risk potential post-
manufacturing could facilitate decision-making in the EPA' New Chemicals program 
and in other frameworks. 
− Targeted cross-comparison of ATS with standard assays may be needed for ATS to 
be incorporated as an accepted component of categorization strategies in some 
regulatory contexts. 
Gebel et al 2014 
Manufactured 
nanomaterials 
categorization 
[…] it seems reasonable to categorise nanomaterials according to their route of exposure, 
physicochemical properties and mode of action. 
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4.8 Chemical category 
Table 4.8 shows the original definitions of the term 'chemical category', which have been 
collected from the literature and used to develop the NANoREG Definition. Definitions 
could be found in documents from international organisations such as OECD (2014a) and 
ISO (2014), in documents from European bodies such as REACH legal text (EC 2009), 
ECHA official guidance for implementation of REACH (ECHA 2008a, 2012c, 2013a, 
2014b, 2015a, 2015b), and JRC reports (JRC 2005), in documents from US bodies such 
as TSCA legal text (TSCA 2002) and US EPA guidance (US EPA 1999), in reports from 
industry associations (CEFIC-LRI 2012, ECETOC 2012), and in peer-reviewed scientific 
literature (van Leeuwen et al 2007, van Leeuwen et al 2009, Godwin et al 2015). The 
definitions that are reported in OECD official guidance documents are given higher 
priority as they have regulatory relevance and are the result of a broad consultation at 
international level. These definitions are reflected in ECHA official guidance for 
implementation of REACH and in reports by industry, and in principle apply to all 
chemicals including NMs. Accordingly, the harmonised definition adopted in NANoREG 
reflects the definitions provided by OECD. The NANoREG Definition also includes those 
considerations made by several organisations (OECD, ECHA GAARN, RIVM, US EPA) and 
scientists with regard to the application of this concept to NMs (ECHA 2013b, OECD 
2014a, Arts et al 2014, RIVM 2015, Godwin et al 2015). 
 
Table 4.8 Literature definitions collected for the key term 'chemical category' and 
considered to develop the NANoREG Definition. 
Source Original definition of the term 'chemical category' 
INTERNATIONAL BODIES 
ISO 2014 
Use of the control 
banding approach 
[…] group of chemicals whose physicochemical and human health and/or ecotoxicological 
properties and/or environmental fate properties are likely to be similar or follow a regular 
pattern, usually as a result of structural similarity 
OECD 2014a 
Guidance on 
grouping of 
chemicals 
Chemicals whose physical-chemical, toxicological and ecotoxicological properties are likely 
to be similar or follow a regular pattern as a result of structural similarity may be 
considered as a group, or 'category' of chemicals. […] the properties of the individual 
chemicals within a category are assessed on the basis of the evaluation of the category as 
a whole, rather than based on measured data for any one particular chemical alone. For 
(a) category member(s) that lacks data for one or more endpoints, the data gap can be 
filled in a number of ways, including by read-across from one or more other category 
members. Within a chemical category, the members are often related by a trend in an 
effect for a given endpoint, and a trend analysis can be carried out through deriving a 
model based on the data for the members of the category. 
An advantage of a chemical category assessment approach is that identification of 
consistent patterns of effects within a category in itself increases confidence in the 
reliability of the results for all the individual chemicals in the category, compared to 
evaluation of data purely on a chemical-by-chemical basis. 
A category of chemicals will often show the presence and absence of a particular effect 
among the members of the category, based on a common functional group, physical-
chemical properties, common reactivity, metabolism, and a presumed mode (and/or 
mechanism) of action based on a similar structure. However, a modulation of effects could 
appear as a result of a constant pattern in changing chemical structure or physical-
chemical properties across the category. 
A chemical category approach may be suitable for more toxicological endpoints or other 
endpoints, since the structural changes across the category may affect changes in 
physical-chemical properties or other molecular descriptors or profilers that would cause 
changes of several toxicological properties or other endpoints of the individual category 
members in a coherent and consistent manner. 
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Table 4.8 (cont.) 
Source Original definition of the term 'chemical category' 
 However, it may only be possible to identify the trends and changes for some, and not all, 
of the endpoints of potential interest. Hence, it may not be possible to use a category 
approach for all relevant hazard endpoints. 
In principle the above-listed non-testing techniques can be used to indicate either the 
presence or the absence of an effect or an estimated value (e.g., a relevant toxicity value 
such as a LOAEL) for an analogue or a group of substances. However, this is highly 
dependent on the substance under consideration, the endpoint, the level of information 
already available, the regulatory purpose, and the confidence that can be derived from its 
interpretation. 
NB. Figure 3 (p. 77) Stepwise approach to category development 
EUROPEAN BODIES 
ECHA 2015b 
Regulatory 
challenges of 
nanomaterials 
workshop 
proceedings 
In a category approach, a group of substances whose properties are likely to be similar or 
follow a regular pattern is constructed. 
ECHA 2015a 
Read-Across 
Assessment 
Framework 
The term category approach is used when read-across is employed between several 
substances that have structural similarity. These substances are grouped together on the 
basis of defined structural similarity and differences between the substances. As a result 
of the structural similarity, the toxicological properties will either all be similar or follow a 
regular pattern. Predictions should cover all parameters as required in the respective 
REACH information requirements. It may be possible to make predictions within the group 
for the target substance(s) on the basis of a demonstrable regular pattern. Alternatively, 
whenever there is more than one source substance in the category and no regular pattern 
is demonstrated for the property under consideration, the prediction may be based on a 
read-across from a category member with relevant information in a conservative manner 
(worst case). The basis for the prediction must be explicit. 
ECHA 2014b 
Use of 
alternatives to 
testing on animals 
for REACH 
Group of substances with physicochemical, toxicological and ecotoxicological properties 
that are likely to be similar or follow a regular pattern as a result of structural similarity. 
ECHA 2013a 
Grouping of 
substances and 
read-across 
approach 
[…] with a higher number of substances in a group the term category approach is used. 
ECHA 2012c 
An introduction to 
the assessment of 
read-across in 
ECHA 
[…] involves a larger group of substances and is supported by regular patterns in this 
group for the endpoint that has to be read across. 
ECHA 2008a 
QSARs and 
grouping of 
chemicals 
A chemical category is a group of chemicals whose physico-chemical and human health 
and/or environmental toxicological properties and/or environmental fate properties are 
likely to be similar or follow a regular pattern as a result of structural similarity (or other 
similarity characteristic). 
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Table 4.8 (cont.) 
Source Original definition of the term 'chemical category' 
 In principle, more members are generally present in a chemical category, enabling the 
detection of trends across endpoints. As the number of possible chemicals being grouped 
into a category increases, the potential for developing hypotheses for specific endpoints 
and making generalisations about the trends within the category will also increase, and 
hence increase the robustness of the evaluation. 
NB. Figure R.6-6 (p. 97) Stepwise procedure to category development 
EC 2009 
REACH Annex XI 
Substances whose physicochemical, toxicological and ecotoxicological properties are likely 
to be similar or follow a regular pattern as a result of structural similarity may be 
considered as a group, or ‘category’ of substances. 
JRC 2005 
Chemical 
categories and 
read-across 
A chemical category is a group of chemicals whose physicochemical and toxicological 
(including ecotoxicological) properties are likely to be similar or follow a regular pattern as 
a result of structural similarity. These structural similarities may create a predictable 
pattern in any or all of the following parameters: physicochemical properties, 
environmental fate and environmental effects, and/or human health effects. The 
similarities may be based on the following: 
− a common functional group (e.g., aldehyde, epoxide, ester, etc.) related to specific 
−  activity; or 
− the likelihood of common precursors and/or breakdown products, via physical or 
biological processes, which result in structurally similar chemicals (e.g., the "family 
−  approach" of examining related chemicals such as acid/ester/salt); and 
− an incremental and constant change across the category (e.g., the methylene group 
difference between adjacent members of the alpha-olefins). 
Within a category different members may be selected for the endpoint desired. If the 
available test results show that the chemicals in a category behave in a similar or 
predictable manner, then interpolation and/or extrapolation may be used to assess the 
chemicals instead of conducting additional testing. 
US BODIES 
US EPA 2014a 
Nanomaterials 
under TSCA 
Presentation at 
ECHA workshop 
Given the lack of data, EPA uses analogs to make determinations. 
− For many nanoscale materials where there are insufficient data, EPA uses data for 
the category "Respirable, Poorly Soluble Particulates" to assess potential hazard. 
− Category is limited to effects on the lung as a result of inhaling particles < 10 um in 
diameter. 
US EPA 1999 
Chemical 
categories 
A chemical category, for the purposes of the Challenge Program, is a group of chemicals 
whose physicochemical and toxicological properties are likely to be similar or follow a 
regular pattern as a result of structural similarity. These structural similarities may create 
a predictable pattern in any or all of the following parameters: physicochemical 
properties, environmental fate and environmental effects, and/or human health effects. 
The similarities should be based on the following: 
− a common functional group (e.g., aldehyde, epoxide, ester, etc.); or 
− the likelihood of common precursors and/or breakdown products, via physical or 
biological processes, which result in structurally similar chemicals (e.g., the "family 
approach" of examining related chemicals such as acid/ester/salt); and 
− an incremental and constant change across the category (e.g., the dimethylene 
group difference between adjacent members of the alpha-olefins – see Appendix).  
Within a category different members can be selected for the endpoint desired - i.e., those 
selected for a category approach for environmental effects endpoints may not be suitable 
for assessing human health effect endpoints. […] 
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Table 4.8 (cont.) 
Source Original definition of the term 'chemical category' 
 If these test results show that the chemicals in the category behave in a similar or 
predictable manner, then interpolation and/or extrapolation can be used to assess the 
chemicals in lieu of conducting additional screening-level testing. 
TSCA 2002 
US Toxic 
Substances 
Control Act 
The term ‘‘category of chemical substances’’ means a group of chemical substances the 
members of which are similar in molecular structure, in physical, chemical, or biological 
properties, in use, or in mode of entrance into the human body or into the environment, 
or the members of which are in some other way suitable for classification as such for 
purposes of this Act, except that such term does not mean a group of chemical 
substances which are grouped together solely on the basis of their being new chemical 
substances. 
INDUSTRY ASSOCIATIONS 
CEFIC-LRI 2012 
Experts workshop 
on read-across 
assessment 
[…] is a group of substances whose physico-chemical and human health and/or 
environmental toxicological properties and/or environmental fate properties are likely to 
be similar or follow a regular pattern as a result of structural similarity. In principle, more 
members are generally present in a chemical category, enabling the evaluation of trends 
within endpoints. 
ECETOC 2012 
Category 
approaches, read-
across,  
(Q)SAR 
In this report, the term 'category approach' and 'analogue approach' are used to describe 
techniques for grouping chemicals, whilst the term 'read-across' is reserved for a 
technique of filling data gaps in either approach. […] A chemical category describes a 
group of chemicals whose physicochemical and human health/environmental toxicological 
properties and/or environmental fate properties are likely to be similar or follow a regular 
pattern as a result of structural similarity (or other similar characteristic). 
The category approach is, by its very nature, a weight of evidence approach (WoE), since 
it typically integrates both estimated and experimental data, and involves expert 
judgment. 
[…] also provides a mean of strategic testing. 
PEER-REVIEWED SCIENTIFIC LITERATURE 
Godwin et al 2015 
Nanomaterial 
categorization 
[…] a chemical category is a group of chemicals whose physicochemical and human health 
and/or ecotoxicological properties and/or environmental fate properties are likely to be 
similar or follow a regular pattern, usually as a result of structural similarity. 
Van Leeuwen et 
al 2009 
Using chemical 
categories to fill 
data gaps in 
hazard 
assessment 
Although the legal definitions of a chemical category may vary and will evolve through 
use, a chemical category is generally considered to be a group of chemicals whose 
properties are likely to be similar or follow a regular pattern as a result of mechanism, 
mode of toxic action or structural similarity. These similarities may create a predictable 
pattern in all or only some of the following parameters: physicochemical properties, 
quantum chemical properties, environmental fate, environmental effects and/or human 
health effects. The problem is there is no generally accepted method for measuring 
similarity. The similarities may be based on: 
− a common functional group (e.g. aldehyde, epoxide, ester) related to specific 
activity; 
− the likelihood of common precursors and/or breakdown products, via physical or 
toxicological processes, which result in structurally similar chemicals (e.g. the ‘family 
approach’ of examining related chemicals such as acid/ester/salt); 
− an incremental and constant change of key physicochemical properties across the 
category which determines other properties such as biological and (eco)toxicological 
effects (e.g. the methylene group difference between adjacent members of the 
alpha-olefins). 
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Table 4.8 (cont.) 
Source Original definition of the term 'chemical category' 
 Within a category, different members may be selected for the endpoint to be assessed. If 
the available test results show that the chemicals in a category behave in a similar or 
predictable manner, then interpolation and/or extrapolation may be used to assess the 
untested chemicals instead of conducting additional testing. Chemical categories are 
‘designed’ on the basis of scientific considerations such as mechanistic or behavioural 
similarity to enable reliable data gap filling using read-across, trend analysis, structural 
alerts and QSAR models. 
Van Leeuwen et 
al 2007 
Intelligent testing 
strategies 
A chemical category is a group or “family” of chemicals whose physicochemical, 
toxicological and ecotoxicological properties are likely to be similar or follow a regular 
pattern as a result of structural similarity. These structural similarities may create a 
predictable pattern in all or the following parameters: physicochemical properties, 
environmental fate, environmental effects, and/or human health effects. The similarities 
may be based on: 
− A common functional group (e.g., aldehyde, epoxide, ester) related to specific 
activity.  
− The likelihood of common precursors and/or breakdown products, via physical or 
toxicological processes, which result in structurally similar chemicals (e.g., the 
“family approach” of examining related chemicals such as acid/ester/salt). 
− An incremental and constant change of key physicochemical properties across the 
category which determines other properties such as biological and (eco)toxicological 
effects (e.g., the methylene group difference between adjacent members of the 
alphaolefins). 
Within a category, different members may be selected for the endpoint desired. If the 
available test results show that the chemicals in a category behave in a similar or 
predictable manner, then interpolation and/or extrapolation may be used to assess the 
chemicals instead of conducting additional testing. 
 
4.9 Chemical Safety Assessment (CSA) 
Table 4.9 shows the original definitions of the term 'Chemical Safety Assessment (CSA)', 
which have been collected from the literature and used to develop the NANoREG 
Definition. The term 'Chemical Safety Assessment (CSA)' is mainly used in REACH legal 
text and in principle applies to all substances including NMs (EP and EC 2006). 
Definitions could only be found in documents from European bodies such as REACH (EP 
and EC 2006) and Cosmetic Products Regulation (EP and EC 2008) legal texts, and ECHA 
official guidance for implementation of REACH (ECHA 2009, 2011b). Accordingly, the 
harmonised definition adopted in NANoREG reflects the definitions provided by ECHA. 
 
Table 4.9 Literature definitions collected for the key term 'Chemical Safety Assessment 
(CSA)' and considered to develop the NANoREG Definition. 
Source Original definition of the term 'Chemical Safety Assessment (CSA)' 
EUROPEAN BODIES 
ECHA 2011b 
Introduction to 
the guidance 
document 
The goal of the assessment is not to establish whether or not there is a risk, but to 
identify and describe the conditions under which the risks are controlled. Risks are 
regarded as controlled when the estimated exposure levels do not exceed the predicted 
no effect levels (DNEL or PNEC). For substances for which such no-effect levels cannot be 
determined, the risk characterisation consists of semi-quantitative or qualitative 
assessment of the likelihood that adverse effects are avoided. 
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Table 4.9 (cont.) 
Source Original definition of the term 'Chemical Safety Assessment (CSA)' 
ECHA 2009  
Guidance in a 
nutshell chemical 
safety 
assessment 
Is the process that identifies and describes the conditions under which the manufacturing 
and use of a substance is considered to be safe. There are three major steps in the CSA 
process. These are:  
− Hazard assessment 
− Exposure assessment 
− Risk characterisation 
EP and EC 2009 
Cosmetic 
Products 
Regulation 
In order to demonstrate that a cosmetic product complies with Article 3, the responsible 
person shall, prior to placing a cosmetic product on the market, ensure that the cosmetic 
product has undergone a safety assessment on the basis of the relevant information and 
that a cosmetic product safety report is set up in accordance with Annex I. 
EP and EC 2006 
REACH 
A chemical safety assessment of a substance shall include the following steps: 
a) Human health hazard assessment 
b) Physicochemical hazard assessment 
c) Environmental hazard assessment 
d) Persistent, bioaccumulative and toxic (PBT) and very persistent and very 
bioaccumulative (vPvB) assessment 
If, […] the registrant concludes that the substance meets the criteria for classification as 
dangerous […] or is assessed to be a PBT or vPvB, the chemical safety assessment shall 
include the following additional steps: 
a) Exposure assessment including the generation of exposure scenario(s) (or the 
identification of relevant use and exposure categories if appropriate) and 
exposure estimation; 
b) Risk characterisation. 
 
4.10 Class of substances 
Table 4.10 shows the original definitions of the term 'class of substances', which have 
been collected from the literature and used to develop the NANoREG Definition. 
Definitions could be found in documents from international organisations such as UN 
(2003), in documents from European bodies such as CLP Regulation legal text (EP and 
EC 2008), and in documents from US/Canadian authorities including a report by NIESH 
(1997), CEPA legal text (CEPA 1999), and a report by RCC (2013). The term 'class of 
substances' is used with a different meaning in the considered sources. The harmonised 
definition adopted in NANoREG reflects the definitions provided by UN and considered in 
EU legislation, which in principle apply to all chemicals including NMs.  
 
Table 4.10 Literature definitions collected for the key term 'class of substances' and 
considered to develop the NANoREG Definition. 
Source Original definition of the term 'class of substances' 
INTERNATIONAL BODIES 
RCC 2013 
Joint 
Nanomaterials 
Classification 
Scheme 
[…] the term "classification scheme" will refer to the organization of nanomaterials for 
regulatory purposes. The word 'classification' is not intended to be similar to its use in 
other regulatory/policy documents in Canada, the US or internationally. 
[…] to establish criteria for identifying key characteristics of nanomaterials and 
subsequently determining which nanomaterials are sufficiently different from their non-
nano counterparts to warrant a closer examination for environmental, human health, and  
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Table 4.10 (cont.) 
Source Original definition of the term 'class of substances' 
 safety endpoints (those of concern); and which nanomaterials are sufficiently similar to 
their non-nano counterparts to be considered as traditional chemicals for regulatory 
purposes (those of no-concern).  
[…] a classification scheme for nanomaterials based on similarities in chemical 
composition that will support the use of analogue/read across information. 
UN 2003 
Globally 
Harmonised 
System 
Hazard class means the nature of the physical, health or environmental hazard, e.g. 
flammable solid, carcinogen, oral acute toxicity;  
[…] the hazard classification process refers principally to the hazards arising from the 
intrinsic properties of the substances and mixtures […]  
EUROPEAN BODIES 
EP and EC 2008 
CLP Regulation 
‘hazard class’ means the nature of the physical, health or environmental hazard; 
US BODIES 
NIEHS 1997 
Validation of 
alternative 
methods 
Hazard classification: Assignment of a chemical or product hazard into a category of 
severity based on the results of a standard test method for a specific toxic endpoint; most 
commonly used for labelling purposes. 
CANADIAN BODIES 
CEPA 1999 
Canadian 
Environmental 
Protection Act 
[…] “class of substances” means any two or more substances that  
(a) contain the same portion of chemical structure; 
(b) have similar physico-chemical or toxicological properties; or 
(c) for the purposes of sections 68, 70 and 71, have similar types of use. 
 
4.11 Control Banding (CB) 
Table 4.11 shows the original definitions of the term 'Control Banding (CB)', which have 
been collected from the literature and used to develop the NANoREG Definition. 
Definitions could be found in documents from international organisations such as ISO 
(2012, 2014), in documents from US bodies (NIOSH 1999), and in peer-reviewed 
scientific literature (Brouwer 2012, Hoehener and Hoeck 2013). The definitions that are 
reported in ISO standards are given higher priority as they have regulatory relevance 
and are the result of a broad consultation at international level. Accordingly, the 
harmonised definition adopted in NANoREG reflects the definitions provided by ISO. The 
NANoREG harmonised definition also includes those considerations made in a recent 
peer-reviewed scientific publication (Brouwer 2012) with regard to the application of this 
concept to NMs. 
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Table 4.11 Literature definitions collected for the key term 'Control Banding (CB)' and 
considered to develop the NANoREG Definition. 
Source Original definition of the term 'Control Banding (CB)' 
INTERNATIONAL BODIES 
ISO 2014  
Use of the control 
banding approach 
Control banding is a pragmatic approach which can be used for the control of workplace 
exposure to possibly hazardous agents with unknown or uncertain toxicological properties 
and for which quantitative exposure estimations are lacking. It may complement the 
traditional quantitative methods based on air sampling and analysis with reference to 
OELs when they exist. It can provide an alternative risk assessment and risk management 
process, by grouping occupational settings in categories presenting similarities of hazards 
and/or exposure, while incorporating professional judgment and monitoring. This process 
applies a range of control techniques (such as general ventilation or containment) to a 
specific chemical, considering its range (or band) of hazard and the range (or band) of 
exposure. 
In general, control banding is based on the idea that while workers can be exposed to a 
diversity of chemicals, implying diversity in risks, the number of common approaches to 
risk control is limited. These approaches are grouped into levels based on how much 
protection the approach offers (with “stringent” controls being the most protective). The 
greater the potential for harm, the greater the levels of protection needed for exposure 
control. 
ISO 2012  
Occupational risk 
management 
applied to 
engineered 
nanomaterials  
Control banding (CB) is an approach by which control methods are selected based on 
knowledge or assumptions about the hazardous nature of the materials being used and 
the exposure potential of the situation. CB has frequently been used in risk management 
guidance for other particles and chemicals and is usually based on a matrix having the 
axes exposure and hazard into which various control approaches are placed. CB therefore 
requires the user to have knowledge of, or make judgments concerning, the relative 
hazard of the materials being used and/or the relative exposure potential of the material 
and situation. Paik et al.[30] have described the development of a pilot control banding 
tool for NOAAs. ISO/TS 12901- 2 describes a specific tool based on control banding to 
further support the implementation of good practice in this area. 
US BODIES 
NIOSH 2009 
Control banding  
A strategy that groups workplace risks into control categories or bands based on 
combinations of hazard and exposure information. The following four main CBs have been 
developed for exposure to chemicals by inhalation: Band 1: Use good industrial hygiene 
(IH) practice and general ventilation. Band 2: Use local exhaust ventilation. Band 3: 
Enclose the process. Band 4: Seek expert advice. This qualitative strategy to assess and 
manage risk focuses resources on exposure controls and describes how strictly a risk 
needs to be managed. 
PEER-REVIEWED SCIENTIFIC LITERATURE 
Hoehener and 
Hoeck 2013 
Consolidated 
framework EHS 
draft 
In the absence of occupational exposure limits and definitive knowledge of toxicity, 
control banding is a qualitative strategy for classifying and handling chemicals and 
hazards associated with chemical exposures in the workplace, as well as for assessing 
potential risks for consumers and the environment. 
Brouwer 2012 
Control banding 
for nanomaterials 
Basically, it is a risk assessment approach in a context of uncertainty using the generally 
accepted risk paradigm, where risk is a function of severity of impact (hazard) and the 
anticipated probability of that impact (exposure). Both hazard and exposure are graded 
into two to five different levels, usually referred as bands. The two sets of bands are 
combined, most often in a matrix, resulting into control or risk bands. 
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4.12 Data gap 
Table 4.12 shows the original definitions of the term 'data gap', which have been 
collected from the literature and used to develop the NANoREG Definition. One definition 
could be found (OECD 2014a). The definitions that are reported in OECD official 
guidance documents are given higher priority as they have regulatory relevance and are 
the result of a broad consultation at international level. Accordingly, the harmonised 
definition adopted in NANoREG reflects the definition provided by OECD.  
 
Table 4.12 Literature definitions that have been collected for the key term 'data gap' 
and have been considered to develop the NANoREG Definition. 
Source Original definition of the term 'data gap' 
INTERNATIONAL BODIES 
OECD 2014a 
Guidance on 
grouping of 
chemicals 
A data gap is a physical-chemical, environmental fate, ecotoxicological, or mammalian 
toxicological/human health endpoint for which data are not available when required for an 
assessment. 
 
4.13 Data gap filling 
Table 4.13 shows the original definitions of the term 'data gap filling', which have been 
collected from the literature and used to develop the NANoREG Definition. Definitions 
could be found in documents from international organisations such as OECD (OECD 
2014a), in document from EU bodies such as ECHA official guidance for implementation 
of REACH (ECHA 2008a), and in reports from industry associations (ECETOC 2012). The 
definitions that are reported in OECD official guidance documents are given higher 
priority as they have regulatory relevance and are the result of a broad consultation at 
international level. Accordingly, the harmonised definition adopted in NANoREG reflects 
the definitions provided by OECD. 
 
Table 4.13 Literature definitions collected for the key term 'data gap filling' and 
considered to develop the NANoREG Definition. 
Source Original definition of the term 'data gap filling' 
INTERNATIONAL BODIES 
OECD 2014a 
Guidance on 
grouping of 
chemicals 
[…] is the process of providing data to inform upon a particular endpoint by whatever 
means is scientifically justified including alternative techniques to direct testing. 
[…] non-testing methods for filling data gaps: 
− Read-across; 
− Trend analysis and use of computational methods based on internal models; 
− Use of computational methods based on external models. 
EUROPEAN BODIES 
ECHA 2008a 
QSARs and 
grouping 
Non-testing data can be generated by three main approaches: a) grouping approaches, 
which include read-across and chemical category formation; (quantitative) structure-
activity relationships ((Q)SARs); and c) expert systems.  
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Table 4.13 (cont.) 
Source Original definition of the term 'data gap filling' 
 The development and application of all kinds of non-testing methods is based on the 
similarity principle, i.e. hypothesis that similar compounds should have similar biological 
activities. 
Within a chemical category, data gaps may be filled by read-across, trend analysis and 
QSARs. 
[…] non-testing techniques for filling data gaps: 
− read-across 
− trend analysis and use of computational methods based on internal models 
− use of computational methods based on external models 
INDUSTRY ASSOCIATIONS 
ECETOC 2012 
Category 
approaches, 
read-across, 
(Q)SAR 
Whenever a category is formed, data gaps may be filled in using read-across (qualitative 
or quantitative), trend analysis (local (Q)SAR) and external (Q)SAR models and expert 
systems. 
 
4.14 Endpoint 
Table 4.14 shows the original definitions of the term 'endpoint', which have been 
collected from the literature and used to develop the NANoREG Definition. Definitions 
could be found in documents from international organisations such as OECD (OECD 
2005, 2012a, 2014a), in documents from EU bodies such as ECHA official guidance for 
implementation of REACH (ECHA 2014b, 2015a), and in reports from European national 
authorities (Danish EPA 2013). The definitions that are reported in OECD official 
guidance documents are given higher priority as they have regulatory relevance and are 
the result of a broad consultation at international level. Accordingly, the harmonised 
definition adopted in NANoREG reflects the definitions provided by OECD.  
 
Table 4.14 Literature definitions collected for the key term 'endpoint' and considered to 
develop the NANoREG Definition. 
Source Original definition of the term 'endpoint' 
INTERNATIONAL BODIES 
OECD 2014a 
Guidance on 
grouping of 
chemicals 
An endpoint refers to a broad description of a specific environmental or toxicological 
property, for example acute oral toxicity, or water solubility. 
OECD 2012b 
Collection of 
working 
definitions 
The recorded observation coming from an in chemico method, an in vitro assay or an in 
vivo assay.  
The measurement of a biological effect, e.g. LC50 or EC50. A large number of endpoints 
are used in regulatory assessments of chemicals. These include lethality, carcinogenicity, 
immunological responses, organ effects, developmental and reproductive effects, etc. In 
QSAR analysis, it is important to develop models for individual toxic endpoints. 
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Table 4.14 (cont.) 
Source Original definition of the term 'endpoint' 
OECD 2005 
Validation of new 
or updated test 
methods 
The biological or chemical process, response, or effect, assessed by a test. 
EUROPEAN BODIES 
ECHA 2015a 
Read-Across 
Assessment 
Framework 
The word “endpoint” has different meanings depending on the context in which it is used 
and so can lead to misunderstandings. In the context of the REACH information 
requirements, endpoints are listed in column 1 of the standard information requirements 
(Annex VI to X) and are described either as a property itself (e.g. skin irritation) and/or as 
a type of study (e.g. carcinogenicity study). 
Other hazardous properties of a substance partially/not covered by the column 1 
information requirements (e.g. immunotoxicity) may also be relevant to understanding 
the hazards and risks a substance may present. 
Due to the different complexities (e.g. key parameters, biological targets) of each 
endpoint, a read across must be specific to the endpoint or property under consideration. 
In the context of this document, preference is given to the term “property”, which is used 
to describe the outcome of a relevant study used to fulfil a REACH information 
requirement. 
ECHA 2014b 
Use of 
alternatives to 
testing on animals 
for REACH 
Observable or measurable inherent property/data point of a chemical substance. It may 
refer to a physical-chemical property (such as vapour pressure), or to degradability, or to 
a biological effect that a given substance has on human health or the environment (e.g. 
carcinogenicity, irritation, or aquatic toxicity). 
EUROPEAN NATIONAL AUTHORITIES 
Danish EPA 2013 
IRNANO 
An endpoint or parameter defines more precisely what the outcome investigated during 
the testing is, e.g. mortality or behavioural changes in (eco-)toxicity studies. Thus, 
toxicological testing often looks at several endpoints/parameters within a given test. 
 
4.15 Exposure Scenario (ES) 
Table 4.15 shows the original definitions of the term 'Exposure Scenario (ES)', which 
have been collected from the literature and used to develop the NANoREG Definition. 
Definitions could be found in documents from international organisations such as OECD 
(2003) and IPSC (2004), in documents from EU bodies such as REACH legal text (EP and 
EC 2006) and ECHA official guidance for REACH implementation (ECHA 2011b), and in 
documents from US bodies such as US EPA (1992, 1998). Several organisations (i.e. 
IPSC, OECD and US EPA) propose a generic definition of ES in risk assessment. In the 
context of REACH, a specific definition of ES is used. The harmonised definition adopted 
in NANoREG includes and discusses both types of definition. 
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Table 4.15 Literature definitions collected for the key term 'Exposure Scenario (ES)' and 
considered to develop the NANoREG Definition. 
Source Original definition of the term 'Exposure Scenario (ES)' 
INTERNATIONAL BODIES 
IPCS 2004 
Risk assessment 
terminology 
A set of conditions or assumptions about sources, exposure pathways, amounts or 
concentrations of agent(s)involved, and exposed organism, system, or (sub)population 
(i.e., numbers, characteristics, habits) used to aid in the evaluation and quantification of 
exposure(s) in a given situation. 
A combination of facts, assumptions, and inferences that define a discrete situation where 
potential exposures may occur. These may include the source, the exposed population, 
the time frame of exposure, microenvironment(s), and activities. Scenarios are often 
created to aid exposure assessors in estimating exposure. 
OECD 2003 
Key generic terms 
A set of conditions or assumptions about sources, exposure pathways, amount or 
concentrations of agent(s) involved, and exposed organism, system, or (sub) population 
(i.e., numbers, characteristics, habits) used to aid in the evaluation and quantification of 
exposure(s) in a given situation. 
EUROPEAN BODIES 
ECHA 2011b 
Introduction to 
guidance 
document 
[…] identify and document the conditions of manufacture and use which are needed for 
controlling the risks to human health and the environment. This includes operational 
conditions (OC) and risk management measures (RMM). In REACH this set of information 
is called “exposure scenario” (ES). 
The goal of the assessment is not to establish whether or not there is a risk, but to 
identify and describe the conditions under which the risks are controlled. 
EP and EC 2006 
REACH Regulation 
[…] means the set of conditions, including operational conditions and risk management 
measures, that describes how the substance is manufactured or used during its life-cycle 
and how the manufacturer or importer controls, or recommends downstream users to 
control, exposures of humans and the environment. These exposure scenarios may cover 
one specific process or use several processes or uses as appropriate; […] 
US BODIES 
US EPA 1998 
Guidance on 
ecological risk 
assessment 
A set of assumptions concerning how an exposure may take place, including assumptions 
about the exposure setting, stressor characteristics, and activities that may lead to 
exposure. 
US EPA 1992 
Guidance on 
exposure 
assessment  
In exposure scenario evaluation, the assessor attempts to determine the concentrations of 
chemicals in a medium or location and link this information with the time that individuals 
or populations contact the chemical. The set of assumptions about how this contact takes 
place is an exposure scenario. 
An exposure scenario is the set of information about how exposure takes place. An 
exposure scenario generally includes facts, data, assumptions, inferences, and sometimes 
professional judgment about the following: 
− The physical setting where exposure takes place (exposure setting).  
− The exposure pathway(s) from source(s) to exposed individual(s) (exposure 
pathways). 
− The characterization of the chemical, i.e., amounts, locations, time variation of 
concentrations, source strength, environmental pathways from source to exposed 
individuals, fate of the chemical in the environment, etc. (characterization of the 
chemical). 
− Identification of the individual(s) or population(s) exposed, and the profile of contact 
with the chemical based on behaviour, location as a function of time, characteristics 
of the individuals, etc. (characterization of the exposed population). 
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Table 4.15 (cont.) 
Source Original definition of the term 'Exposure Scenario (ES)' 
 − If the dose is to be estimated, assumptions about the transfer of the chemical across 
the boundary, i.e., ingestion rates, respiration rates, absorption rates, etc. (intake 
and uptake rates). 
Exposure scenario - A set of facts, assumptions, and inferences about how exposure takes 
place that aids the exposure assessor in evaluating, estimating, or quantifying exposures. 
 
4.16 Extrapolation 
Table 4.16 shows the original definitions of the term 'extrapolation', which have been 
collected from the literature and used to develop the NANoREG Definition. Definitions 
could be found in documents from international organisations such as OECD (2014a), in 
documents from European bodies such as a report by JRC (2005), and in reports from 
industry associations (CEFIC-LRI 2012). The definitions that are reported in OECD official 
guidance documents are given higher priority as they have regulatory relevance and are 
the result of a broad consultation at international level. Accordingly, the harmonised 
definition adopted in NANoREG reflects the definitions provided by OECD.  
 
Table 4.16 Literature definitions collected for the key term 'extrapolation' and 
considered to develop the NANoREG Definition. 
Source Original definition of the term 'extrapolation' 
INTERNATIONAL BODIES 
OECD 2014a 
Guidance on 
grouping of 
chemicals 
[…] the process where data from category members at one side of the category is used to 
predict the hazards of those members at the other side. Of course, it could also be said 
that an analogue approach itself is by default an extrapolation, unless there are analogues 
identified that bracket the target chemical.  
[…] refers to the estimation of a value for a member that is near or at the category 
boundary using measured values from internal category members.  
There is a preference for the use of interpolation rather than extrapolation, because 
extrapolation is perceived to be more uncertain and therefore less reliable. 
EUROPEAN BODIES 
JRC 2005 
Chemical 
categories and  
read-across 
[…] extrapolation refers to the estimation of a value for a member that is near or at the 
category boundary using measured values from internal category members […] 
In general, interpolation between category members is preferred to extrapolation. 
However, in certain cases, such as where toxicity does not change among tested category 
members, extrapolation to other category members may be acceptable.  
INDUSTRY ASSOCIATIONS 
CEFIC-LRI 2012 
Experts workshop 
on read-across 
assessment 
It is intuitive that confidence in the read-across prediction is enhanced when experimental 
data for structural analogues allows for interpolation rather than extrapolation. For 
analogue approaches the interpolation/extrapolation distinction is perhaps less 
meaningful. An analogue approach by default is an extrapolation since the target chemical 
compared to the source either possesses the toxicity-determining features to a lesser 
degree (target predicted less potent than source) or a greater degree (target predicted 
more potent than source). 
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4.17 Framework 
Table 4.17 shows the original definitions of the term 'framework', which have been 
collected from the literature and used to develop the NANoREG Definition. Definitions 
could be found in online dictionaries (Merriam-Webster 2015) and in peer-reviewed 
scientific literature (Hristozov et al 2012). Accordingly, the harmonised definition 
adopted in NANoREG combines elements of these definitions and proposes a suitable one 
for the project.  
 
Table 4.17 Literature definitions collected for the key term 'framework' and considered 
to develop the NANoREG Definition. 
Source Original definition of the term 'framework' 
ONLINE DICTIONARIES 
Merriam-Webster 
2015 
1 /a : a basic conceptional structure (as of ideas) /b : a skeletal, openwork, or 
structural frame 
2: frame of reference 
3: the larger branches of a tree that determine its shape" 
PEER-REVIEWED SCIENTIFIC LITERATURE 
Hristozov et al 2012 A “framework” is a set of practices, organised in a conceptual manner that constitute a 
policy; 
 
4.18 Grouping 
Table 4.18 shows the original definitions of the term 'grouping', which have been 
collected from the literature and used to develop the NANoREG Definition. Definitions 
could be found in documents from international organisations such as OECD (OECD 
2014a; 2014b, Igarashi 2014), in documents from European bodies such as REACH legal 
text (EP and EC 2006, EC 2009) and ECHA official guidance for implementation of REACH 
(ECHA 2008a; 2013a; 2013b; 2015a), in reports from European national authorities 
(RIVM 2015), in reports from industry associations (ECETOC 2012), and in peer-
reviewed scientific literature (Walser and Studer 2015, Arts et al 2014). The definitions 
that are reported in OECD official guidance documents are given higher priority as they 
have regulatory relevance and are the result of a broad consultation at international 
level. These definitions are reflected in ECHA official guidance documents for 
implementation of REACH and in guidance by industry and apply to all chemicals 
including NMs. Accordingly, the harmonised definition adopted in NANoREG reflects the 
definitions provided by OECD. The NANoREG harmonised definition also includes those 
clarifications made by several organisations (OECD, ECHA GAARN, RIVM) and scientists 
with regard to the application of this concept to NMs (ECHA 2013b; OECD 2014a; Arts et 
al 2014; RIVM 2015; Godwin et al 2015). 
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Table 4.18 Literature definitions collected for the key term 'grouping' and considered to 
develop the NANoREG Definition. 
Source Original definition of the term 'grouping' 
INTERNATIONAL BODIES 
Igarashi T 2014 
Expert meeting 
on categorisation 
of manufactured 
nanomaterials 
OECD member 
countries' 
approaches to 
grouping, read-
across, 
equivalence of 
nanomaterials 
Concept of grouping: This may be a category approach or an analogue approach, where 
nanomaterials are grouped based on their physical-chemical properties; […] 
Grouping should take into account, that some nanomaterials show very different physico-
chemical properties, only depending on minor surface modifications. Therefore, grouping 
shall not be based on a chemical composition approach alone. 
Until nano-specific practices are developed, if needed, the OECD Guidance on Grouping of 
Substances provides a set of useful approaches that are generally applicable to 
nanomaterials. 
OECD 2014b 
Expert meeting 
on categorisation 
of manufactured 
nanomaterials 
Background 
document 
While the grouping of chemicals, particularly for purposes of hazard assessment, is used 
in many jurisdictions, nanomaterials introduce additional challenges, due to intrinsic and 
extrinsic differences in physical and chemical properties and differences among nano-
forms of a chemical species, and between nano and non-nano forms. Further, they often 
do not exist as distinct species; rather the populations of the materials can consist of 
distinct species and agglomerates and aggregates and their properties are dependent 
upon the medium in which they are found. Thus, in looking at how to group 
nanomaterials, in addition to chemical composition and shape there are also 
considerations of properties, such as surface charge, which add complexity to the 
exercise. The context of this OECD Expert Meeting is regulatory, and regulators typically 
distinguish substances under their respective laws based on a molecular identity 
(material) focus as opposed to only a properties focus. Thus, while a consideration of 
properties should also be considered in developing the scheme, any categories being 
proposed at the workshop should also be based on molecular identity. Specifically, the 
framework of the categorization scheme should start with molecular identity as shown in 
the categorization scheme below. 
OECD 2014a 
Guidance on 
grouping of 
chemicals 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The way in which grouping is undertaken to predict properties of some members of the 
group depends on the purpose of the prediction, e.g., for commercial decision-making, 
screening and priority-setting of chemicals for further evaluation, hazard identification for 
risk assessment and classification and labelling, filling information requirements in 
different regulatory schemes. Therefore, the administrative practice, standard of proof, 
and degree of scientific certainty in the assessment will all vary depending on the purpose 
of the prediction. 
If grouping is applied, not every chemical needs to be tested for every required endpoint. 
Rather, the data for chemicals and endpoints that have been tested can be used to 
estimate the corresponding properties for the untested chemicals and endpoints. Grouping 
of chemicals can lead to the application of a category or an analogue approach. 
The general approach for considering more than one chemical at the same time. It can 
include formation of a chemical category or identification of (a) chemical analogue(s) with 
the aim of filling data gaps as appropriate. […] makes it possible to extend the use of 
measured data to similar untested chemicals. […] reliable estimates that are adequate for 
classification and labelling and/or risk assessment can be made without further testing. 
[…] an alternative to testing individual chemicals and as a result should lead to a decrease 
in the use of animal testing. 
The rationale underpinning the analogue approach and the category approach may be 
based on the following: 
− Common functional group(s) […]; 
− A common mode or mechanism of action or adverse outcome pathway; 
− Common constituents or chemical classes, similar carbon range numbers […]; 
− The likelihood of common precursors and/or breakdown products via physical or 
biological processes that result in structurally similar chemicals […]; 
− An incremental and constant change across the category […]. 
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Table 4.18 (cont.) 
Source Original definition of the term 'grouping' 
 While a category may in principle be based on one of these rationales, in practice 
endpoint justifications and supporting information will be multifaceted. All pre-existing 
experimental or other (e.g., from the literature) evidence that can support the category 
needs to be addressed. This could be similar effects in lower-tier studies where these 
exist, availability of “bridging” studies that are not necessarily endpoint related (e.g., 
common results in in vitro or other types of screening studies), evidence from 
computational and non-computational theoretical models, common bioavailability, 
metabolism and reactivity profiles, common mode and/or mechanism of action (MOA), or 
adverse outcome pathway (AOP). 
The definition of a group starts with structural similarity and allowed structural differences 
and then continues with investigating the hypothesis for common mode of action. The 
possibility to confirm a common mode (and/or mechanism) of action within a chemical 
category has been further investigated in the last years at OECD via the development of 
the concept of adverse outcome pathways (AOPs). 
In principle the above-listed non-testing techniques can be used to indicate either the 
presence or the absence of an effect or an estimated value (e.g., a relevant toxicity value 
such as a LOAEL) for an analogue or a group of substances. However, this is highly 
dependent on the substance under consideration, the endpoint, the level of information 
already available, the regulatory purpose, and the confidence that can be derived from its 
interpretation. 
At present, it seems premature to develop guidance on grouping specifically for 
nanomaterials. Nevertheless, research efforts will pave the way for common approaches 
and frameworks to grouping nanomaterials for purpose of hazard assessment in the 
future. In addition, expand further on why certain properties tend to elicit certain effects 
in vitro or in vivo and where opportunities may exist to group nanomaterials together to 
rationalize testing. Section 6.9 will be amended as accepted principles for grouping and 
read-across of nanomaterials arise from these activities. 
EUROPEAN BODIES 
ECHA 2015a 
Read-Across 
Assessment 
Framework 
Substances whose physicochemical, toxicological and ecotoxicological properties are likely 
to be similar or follow a regular pattern as a result of structural similarity may be 
considered as a group, or ‘category’ of substances. 
Structural similarity is a pre-requisite for any grouping and read-across approach under 
REACH. These similarities may be due to a number of factors: 
− Common functional group (i.e. chemical similarity within the group), 
− Common precursors and/or likelihood of common breakdown products via physical 
and/or biological processes which result in structurally-similar degradation products 
(i.e. similarity through (bio)transformation), or 
− A constant pattern in the changing of the potency of the properties across the group 
(i.e. of physico-chemical and/or biological properties). 
ECHA 2013b 
Second GAARN 
meeting 
Best practices for 
REACH registrants 
A basis for grouping the nanoforms/nanomaterials of interest (in terms of their similarity) 
should be established using the similarity rules specified in Annex XI of the REACH 
Regulation. The hypothesis, or basis for the grouping, should be used to define what 
characteristics a nanoform/nanomaterial should have in order to belong to a category. 
The similarity rules (which could also be called criteria or principles) might be used 
individually and are case-dependent. However, a category (and similarity) may be 
justified on more than one basis, as multiple justifications usually increase the confidence 
in the category. The hypothesis will help to show if the grouping applies to the category 
members for either environmental or toxicological endpoints or both, and if it is adequate 
for all routes of exposure and duration of effects (Practical Guide 6, ECHA 2009). 
The registration dossier should contain a comprehensive physicochemical characterisation 
of the registered nanoform(s) (First GAARN meeting best practices report). Only when 
well-characterised nanoforms are reported in the dossier, can a read-across approach or 
use of existing data (e.g. weight of evidence) be considered for the purpose of hazard 
assessment. Generating data on toxicokinetics might also be considered for grouping 
substances in relation to read-across approaches, or extrapolating from in vitro to in vivo 
situations. 
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Table 4.18 (cont.) 
Source Original definition of the term 'grouping' 
ECHA 2013a 
Grouping of 
substances and 
read across 
approach 
Substances that are structurally similar with physicochemical, toxicological, 
ecotoxicological and/or environmental fate properties that are likely to be similar or to 
follow a regular pattern may be considered as a group of substances. 
These similarities may be due to a number of factors: 
− Common functional group (i.e. chemical similarity within the group) 
− Common precursors and/or likely common breakdown products via physical and/or 
biological processes which result in structurally-similar degrading chemicals 
− A constant pattern in the properties across the group […] 
ECHA 2008a 
QSARs and 
grouping of 
chemicals 
[…] describes the general approach to assessing more than one chemical at the same 
time. It can include formation of a chemical category or identification of a chemical 
analogue for which read-across may be applied. 
The similarities may be based on the following: 
− Common functional group(s) […]; 
− A common mode or mechanism of action or adverse outcome pathway; 
− Common constituents or chemical classes, similar carbon range numbers […]; 
− The likelihood of common precursors and/or breakdown products via physical or 
biological processes that result in structurally similar chemicals […]; 
− An incremental and constant change across the category […]. 
EP and EC 2006; 
EC 2009 
REACH Annex XI 
Substances whose physicochemical, toxicological and ecotoxicological properties are likely 
to be similar or follow a regular pattern as a result of structural similarity may be 
considered as a group, or ‘category’ of substances.  
The similarity may be based on: 
(1). A common functional group; 
(2). The common precursors and/or the likelihood of common breakdown products via 
physical and biological processes, which result in structurally similar chemicals; or 
(3). A common pattern in the changing of the potency of the properties across the 
category. 
EUROPEAN NATIONAL AUTHORITIES 
RIVM 2015 
Grouping 
nanomaterials 
Scientists have determined many ways in which changing the size of a particle can change 
the properties of a material and have identified many of the other important variables that 
influence the behaviour of a nanomaterial […]. The results of research to date do not allow 
for tightly defined algorithms for grouping nanomaterials. They do allow, as described in 
this report, for drawing some "read-across" conclusions based on the weight of evidence. 
Some physicochemical data are so essential to characterising a nanomaterial that they 
should be compiled during the initial step in the process. These data include chemical 
composition, surface characteristics, impurities and surface area. 
INDUSTRY ASSOCIATIONS 
ECETOC 2012 
Category 
approaches, 
Read-across, 
(Q)SAR 
In this report, the term 'category approach' and 'analogue approach' are used to describe 
techniques for grouping chemicals, whilst the term 'read-across' is reserved for a 
technique of filling data gaps in either approach. 
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Table 4.18 (cont.) 
Source Original definition of the term 'grouping' 
PEER-REVIEWED SCIENTIFIC LITERATURE 
Walser and 
Studer 2015 
Nanomaterial 
sameness and 
grouping schemes 
A grouping scheme is therefore required which allows for bundling similar nanomaterials 
into clouds with underlying test strategies. A cloud may be constructed on the basis of 
modes of action (MOA), which can lead via adverse outcome pathways (AOP) to impacts 
such as chronic toxicity, reproductive toxicity, genotoxicity, etc. (OECD 2014). […] 
Clouds can accommodate nanomaterials of different entities (and hence different 
physicochemical properties) as long as their hazard is based on the same AOPs. In 
addition, test results can be transferred from one to another cloud if the underlying AOPs 
are the same for a specific endpoint (read across). 
[…] the clouds and the entities are complementary concepts to be combined in the 
regulatory hazard assessment of nanomaterials. The grouping of unlimited identities into 
entities allows us (i) to distinguish different nanomaterials and (ii) to unify similar 
nanomaterials. Hence, it provides an interpretation of ‘‘sameness’’ based on physico-
chemical properties. The grouping strategy helps industry, research and regulatory 
authorities to decide on a new notification or to identify a similar nanomaterial of the 
same entity already notified. 
Arts et al 2014 
Critical appraisal 
grouping 
nanomaterials 
[…] This grouping concept implies that some, if not all, information on the hazard of a NM 
can be derived from the respective bulk material, from molecules or ions of its 
constituents, or from similar NMs. 
[…]NM grouping should not be restricted to the determination of nanostructure–activity 
relationships, but should take into account all aspects of the substance’s entire life cycle. 
These aspects include the NM’s material properties (e.g. size, shape, crystallinity) and 
biophysical interactions (e.g. generation of oxidative species), its intended use (and hence 
incorporation into the respective product and possible release therefrom), the ‘external 
exposure’ to the NM (i.e. the dose level and physicochemical form of the NM exposure 
outside the body), NM uptake and ‘internal exposure’ (referring to the NM’s concentration 
and physico-chemical form at the site of action in the organism), and, finally, its 
biokinetics and possible early biological and apical effects. 
 
4.19 Harmonisation 
Table 4.19 shows the original definitions of the term 'harmonisation', which have been 
collected from the literature and used to develop NANoREG Definition. Definitions could 
be found in documents and webpages from international organisations such as UN 
(2003) and OECD (2015). The term is defined at UN and OECD level with different 
scope/meaning. Accordingly, the harmonised definition adopted in NANoREG includes a 
generic definition of the term 'harmonisation' and considers OECD and UN activities as 
examples of such a process. 
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Table 4.19 Literature definitions collected for the key term 'harmonisation' and 
considered to develop the NANoREG Definition. 
Source Original definition of the term 'harmonisation' 
INTERNATIONAL BODIES 
OECD 2015 
Testing of 
chemicals 
OECD assists countries in harmonising test methods for chemical safety and good 
laboratory practice, in order to ensure high quality and reliable data and for countries and 
industry to fully benefit from the OECD agreement on Mutual Acceptance of Data and 
avoid duplicative testing. 
Under the Mutual Acceptance of Data system, results from a chemical safety test 
conducted in OECD countries shall be accepted by other OECD and adhering countries if 
the test was carried out according to OECD Test Guidelines and GLP Principles. 
UN 2003 
Globally 
Harmonised 
System 
[…] harmonisation means establishing a common and coherent basis for chemical hazard 
classification and communication, from which the appropriate elements relevant to means 
of transport, consumer, worker, and environment protection can be selected; […] 
 
4.20 Information requirement 
Table 4.20 shows the original definitions of the term 'information requirement', which 
have been collected from the literature and used to develop the NANoREG Definition. No 
definitions in documents from international organisations could be found. Definitions 
could only be retrieved from documents prepared by European bodies such as REACH 
legal text (EP and EC 2006) and reports from national authorities (Danish EPA 2013). 
Accordingly, the harmonised definition adopted in NANoREG reflects the definition 
provided by Danish EPA as the text of this definition is generic enough to cover any type 
of information on chemicals required by any legal text including REACH. 
 
Table 4.20 Literature definitions collected for the key term 'information requirement' 
and considered to develop the NANoREG Definition. 
Source Original definition of the term 'information requirement' 
EUROPEAN BODIES 
EP and EC 2006 
REACH Annex VI 
Annexes VI to XI specify the information that shall be submitted for registration and 
evaluation purposes according to Articles 10, 12, 13, 40, 41 and 46. 
[…] what information is required for registration. 
EUROPEAN NATIONAL AUTHORITIES 
Danish EPA 2013 
IRNANO 
An information requirement is generally understood as the entry in a legal text requiring 
information on e.g. physicochemical, toxicological and ecotoxicological properties. 
 
4.21 Interpolation 
Table 4.21 shows the original definitions of the term 'interpolation', which have been 
collected from the literature and used to develop the NANoREG Definition. Definitions 
could be found in documents from international organisations such as OECD (2014a) and 
IUPAC (Duffus et al 2007), in documents from European bodies such as JRC (2005), and 
 55 
 
reports from industry associations (CEFIC-LRI 2012). The definitions that are reported in 
OECD official guidance documents are given higher priority as they have regulatory 
relevance and are the result of a broad consultation at international level. These 
definitions are taken on board by industry in their guidance documents and in principle 
apply to all chemicals including NMs. Accordingly, the harmonised definition adopted in 
NANoREG reflects the definitions provided by OECD. 
 
Table 4.21 Literature definitions collected for the key term 'interpolation' and 
considered to develop the NANoREG Definition. 
Source Original definition of the term 'interpolation' 
INTERNATIONAL BODIES 
OECD 2014a 
Guidance on 
grouping of 
chemicals 
Within a category where trends in toxicity or factors influencing toxicity have been 
identified and the category members arranged in line with the trend as illustrated in 
Figure 1, interpolation can be described as the process whereby data from category 
members on either side of a datapoor category member is used to predict its hazards. 
[…] the estimation of a value for a member using measured values from other members 
on "both sides" of that member within the defined category spectrum 
There is a preference for the use of interpolation rather than extrapolation, because 
extrapolation is perceived to be more uncertain and therefore less reliable. 
Duffus et al 2007 
IUPAC 
recommandations 
Estimation of a value between two known data points. 
EUROPEAN BODIES 
JRC 2005 
Grouping and 
read-across 
approaches 
Interpolation is the estimation of a value for a member using measured values from other 
members on “both sides” of that member within the defined category spectrum. 
In general, interpolation between category members is preferred to extrapolation. 
However, in certain cases, such as where toxicity does not change among tested category 
members, extrapolation to other category members may be acceptable. Interpolation can 
be performed with a certain confidence when the series of values is monotonic (all 
increasing or decreasing), but guidance is needed in the case that one or more values are 
outliers to the trend. 
INDUSTRY ASSOCIATIONS 
CEFIC-LRI 2012 
Expert workshop 
on read-across 
assessment 
It is intuitive that confidence in the read-across prediction is enhanced when experimental 
data for structural analogues allows for interpolation rather than extrapolation. For 
analogue approaches the interpolation/extrapolation distinction is perhaps less 
meaningful. An analogue approach by default is an extrapolation since the target chemical 
compared to the source either possesses the toxicity-determining features to a lesser 
degree (target predicted less potent than source) or a greater degree (target predicted 
more potent than source). 
The legal text expressly stipulates interpolation. 
 
4.22 Life cycle 
Table 4.22 shows the original definitions of the term 'life cycle', which have been 
collected from the literature and used to develop the NANoREG Definition. Definitions 
could be found in documents from international organisations such as ISO (2006) and in 
documents from European bodies such as ECHA official guidance for implementation of 
REACH (ECHA 2010b; 2011b). The definitions that are reported in ISO standards are 
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given higher priority as they have regulatory relevance and are the result of a broad 
consultation at international level. However, these definitions are generic and applicable 
to any product system. Since REACH provisions for chemicals and NMs are extensively 
discussed within NANoREG, the definition of the term 'life cycle of a substance' provided 
by ECHA needs also to be considered. Accordingly, the harmonised definition adopted in 
NANoREG reflects the definitions provided by both OECD and ECHA. 
 
Table 4.22 Literature definitions collected for the key term 'life cycle' and considered to 
develop the NANoREG Definition. 
Source Original definition of the term 'life cycle' 
INTERNATIONAL BODIES 
ISO 2006 
Life cycle 
assessment 
[…] consecutive and interlinked stages of a product system, from raw material acquisition 
or generation from natural resources to final disposal 
EUROPEAN BODIES 
ECHA 2011b 
Introduction to 
the guidance 
document 
The exposure assessment needs to cover manufacture and all identified uses of the 
substance and to consider all life-cycle stages resulting from the manufacture and 
identified uses. It needs to cover all relevant human and environmental exposure routes 
and populations. 
[…] life cycle stages subsequent to identified uses (releases from articles and releases 
from waste life stage). 
[…] information on manufacture (if within EU), use, handling and disposal of the 
substance or of articles containing the substance (i.e. covering its whole life cycle), […] 
The exposure assessment shall cover manufacture and all identified uses of the substance 
and the life cycle stages resulting from these identified uses. This includes, where 
relevant, service-life of articles and the waste life stages of the substance on its own, in 
mixtures or in articles. 
ECHA 2010a 
Use descriptor 
system  
Seven main groups of actors play a role during the life cycle of the substance: 
Manufacturers and importers of chemical substances (including metals and minerals), 
companies mixing and blending chemicals (formulators) to produce mixtures, distributors, 
industrial end-users, professional end-users and consumers. 
The life cycle stage at which a use takes place (manufacture, formulation or end-use), […] 
[…] life cycle stages (manufacture, formulation, end-use or service life) […] 
“Stages” include one or more uses at a certain life cycle stage which are being 
characterised by similar conditions of use with i) regard to the environment and ii) the 
main user group. There are 3 main user groups and 4 stages. For the stages 
“manufacture” and “formulation” it is assumed that they always take place under 
industrial conditions. 
 
4.23 Life Cycle Assessment (LCA) 
Table 4.23 shows the original definitions of the term 'Life Cycle Assessment (LCA)', 
which have been collected from the literature and used to develop a harmonised 
definition in NANoREG. Definitions could be found in documents from international 
organisations such as ISO (2006), in documents from European bodies such as JRC 
(2010) and in peer-reviewed scientific literature (Som et al 2010, SETAC 1993). The 
definitions that are reported in ISO standards are given higher priority as they have 
regulatory relevance and are the result of a broad consultation at international level. 
However, these definitions are generic and applicable to any product system. A specific 
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definition of LCA for chemicals and/or NMs could not be found. Accordingly, the 
harmonised definition adopted in NANoREG reflects the definitions provided by ISO and 
also considers those considerations made by scientists in peer-reviewed scientific 
literature with regard to the application of this concept to NMs (Som et al 2010).  
 
Table 4.23 Literature definitions collected for the key term 'Life Cycle Assessment (LCA)' 
and considered to develop the NANoREG Definition. 
Source Original definition of the term 'life cycle assessment (LCA)' 
INTERNATIONAL BODIES 
ISO 2006 
Life cycle 
assessment 
 
Compilation and evaluation of the inputs, outputs and the potential environmental impacts 
of a product system throughout its life cycle. 
LCA addresses the environmental aspects and potential environmental impacts  (e.g. use 
of resources and the environmental consequences of releases) throughout a product's 
service life cycle from raw material acquisition through production, use, end-of-life 
treatment, recycling and final disposal (i.e. cradle-to-grave). 
EUROPEAN BODIES 
JRC 2010 
ILCD Handbook 
Life Cycle Assessment (LCA) is a structured, comprehensive and internationally 
standardised method. It quantifies all relevant emissions and resources consumed and the 
related environmental and health impacts and resource depletion issues that are 
associated with any goods or services (“products”). 
Life Cycle Assessment takes into account a product's full life cycle: from the extraction of 
resources, through production, use, and recycling, up to the disposal of remaining waste. 
Critically, LCA studies thereby help to avoid resolving one environmental problem while 
creating others: This unwanted “shifting of burdens" is where you reduce the 
environmental impact at one point in the life cycle, only to increase it at another point. 
Therefore, LCA helps to avoid, for example, causing waste-related issues while improving 
production technologies, increasing land use or acid rain while reducing greenhouse 
gases, or increasing emissions in one country while reducing them in another. 
Life Cycle Assessment is therefore a vital and powerful decision support tool, 
complementing other methods, which are equally necessary to help effectively and 
efficiently make consumption and production more sustainable. 
PEER-REVIEWED SCIENTIFIC LITERATURE 
Som et al 2010 
Life cycle 
concepts in safe 
nanoproducts 
The wording ―life cycle assessment‖ stands exclusively for a clearly defined 
methodological framework that has been developed in the early 1990‘s as reported e.g. in 
the ISO 14040/14044 standards. 
LCA is essentially a comprehensive tool for environmental sustainability assessment. In 
theory, it takes into account all inputs (i.e. materials, energy, chemicals, land use etc) 
and all outputs (i.e. emissions, solid waste, products etc.) throughout the life-cycle of a 
product – from the extraction of the resources to the final disposal of the product. LCA 
evaluates thereby the overall impacts of a product system on natural environment, human 
health, natural resources, and man-made environment. LCA can be used for comparing a 
product that includes ENMs with similar products without ENMs and thus to assess the 
relative environmental performance of nanoproducts in comparison with their 
conventional equivalents. 
The main contribution of LCA is often towards impact categories like resource use, global 
warming, acidification, ecotoxicity, human welfare and other. Whereas risk assessment of 
nanomaterials focuses on the toxic impacts, LCA provides a more comprehensive 
overview of the potential environmental impacts of nanoproducts, including all other 
substances used during manufacturing of the product. 
SETAC 1993 
Guidelines for LCA 
LCA is a way of assessing the environmental burdens associated with the whole life cycle 
of a product or service, from its cradle to its grave 
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4.24 Mode of action 
Table 4.24 shows the original definitions of the term 'mode of action', which have been 
collected from the literature and used to develop the NANoREG Definition. Definitions 
could be found in documents from international organisations such as OECD (2011; 
2012a; 2014a) and reports from industry associations (ECETOC 2007). The definitions 
that are reported in OECD official guidance documents are given higher priority as they 
have regulatory relevance and are the result of a broad consultation at international 
level. Accordingly, the harmonised definition adopted in NANoREG reflects the definitions 
provided by OECD. 
 
Table 4.24 Literature definitions collected for the key term 'mode of action' and 
considered to develop the NANoREG Definition. 
Source Original definition of the term 'mode of action' 
INTERNATIONAL BODIES 
OECD 2014a 
Guidance on 
grouping of 
chemicals 
A mode of action describes a functional or anatomical change, at the cellular level, 
resulting from the exposure of a living organism to a chemical. In comparison, a 
mechanism of action describes such changes at the molecular level. 
A mechanism of action denotes the sequence of events leading from the absorption of an 
effective dose of a chemical to the production of a specific biological response in the 
target organ. Understanding a chemical’s mechanism requires appreciation of the 
causality and temporal relationships between the steps leading to a particular toxic 
endpoint, as well as the steps that lead to an effective dose of the chemical at the 
relevant biological target(s). 
OECD 2012b 
Collection of 
working 
definitions 
[…] it relates to the events including, and downstream of, the toxicity pathway. These 
could lead to an adverse effect in an individual. The MoA starts with the molecular 
initiating event. Unlike AOP, it does not (usually) include consideration of exposure or 
effects at higher levels than the individual. 
OECD 2011 
Mechanistic 
information in 
forming chemical 
categories 
The sequence of key events and cellular and biochemical events (measurable 
parameters), starting with the interaction of an agent with the target cell, through 
functional and anatomical changes, resulting in cancer or other adverse health effects 
(USEPA 2005; Boobis, Doe et al. 2008). Mode of action differs from mechanism, in that 
the latter implies a more detailed understanding of the molecular basis of the toxic effect 
(Seed et al. 2005). 
INDUSTRY ASSOCIATIONS 
ECETOC 2007 
Mode of action 
approach for 
specifically acting 
chemicals 
A common set of physiological and behavioural signs that characterise a type of adverse 
biological response, where the major (but not all) biochemical steps are understood. 
 
4.25 Nanoform 
Table 4.25 shows the original definitions of the term 'nanoform', which have been 
collected from the literature and used to develop the NANoREG Definition. Definitions 
could not be found in documents from international organisations. The term is used in 
several documents from European bodies (EC 2008a, JRC and ECHA 2012, ECHA 2012a, 
ECHA 2013a, SCCS 2013, SCCS 2015) and in reports from industry associations (ETUC 
2010), and is often used as a synonymous of 'nanomaterial' (EC 2011). Accordingly, the 
harmonised definition adopted in NANoREG takes inspiration from the definition reported 
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in two documents prepared by European bodies (EC 2008a; JRC and ECHA 2012) and 
linked to REACH. The NANoREG harmonised definition has been developed in agreement 
with ECHA and is in line with the definition of the term 'nanomaterial' developed by the 
European Commission (EC 2011).  
 
Table 4.25 Literature definitions collected for the key term 'nanoform' and considered to 
develop the NANoREG Definition. 
Source Original definition of the term 'nanoform' 
EUROPEAN BODIES 
SCCS 2015 
Factsheet on silica 
in nanoform 
Something is in ‘nanoform’ when particles of that substance are less than 100 nm in size. 
SCCS 2013 
Opinion on carbon 
black (nano-form) 
[…] nanomaterial […] the material in its nano form […] 
ECHA 2013a 
Second GAARN 
meeting 
Best practice for 
REACH registrants 
The registration dossier should contain a comprehensive physicochemical characterisation 
of the registered nanoform(s) (First GAARN meeting best practices report). Only when 
well-characterised nanoforms are reported in the dossier, can a read-across approach or 
use of existing data (e.g. weight of evidence) be considered for the purpose of hazard 
assessment. 
ECHA 2012a 
First GAARN 
meeting 
When the scope of the registered substance involves both nanoforms and bulk forms […] 
JRC and ECHA 
2012 
NANO-SUPPORT 
final report 
Finally, the term ‘nanomaterial’ has in this report been used for dossiers addressing 
nanomaterials only whereas the term ‘nanoform’ has been used for dossiers that (seem 
to) also address other forms (e.g. bulk). Thus, a nanoform registered ‘alone’ (not along 
with non-nanoforms) would be a nanomaterial. In essence, the terms therefore cover the 
same, but a distinction was found useful for reporting the results in this project. 
EC 2008a 
Regulatory 
aspects of 
nanomaterials 
The term “nanoform” will be useful in cases where reference is made to particular forms 
of a substance with nanomaterial properties, as opposed to the “bulk form” of the same 
substance, i.e. (the) form(s) of the substance without nanomaterial properties. 
EUROPEAN NATIONAL AUTHORITIES 
ETUC 2010 
Regulatory 
definition of a 
substance in the 
nanoform 
For regulatory purposes a substance in the nanoform: 
− Is defined when it is a solid at room temperature; and 
− Its PPSDn av or d<100 of the production process shows that more than 80% of the 
(number-) fraction is below 100 nm. (In case the number fraction below 100 nm is 
less than 10% the substance is fully in the bulk. In between 80% and 10% the 
substance is called a multi-constituent substance between its nanoform and bulk). 
When the surface area of the primary particles is treated chemically by more than 20%, 
the untreated substance in the nanoform is different from the treated one. 
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4.26 (Quantitative) Structure-Activity Relationship ((Q)SAR) 
Table 4.26 shows the original definitions of the term '(Quantitative) Structure-Activity 
Relationship ((Q)SAR)', which have been collected from the literature and used to 
develop the NANoREG Definition. Definitions could be found in documents from 
international organisations such as OECD (2005, 2014a) and in documents from 
European bodies such as ECHA official guidance for implementation of REACH (ECHA 
2008a; 2014b). The definitions that are reported in OECD official guidance documents 
are given higher priority as they have regulatory relevance and are the result of a broad 
consultation at international level. These definitions are reflected in ECHA official 
guidance for implementation of REACH and in principle apply to all chemicals including 
NMs. Accordingly, the harmonised definition adopted in NANoREG reflects the definitions 
provided by OECD. 
 
Table 4.26 Literature definitions collected for the key term '(Quantitative) Structure-
Activity Relationship ((Q)SAR)' and considered to develop the NANoREG Definition. 
Source Original definition of the term '(Quantitative) Structure-Activity Relationship 
((Q)SAR)' 
INTERNATIONAL BODIES 
OECD 2014a 
Guidance on 
grouping of 
chemicals 
A SAR is a qualitative relationship that relates a (sub)structure to the presence or absence 
of a property or activity of interest. The substructure may consist of adjacently bonded 
atoms, or an arrangement of non-bonded atoms that are collectively associated with the 
property or activity. SARs can be helpful in the qualitative evaluation of the analogues 
identified as belonging to a category. 
A (Q)SAR is a mathematical model (often a statistical correlation) relating one or more 
quantitative, parameters derived from chemical structure to a quantitative measure of a 
property or activity (e.g. a (eco)toxicological endpoint). (Q)SARs are quantitative models 
yielding a continuous or categorical result. 
OECD 2005 
Validation of new 
and updated test 
methods 
(Q)SAR [(Quantitative) Structure-Activity Relationship]: An expression used to consider, 
simultaneously, SARs and QSARs. 
SAR (Structure-Activity Relationship): A theoretical model for making predictions of 
physicochemical properties, environmental fate parameters, or biological effects (including 
toxic effects in environmental and mammalian species). SARs are qualitative relationships 
in the form of structural alerts that incorporate molecular substructures or fragments 
related to the presence or absence of activity. 
QSAR (Quantitative Structure-Activity Relationship): A QSAR is a theoretical model for 
making predictions of physicochemical properties, environmental fate parameters, or 
biological effects (including toxic effects in environmental and mammalian species). 
QSARs relate quantitative measures of chemical structure to continuous or categorical 
variables describing the property to be predicted. 
EUROPEAN BODIES 
ECHA 2014b 
Use of 
alternatives to 
testing on animals 
for REACH 
Theoretical models that can be used to predict in a quantitative or qualitative manner the 
physicochemical, biological (e.g. (eco) toxicological) and environmental fate properties of 
compounds from knowledge of their chemical structure. A SAR is a qualitative relationship 
that relates a (sub)structure to the presence or absence of a property or activity of 
interest. A (Q)SAR is a mathematical model relating to one or more quantitative 
parameters, which are derived from the chemical structure, to a quantitative measure of a 
property or activity. 
ECHA 2008a 
QSARs and 
grouping of 
chemicals 
SARs and QSARs, collectively referred to as (Q)SARs, are theoretical models that can be 
used to predict in a qualitative or quantitative manner the physico-chemical, biological 
(e.g. toxicological) and environmental fate properties of compounds from a knowledge of 
their chemical structure.  
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Table 4.26 (cont.) 
Source Original definition of the term '(Quantitative) Structure-Activity Relationship 
((Q)SAR)' 
 A SAR is a qualitative relationships that relates a (sub)structure to the presence or 
absence of a property or activity of interest. The substructure may consist of adjacently 
bonded atoms, or an arrangement of non-bonded atoms that are collectively associated 
with the property or activity. 
A QSAR is a mathematical model (often a statistical correlation) relating one or more 
quantitative parameters derived from chemical structure to a quantitative measure of a 
property or activity (e.g. a (eco)toxicological endpoint). QSARs are quantitative models 
yielding a continuous or categorical result. 
 
4.27 (Quantitative) Structure-Activity Relationship ((Q)SAR) 
model validation 
Table 4.27 shows the original definitions of the term '(Quantitative) Structure-Activity 
Relationship ((Q)SAR) model validation', which have been collected from the literature 
and used to develop the NANoREG Definition. Definitions could be found in one 
document from OECD (2007). The definitions that are reported in OECD official guidance 
documents are given higher priority as they have regulatory relevance and are the result 
of a broad consultation at international level. Accordingly, the harmonised definition 
adopted in NANoREG reflects the definitions provided by OECD. 
 
Table 4.27 Literature definitions collected for the key term '(Quantitative) Structure-
Activity Relationship ((Q)SAR) model validation' and considered to develop the 
NANoREG Definition. 
Source Original definition of the term '(Quantitative) Structure-Activity Relationship 
((Q)SAR) model validation' 
INTERNATIONAL BODIES 
OECD 2007 
Validation of 
QSAR models 
 
 
 
 
 
 
 
 
 
 
 
 
 
To facilitate the consideration of a (Q)SAR model for regulatory purposes, it should be 
associated with the following information: 
1. a defined endpoint; 
2. an unambiguous algorithm; 
3. a defined domain of applicability; 
4. appropriate measures of goodness-of-fit, robustness and predictivity; 
5. a mechanistic interpretation, if possible. 
[…] a) the internal performance of a model (as represented by goodness-of-fit and 
robustness), determined by using a training set; and b) the predictivity of a model, 
determined by using an appropriate test set. 
The conventional OECD uses of the terms “reliability” and “relevance” can be extended to 
the validation process for (Q)SAR models. However, because (Q)SAR models are derived 
from experimental data, the concepts of reliability and relevance for test guideline purposes 
are necessary but not necessarily sufficient for validation of (Q)SAR models. This guidance 
document for (Q)SAR validation expands the concepts of reliability in a manner that retains 
that from a test method as the “maximum reliability” which can be expected from (Q)SAR 
model. Since few test methods have documented the reproducibility between laboratories 
for a single chemical, the validation of (Q)SAR models based on experimental data from 
different laboratories incorporates this implicit, but not often documented, reproducibility of 
the experimental test methods along with other important performance elements of the 
(Q)SAR model. 
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Table 4.27 (cont.) 
Source Original definition of the term '(Quantitative) Structure-Activity Relationship 
((Q)SAR) model validation' 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cross-validation 
 
 
 
 
External 
validation 
 
 
 
 
 
 
 
Internal 
validation 
 
 
Model 
performance 
 
Validated vs 
valid 
In particular, the assessment of (Q)SAR reliability places greater emphasis on the accuracy 
of the (Q)SAR predictions with respect to many different chemicals than on the 
reproducibility of the (Q)SAR within and between laboratories. Moreover, reliability is more 
often described for an entire group of tested chemicals than as the reproducibility of 
individual endpoint estimations. 
Likewise, the term “relevance” must be extended for the validation of (Q)SAR models 
because biological effects (endpoints) measured by test methods may appear to be similar 
for different chemicals but result of different molecular interactions and pathways. 
Consequently, even though the relevance of a test endpoint in regulatory assessments may 
be established, an additional assessment of the (Q)SAR model relevance must be made 
with respect to the expected molecular interactions and pathways by which each causes the 
biological effect. This important distinction between experimental test methods and (Q)SAR 
models is sometimes expressed by the extent to which each can be applied to the chemicals 
being regulated. 
The more reliable test methods tend to be more globally applicable to measuring the same 
endpoint for many different chemicals whereas the more reliable (Q)SAR models of major 
toxicity pathways reflected in a given endpoint tend to be relevant for specific classes of 
chemicals. 
Cross-validation refers to the use of one or more statistical techniques in which different 
proportions of chemicals are omitted from the training set (e.g. leave-one-out [LOO], leave-
many-out [LMO]). The QSAR is developed on the basis of the data for the remaining 
chemicals, and then used to make predictions for the chemicals that were omitted. This 
procedure is repeated a number of times, so that a number of statistics can be derived from 
the comparison of predicted data with the known data. 
Cross-validation techniques can be used to assess the robustness of the model (stability of 
model parameters), and to make estimates of predictivity. 
External validation refers to a validation exercise in which the chemical structures selected 
for inclusion in the test set are different to those included in the training set, but which 
should be representative of the same chemical domain. The QSAR model developed by 
using the training set chemicals is then applied to the test set chemicals in order to verify 
the predictive ability of the model.  
Many QSAR practitioners regard external validation to be the most stringent form of 
validation, provided that sufficient experimental data are available, and the test structures 
are selected judiciously, in order to allow for a sufficient coverage of the applicability 
domain of the model.  
In the ideal validation process, the results of external validation will be used to supplement 
the results obtained by internal validation. However, in practice, there may be insufficient 
data to perform an external validation. 
Internal validation refers to a validation exercise in which one or more statistical methods 
are applied to the training set of chemicals. Internal validation results in one or more 
measures of goodness-of-fit, robustness of model parameters, and estimates of predictivity. 
Many QSAR practitioners regard internal validation to be an essential, but not sufficient, 
aspect of statistical validation, which should ideally be supplemented by external validation. 
The performance of a (Q)SAR model refers to its goodness-of-fit, robustness and predictive 
ability in relation to a defined applicability domain. 
Model performance is established by using the techniques of statistical validation. 
A validated (Q)SAR is a model considered to be reliable for a particular purpose based on 
the results of the validation process in which the domain of application and the level of 
uncertainty required is defined. 
A valid (Q)SAR is a model considered to be adequate for the intended purpose either 
because reliability has been demonstrated by historical use or by a validation process. 
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4.28 Read-across 
Table 4.28 shows the original definitions of the term 'read-across', which have been 
collected and used to develop the NANoREG Definition. Definitions could be found in 
documents from international organisations such as OECD (2014a), in documents from 
European bodies such as REACH legal text (EP and EC 2006, EC 2009), ECHA official 
guidance for implementation of REACH (ECHA 2008a), other ECHA scientific reports 
(ECHA 2012c, 2013a, 2013b, 2014b, 2015a, 2015b), and SCCS guidance (SCCS 2012), 
on US EPA official website (US EPA 2015), in a report by US/Canada RCC (2013), in 
reports from industry associations (ECETOC 2012), and in peer-reviewed scientific 
literature (van Leeuwen et al 2007, van Leeuwen et al 2009, Cronin 2013, Godwin et al 
2015, Schultz et al 2015). The definitions that are reported in OECD official guidance 
documents are given higher priority as they have regulatory relevance and are the result 
of a broad consultation at international level. These definitions are reflected in ECHA 
official guidance for implementation of REACH along with guidance by industry and in 
principle apply to all chemicals including NMs. Accordingly, the harmonised definition 
adopted in NANoREG reflects the definitions provided by OECD. The NANoREG Definition 
also includes those considerations made by several organisations (OECD, ECHA GAARN, 
RIVM) and scientists with regard to the application of the 'read-across' concept to NMs 
(ECHA 2013a; OECD 2014a; Arts et al 2014; RIVM 2015; Godwin et al 2015). 
 
Table 4.28 Literature definitions collected for the key term 'read-across' and considered 
to develop the NANoREG Definition. 
Source Original definition of the term 'read-across' 
INTERNATIONAL BODIES 
OECD 2014a 
Guidance on 
grouping of 
chemicals 
The principle of the read-across technique is that endpoint or test information for one 
chemical is used to predict the same endpoint or test for another chemical, which is 
considered to be similar by scientific justification. A chemical used to make an estimate 
can be referred to as a source chemical, and a chemical for which an endpoint is estimated 
can be referred to as a target chemical. 
Theoretically, the technique of read-across can be applied to characterise physical-
chemical properties, environmental fate, human health effects and ecotoxicity. For any of 
these areas, read-across may be performed in a qualitative or quantitative manner. 
Within a group of chemicals, read-across can be performed in the following ways to fill 
data gaps: 
− One-to-one (one analogue used to make an estimation for a single chemical); 
− Many-to-one (two or more analogues used to make an estimation for a single 
chemical); 
− One-to-many (one analogue used to make estimations for two or more chemicals); 
or 
− Many-to-many (two or more analogues used to make estimations for two or more 
chemicals). 
In qualitative read-across, the presence (or absence) of a property/activity for the target 
chemical is inferred from the presence (or absence) of the same property/activity for one 
or more source chemicals. Qualitative read-across gives a “binary” or “yes/no” answer. In 
quantitative read-across, the known value(s) of a property for one or more source 
chemicals is used to estimate the unknown value of the same property for the target 
chemical. Quantitative read-across is used to obtain a quantitative value for an endpoint, 
such as a dose-response relationship […]. 
The purpose of the read-across can be to replace the results of a standard experimental 
study entirely (i.e. standalone read-across), or may have supporting role. 
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Table 4.28 (cont.) 
Source Original definition of the term 'read-across' 
 To increase confidence in the read-across approach when applied to analogues or a 
category, evidence must be provided to underpin the hypothesis on which the read-across 
is based. This can be done by adding new elements to reinforce and develop the initial 
hypothesis, or by providing new scientific evidence that the category parameter is 
behaving as expected. The most compelling evidence in support of a read-across 
hypothesis is information on a common mode of action of the substances and a 
mechanistic rationale for their common biological behaviour. 
[…] read-across can only be used on a case-by-case basis by providing a hypothesis on 
which the read-across is based. 
RCC 2013 
Joint 
Nanomaterials 
Classification 
Scheme 
That is, identification of a chemical analogue to the nanomaterial in question and 
allocation of known characteristics from that analogue to the new nanomaterial. 
[…] to select appropriate analogue/read-across information within a class of 
nanomaterials. 
The physicochemical parameters listed (in the white boxes) represent the intrinsic 
physicochemical parameters which must be similar between two nanomaterials for them 
to be considered for analogue/read-across information. 
EUROPEAN BODIES 
ECHA 2015b 
Regulatory 
challenges 
nanomaterials 
workshop 
proceedings 
In a read-across approach, endpoint information from one or many chemicals is used to 
predict the same endpoint, either qualitatively or quantitatively, for one or many other 
chemicals. 
For predictions of nanomaterial properties using read-across or categories, three main 
possible scopes of prediction are conceivable: 
1. from bulk to all nano-forms, 
2. from bulk to specific nano-forms, 
3. from one or many nano-forms to one or many nano-forms (of the same chemical 
identity but with differences in physicochemical characteristics, differently coated nano-
forms, or nano-forms of different chemical identity). 
Read-across is recognised as one of the key issues in finding a pragmatic way to bridge 
existing data gaps in the hazard characterisation of nanomaterials. Therefore, there is a 
push from both academia and policy makers, to find a way forward in agreeing on key 
issues within read-across and categorisation of nanomaterials; for example, establishing 
criteria for when and how read-across may be acceptable. Currently, in several FP7 
projects, read-across is an identified deliverable and the issue is also discussed at a global 
level in an OECD context. 
Any read-across and category approach applied for nanomaterials in a regulatory context 
must not compromise the insurance of the safe use of the substance and thus must be 
based on a robust scientific justification. The approach should identify and consider the 
properties or parameters that drive the endpoint in question. 
ECHA 2015a 
Read-Across 
Assessment 
Framework 
The application of the grouping concept described above means that REACH information 
requirements for physicochemical, human health and/or environmental properties may be 
predicted from information from tests conducted on reference substance(s) within the 
group, referred to in this document as source substance(s), by interpolation to other 
substances in the group, referred to as target substance(s), and this is called read-across.  
Thus, in principle, read-across is regarded as a technique for predicting endpoint 
information for one substance (target substance), by using data from the same endpoint 
from (an)other substance(s), (source substance(s)). 
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Table 4.28 (cont.) 
Source Original definition of the term 'read-across' 
ECHA 2014b 
Use of 
alternatives to 
testing on animals 
for REACH 
Read-across is an approach for filling data gaps, either by using a category or an analogue 
approach. For the purposes of the REACH Regulation (Article 13(1)), read-across is 
considered by ECHA to be an alternative method. 
ECHA 2013a 
Second GAARN 
meeting 
Best practice for 
REACH registrants 
The use of non-testing data, such as data generated by read-across, is supported for 
nanomaterials as for any other substance. When considering reading across to another 
nanoform or a counterpart bulk material, a solid scientific justification should be provided 
in the IUCLID dossier of the registered substance. It is insufficient to justify the use of 
data for read-across based only on the chemical composition of a nanomaterial, and 
further physicochemical parameters such as aspect ratio, shape, form, solubility, surface 
area, charge, surface treatment etc. should provide a reliable dataset to support a sound 
scientific interpretation of the similarities or differences among (nano)forms. 
The registration dossier should contain a comprehensive physicochemical characterisation 
of the registered nanoform(s) (First GAARN meeting best practices report). Only when 
well-characterised nanoforms are reported in the dossier, can a read-across approach or 
use of existing data (e.g. weight of evidence) be considered for the purpose of hazard 
assessment. Generating data on toxicokinetics might also be considered for grouping 
substances in relation to read-across approaches, or extrapolating from in vitro to in vivo 
situations. 
ECHA 2013b 
Grouping of 
substances and 
read-across 
approach 
Within a group of substances, a data gap might be filled by read-across [….] 
[…] REACH information requirements for physicochemical properties, human health effects 
and/or environmental effects may be predicted from tests conducted on reference 
substance(s) within the group, referred to as source substance(s), by interpolation to 
other substances in the group, referred to as target substance(s), and this is called read-
across. 
Thus, read-across is regarded as a technique for predicting endpoint information for one 
substance (target substance), by using data from the same endpoint from (an)other 
substance(s), (source substance(s)). 
[…] endpoint-by-endpoint basis […] 
ECHA 2012c 
An introduction to 
the assessment of 
read-across in 
ECHA 
The framework is only to deal with read-across that is aimed at meeting specific 
information requirements for substances (i.e. studies from Annex VII to Annex X of the 
REACH Regulation). The starting point is a study with a 'source substance' (i.e. the 
'analogue'). The core of the read-across consists of the explanation by the registrant why 
the result of this study can also be applied to the 'target substance', so that the prediction 
can be used to meet the REACH information requirement for the target substance (i.e. the 
registered substance). It should be noted that the RAAF is to assess read-across of study 
results, not of classifications of the source substance or of hazardous properties of the 
source substance predicted by nonstandard methods or by means of a weight-of-evidence 
approach. 
The REACH guidance distinguishes two types of read-across: analogue-approach read-
across and grouping/category-approach read-across. The first type is concerned with 
read-across between two or among a few analogues, the second type involves a larger 
group of substances and is supported by regular patterns in this group for the endpoint 
that has to be read across. The RAAF covers both, analogue-approach and 
grouping/category-approach read-across. (The broader approach to chemical categories 
or grouping used in some other regulatory schemes or for other purposes should not be 
confused with the specific purpose for REACH information requirements examined in the 
RAAF.) 
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Table 4.28 (cont.) 
Source Original definition of the term 'read-across' 
ECHA 2008a 
QSARs and 
grouping of 
chemicals 
Read-across is a technique used to predict endpoint information for one chemical by using 
data from the same endpoint from another chemical which is considered to be similar in 
some way (on the basis of structural similarity and similar properties and/or activities).  
While read-across is a technique for data gap filling within the context of a category 
approach, it is also a useful tool for data gap filling in cases where comparisons are based 
on a very limited number of chemicals. 
Theoretically, the technique of read-across can be applied to characterise physical-
chemical properties, environmental fate, human health effects and ecotoxicity. For any of 
these areas, read-across may be performed in a qualitative or quantitative manner. 
In qualitative read-across, the presence (or absence) of a property/activity for the target 
chemical is inferred from the presence (or absence) of the same property/activity for one 
or more source chemicals. Qualitative read-across gives a “binary” or “yes/no” answer. In 
quantitative read-across, the known value(s) of a property for one or more source 
chemicals is used to estimate the unknown value of the same property for the target 
chemical. Quantitative read-across is used to obtain a quantitative value for an endpoint, 
such as a dose-response relationship […]. 
[…] comparison between two chemicals. This form of evaluation is often called a read-
across approach, and this is the term used in Annex XI of REACH. 
EP and EC 2006; 
EC 2009 
REACH Annex XI 
[…] physicochemical properties, human health effects and environmental effects or 
environmental fate may be predicted from data for reference substance(s) within the 
group by interpolation to other substances in the group (read-across approach). This 
avoids the need to test every substance for every endpoint. 
SCCS 2012 
Safety 
assessment of 
nanomaterials in 
cosmetics 
In view of the current insufficient level of scientific understanding, and the high level of 
uncertainties over the potential deviations in the properties, behaviour, and effects of 
nanomaterials compared to conventional equivalents, the SCCS is of the view that the use 
of a read-across or categorisation approach based on inter- or intra- nanomaterial 
extrapolation for risk assessment of nanomaterials is currently not possible. This means 
that risk assessment shall be carried out on a case-by-case basis, using a precautionary 
approach where necessary – in terms of requirement for further testing, or by taking a 
conservative approach in the application of assessment factors. 
US BODIES 
US EPA 2015 
Glossary 
Read Across from Analogs/Categories – “Read across” is a technique of filling data gaps. 
To “read across” is to apply data from a tested chemical for a particular property or effect 
(cancer, reproductive toxicity, etc.) to a similar untested chemical. The read across 
technique is often applied within groups of similar chemicals assembled for assessment 
using either analog approach (grouping based on a very limited number of chemicals) or 
category approach (grouping based on a larger number of chemicals). In an 
analog/category approach, not every chemical needs to be tested for every endpoint. 
INDUSTRY ASSOCIATIONS 
ECETOC 2012 
Category 
approaches, 
read-across, 
(Q)SAR 
In this report, the term 'category approach' and 'analogue approach' are used to describe 
techniques for grouping chemicals, whilst the term 'read-across' is reserved for a 
technique of filling data gaps in either approach. 
Endpoint information for one chemical is used to predict the same endpoint for another 
chemical, which is considered to be similar in some way (usually on the basis of structural 
similarity or same mode of action or other properties). 
Qualitative read-across is similar to the use of a SAR […] 
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Table 4.28 (cont.) 
Source Original definition of the term 'read-across' 
PEER-REVIEWED SCIENTIFIC LITERATURE 
Godwin et al 2015 
Nanomaterial 
categorization 
Read across refers to the process where endpoint information for one chemical (the 
source chemical) is used to predict the same endpoint for another chemical (the target 
chemical), which is considered to be "similar" in some way (usually on the basis of 
similarities in physicochemical properties that are deemed to be indicative of risk, hazard, 
or exposure potential).  
Schultz et al 2015 
A strategy for 
read-across 
The underlying philosophy of read-across is that substances which are similar in chemical 
structure will have similar properties and thereby, have similar toxicokinetic and 
toxicodynamic properties. Therefore, experimentally-derived toxicological properties from 
one substance, often referred to as the source chemical, can be read across to fill the data 
gap for a second substance, the target chemical, which has a similar chemical structure 
and for which a toxicology study may be lacking. 
[…] the aim of the read-across is to provide a prediction(s) that is (more or less) 
equivalent to the omitted standard animal study and hence be acceptable for regulatory 
purposes. 
[…] Whilst no consensus has been reached by stakeholders and users, there is growing 
agreement that when read-across is applied to make predictions to fulfil information 
requirements, this must be done on an endpoint-by-endpoint basis, i.e. for the particular 
toxicology study to be predicted. This approach to apply to endpoints individually is due, 
even when there is an over-arching category hypothesis, to different applicability 
domains, different source chemicals and/or different Weights-of-Evidence (WoE) which 
may apply to making predictions for different endpoints. Obviously, there will be 
occasions where one or more endpoints will be closely related and knowledge may be 
transferable, thus allowing read-across arguments to build, partially, on each other. 
[…] Within the applicability domain of a chemical category, read-across can be performed 
to fill data gaps with a number of approaches which can be summarised into the following 
four techniques: 
(1) one-to-one read-across (i.e., one source substance used to make a prediction for a 
single target chemical), 
(2) many-to-one read-across (i.e., two or more source substances used to make a 
prediction for a single target chemical), 
(3) one-to-many read-across (i.e., one source substance used to make a prediction for 
two or more target chemicals), or 
(4) many-to-many read-across (i.e., two or more source substances used to make 
predictions for two or more target chemicals). 
Techniques 3 and 4 may be considered as being multiple simultaneous applications of 
techniques 1 and 2, respectively. Given limited data availability, the ‘‘one-to-one’’, or 
analogue approach, is often the only viable option. Ideally, however, the ‘‘many-to-one’’ 
or category approach is preferred as it inherently possesses a greater WoE in that each 
analogue in the category supports the others. 
Cronin 2013 
Chemical 
grouping, 
categories and 
read-across 
If a compound belongs to a group of compounds with a well categorised toxicological 
profile, it can be possible to interpolate its activity. These interpolations, (predictions) of 
toxicity may, when utilised properly, provide hazard information that can be used in the 
assessment procedure described above. The process of prediction is termed ‘‘read-across’’ 
as it assumes that activities, toxicities or properties can be read across between 
compounds within a category. 
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Table 4.28 (cont.) 
Source Original definition of the term 'read-across' 
van Leeuwen et al 
2009 
Using chemical 
categories to fill 
data gaps in 
hazard 
assessment 
In read-across, one or more properties of a chemical of interest are inferred by 
comparison to a chemical that is similar in structure and interaction mechanisms for which 
the properties of interest are known (Figure 1). These properties may include 
physicochemical properties, environmental fate or toxic effects. An assessment of 
similarity underpins the approach. The basic assumption is that similarity in chemical 
structure implies similarity in their activities or properties. 
Read-across has been proposed to estimate missing data from a single or restricted 
number of compounds using the analogue approach [14]. In this approach, endpoint 
information for a tested substance is used to predict the same endpoint for a similar but 
untested substance. In its simplest form, qualitative read-across, the presence or absence 
of an activity for the untested chemical of interest can be inferred from the presence or 
absence of the same activity for the tested analogue(s). The key to success in using read-
across to predict toxicity is selecting the analogous set of chemicals based on the 
likelihood that each member of the set will show a common behaviour or a consistent 
trend for the toxicological effect in question [13]. An advantage of the analogue read-
across approach is that the identification of consistent patterns of measured effects within 
an analogues category increases confidence in both the measured and predicted results 
for the individual chemicals within the category. In the case of quantitative read-across, 
the value of a particular parameter for tested analogue(s) is used to estimate the toxicity 
for the untested chemical with the assumption that the potency of the effect of interest is 
shared by both the tested and untested analogue. Quantitative read-across works best for 
homologous series of chemicals where the metric needed to extrapolate from one 
substance to another can be linked to a particular property of the category. However, 
when the members of the category are not simple homologues, it is essential that some 
parameter that scales the trend in toxicity across the members of the category be 
established in order to better use measured toxicity values to predict the missing value of 
an untested compound. 
van Leeuwen et al 
2007 
Intelligent testing 
strategies 
In read-across, one or more properties of a chemical of interest are inferred by 
comparison to a similar chemical or chemicals, for which the properties of interest are 
known (Figure 11.4). These properties may include physicochemical properties, 
environmental fate, toxicity and ecotoxicity. An assessment of similarity underpins the 
approach. The basic assumption is that similarity in structure implies similarity in activities 
or properties. The read-across can be qualitative or quantitative: 
1. Qualitative read-across can be regarded as an application of SAR. The process involves: 
(a) the identification of a chemical substructure that is common to the two substances 
(which are therefore analogues) and (b) the assumption that the presence (or absence) of 
a property/activity for a substance can be inferred from the presence (or absence) of the 
same property/activity for an analogous substance. This assumption implies that 
analogues behave qualitatively similarly, and is usually the result of an expert judgement 
evaluation. 
2. Quantitative read-across involves the identification of a chemical substructure that is 
common to the two substances (which are therefore analogues), and the assumption that 
the known value of a property for one substance can be used to estimate the unknown 
value of the same property for another substance. This assumption implies that the 
potency of an effect shared by different analogous substances is similar, and is also 
usually the result of an expert judgement evaluation [25, 26]. 
 
4.29 Read-Across Assessment Framework (RAAF) 
Table 4.29 shows the original definitions of the term 'Read-Across Assessment 
Framework (RAAF)', which have been collected from the literature and used to develop 
the NANoREG Definition. The term 'Read-Across Assessment Framework (RAAF)' is used 
in the context of REACH and in principle applies to all substances including NMs. 
Definitions could only be found in scientific documents prepared by European bodies 
such as ECHA (2012c, 2014c, 2015a) and in reports from industry associations (CEFIC-
LRI 2012). Accordingly, the harmonised definition adopted in NANoREG reflects the 
definitions provided by ECHA. 
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Table 4.29 Literature definitions collected for the key term 'Read-Across Assessment 
Framework (RAAF)' and considered to develop the NANoREG Definition. 
Source Original definition of the term 'Read-Across Assessment Framework (RAAF)' 
EUROPEAN BODIES 
ECHA 2015a 
Read-Across 
Assessment 
Framework 
ECHA is therefore in the process of codifying a systematic approach to assessing those 
read-across cases that are encountered in its dossier evaluation activities. This systematic 
approach is called ‘The Read-Across Assessment Framework’, or RAAF. The RAAF provides 
a framework and guidance for consistent evaluation of the scientific aspects of a proposed 
read-across case, resulting in an output which is suitable for subsequent regulatory 
consideration of the read-across case. 
ECHA 2014c 
Workshop on the 
RAAF 
[…] a systematic approach to the assessment of read-across cases […] 
[…] a structured method for the assessment of read-across cases by ECHA evaluators. 
ECHA 2012c 
An Introduction to 
the assessment of 
read-across in 
ECHA 
‘The Read-Across Assessment Framework’, or RAAF. This framework is meant to present a 
structured tool for the assessment of read-across cases by the ECHA evaluators. It is thus 
not meant to serve as guidance for registrants, […] 
The RAAF consists of a two-tiered assessment scheme.  
INDUSTRY ASSOCIATIONS 
CEFIC-LRI 2012 
Expert workshop 
on read-across 
assessment 
The RAAF is a tiered systematic approach, developed by ECHA to facilitate its internal 
evaluation of read-across. 
 
4.30 Regulatory acceptance 
Table 4.30 shows the original definitions of the term 'regulatory acceptance', which have 
been collected from the literature and used to develop the NANoREG Definition. 
Definitions could be found in documents from international organisations such as OECD 
(2005) and on European bodies' websites (EURL ECVAM 2015). The definitions that are 
reported in OECD official guidance documents are given higher priority as they have 
regulatory relevance and are the result of a broad consultation at international level. 
These definitions are reflected in the EURL ECVAM Glossary and in principle apply to all 
chemicals including NMs. Accordingly, the harmonised definition adopted in NANoREG 
reflects the definitions provided by OECD.  
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Table 4.30 Literature definitions collected for the key term 'regulatory acceptance' and 
considered to develop the NANoREG Definition. 
Source Original definition of the term 'regulatory acceptance' 
INTERNATIONAL BODIES 
OECD 2005 
Test methods for 
hazard 
assessment 
The formal acceptance of a test method by regulatory authorities indicating that the test 
method may be used to provide information to meet a specific regulatory requirement. 
Regulatory acceptance is dependent upon the outcome of the validation […] 
The regulatory acceptance process has generally been on a case-by-case basis, and 
regulatory authorities have the option to accept results generated using a test method 
that has not undergone what today would be considered formal validation (e.g., methods 
used in mechanistic studies that could help underpin or explain results derived from other 
tests). However, acceptance of a test method by a specific regulatory authority does not 
necessarily indicate universal acceptance by other authorities. Acceptance policies differ 
from country to country and even, at times, among regulatory authorities within a 
country. 
Harmonisation of international regulatory acceptance of adequately validated test methods 
may be achieved by considering the guidance provided in this document. The regulatory 
acceptance of tests that have not been subjected to prevailing validation processes is 
discouraged. In cases in which validation is not considered necessary or appropriate, a 
written justification should be available. 
After a test method has undergone formal validation and is considered acceptable for 
specific proposed uses, a recommendation may be made that it be adopted as an OECD 
Test Guideline. As mentioned earlier in this document, regulatory acceptance would be 
greatly facilitated by the involvement, as early as possible in the validation process, of the 
regulatory agencies to which test results derived from the validated method will be 
submitted. 
EUROPEAN BODIES 
EURL ECVAM 
2015 
Glossary 
Regulatory acceptance of a test method is its formal acceptance by regulatory authorities 
indicating that the test method may be used to provide information to meet a specific 
regulatory requirement. This includes, but is not limited to, a formal adoption of a test 
method by EU and/or OECD as an EU test method and included in the EU Test Methods 
Regulation (EC, 2008) and/or as an OECD Test Guideline, respectively. 
 
4.31 Safe-by-design 
Table 4.31 shows the original definitions of the term 'safe-by-design', which have been 
collected from the literature and used to develop the NANoREG Definition. Definitions 
could be retrieved from peer-reviewed scientific literature (Ariëns 1980, Behm 2005, 
Anastas and Warner 2005, Kelty 2009, Sealy 2011, Sips et al 2013, Lynch et al 2014, 
Movia et al 2014, Burello and Worth 2015, Zimmerman and Anastas 2015). Most of 
publications discuss the concept of safe-by-design in the field of material/chemical 
engineering. Some of them attempt to adapt the concept to the field of nanotechnology 
and synthesis of NMs but none provides a comprehensive and clear definition. The 
harmonised definition adopted in NANoREG takes inspiration from the definition of 'safe-
by-design' as proposed in NANoREG Deliverable 6.3 on "Comparison on toxicity testing 
in drug development and in present MNMs safety testing" (submitted on 3 December 
2014), which is also used in the context of ProSafe and NANoREG II. 
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Table 4.31 Literature definitions collected for the key term 'safe-by-design' and 
considered to develop the NANoREG Definition. 
Source Original definition of the term 'safe-by-design' 
PEER-REVIEWED SCIENTIFIC LITERATURE 
Zimmerman and 
Anastas 2015 
Designing safer 
chemicals 
[…] how do we design future substances to eliminate the need for engineered control 
systems. 
Burello and Worth 
2015 
A rule for 
designing safer 
nanomaterials 
All these information point towards the emergence of an effective rule for designing safer 
nanomaterials, that is to design nanomaterials that do not interfere with the redox 
equilibrium of the cell. Although currently there is no clear and structured safe-by-design 
strategy, at TNO we are developing a number of rules to support the synthesis of safer 
nanomaterials. The key element is to align functionality and safety, and, in essence, 
understand how we could modify certain properties which make a nanomaterial appealing 
for its use – but also possibly hazardous for the environment, health and safety domains, 
while preserving its functionality. 
Lynch et al 2014 
A basis for safer-
by-design NMs 
Identification of critical properties (physicochemical descriptors) that confer the ability to 
induce harm in biological systems is crucial, enabling both prediction of impacts from 
related NMs (via quantitative nanostructure-activity relationships (QNARs) and read-
across approaches) and development of strategies to ensure these features are avoided or 
minimised in NM production in the future (‘‘safety by design’’). A number of challenges to 
successful implementation of such a strategy exist, including: (i) the lack of widely 
available systematically varied libraries of NMs to enable generation of sufficiently robust 
datasets for development and validation of QNARs; (ii) the fact that many 
physicochemical properties of pristine NMs are inter-related and thus cannot be varied 
systematically in isolation from others (e.g. increasing surface charge may impact on 
hydrophobicity, or changing the shape of a NM may introduce defects or alter the atomic 
configuration of the surface); and (iii) the effect of ageing, transformation and 
biomolecule coating of NMs under environmental or biological conditions. 
Movia et al 2014 
Safe-by-design 
Such approach finds his routes in the concept of safe-by-design nanomaterials, where 
efforts are focused on characterizing the physical, chemical and biological properties of 
the core material, followed by “layering” as a method to produce safe nano-enabled 
theranostics [16]. 
Sips et al 2013 
Safer-by-design 
Safe(r) by design aims at an integrated and iterative process where safety and 
functionality are weighed. This concept seems by nature plausible for many stakeholders. 
It is thought to reduce the necessity for risk management activities, which can be 
beneficial both for industry and for upholding authorities. On the other hand, it might 
require larger investments in research and development. This already implies that the 
development in iterative loops between safety and functionality needs to be done very 
efficiently. 
Sealy 2011 
Safe-by-design 
nanoparticles 
Now researchers from the US and Germany have taken a ‘safe-by-design’ approach to 
reduce the in vivo toxicity of ZnO nanoparticles by doping with Fe. 
The results demonstrate that it is possible to design and synthesize a widely used 
nanomaterial as a less toxic nanoparticle […] 
An understanding of hazardous nanomaterial properties is essential for safe design from 
both the lifecycle as well as the biological perspective […] 
Kelty 2009 
The story of 
safety by design 
[…] ‘safety by design’ idea, the idea that you can study implications and from that go back 
and engineer materials and processes to be safer and to have less of the impact that you 
don’t want them to have […] 
The outcome of this arrangement is the story we tell here, the attempt to make ‘safety’ a 
fundamental property of new nanomaterials: ‘safety by design.’ 
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Table 4.31 (cont.) 
Source Original definition of the term 'safe-by-design' 
 […] a kind of strategic working over of the demand for responsibility, into a form of 
science that is both application and implication at once, both concern and control: it was 
an attempt to define safety as a fundamental property of materials. 
[…] it presumed that safety was an issue of design, not a feature of the established risk 
framework of hazard levels and exposure routes; […] 
Rather, it creates a new mode of veridiction—a new set of truth claims about safety as a 
fundamental property of matter, claims that might be made about wide classes of 
materials and their uses and ultimately replace one version of risk analysis (‘is it safe?’) 
with another and quite different version (‘how do you engineer towards safety?’). 
Anastas and 
Warner 2005 
Hazard reduction 
as a chemical 
design criterion in 
green chemistry 
Green chemistry seeks to incorporate hazard reduction ab initio, in other words, as an 
integral part of the design process. […] green chemistry’s goal is to prevent adverse 
consequences of the design of chemicals by making informed design choices that 
minimize hazard. As a design criterion, hazard reduction would occupy equal status with 
the other physicochemical attributes associated with chemical structure and function. 
Hazard should be considered a design flaw and efforts need to be made in the designing 
phase to minimize or eliminate it.  
Behm 2005 
Design for 
construction 
safety concept 
The design for construction safety concept is defined as the consideration of construction 
site safety in the design of a project.  
Ariëns 1980 
Design of safer 
chemicals 
The goals are not to cure but to prevent, implying efforts to design safer chemicals. […] 
Design involves control of potentially toxic actions of chemical agents by molecular 
manipulation, which requires an insight into the chemical mechanisms of toxic action, and 
therewith an insight into the relationship between structure and toxic action. 
 
4.32 Standardisation 
Table 4.32 shows the original definitions of the term 'standardisation', which have been 
collected from the literature and used to develop the NANoREG Definition. Definitions 
could be retrieved from webpages of international organisations such as ISO (2015a, 
2015b) and CEN (2015). As both ISO and CEN are standardisation organisations the 
harmonised definition adopted in NANoREG reflects these definitions. 
 
Table 4.32 Literature definitions collected for the key term 'standardisation' and 
considered to develop the NANoREG Definition. 
Source Original definition of the term 'standardisation' 
INTERNATIONAL BODIES 
ISO 2015a 
Glossary 
Standardization: Activity of establishing, with regard to actual or potential problems, 
provisions for common and repeated use, aimed at the achievement of the optimum 
degree of order in a given context (from ISO/IEC Guide 2:2004, definition 1.1). 
ISO 2015b 
Homepage 
A standard is a document that provides requirements, specifications, guidelines or 
characteristics that can be used consistently to ensure that materials, products, processes 
and services are fit for their purpose. 
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Table 4.32 (cont.) 
Source Original definition of the term 'standardisation' 
 ISO International Standards ensure that products and services are safe, reliable and of 
good quality. For business, they are strategic tools that reduce costs by minimizing waste 
and errors and increasing productivity. They help companies to access new markets, level 
the playing field for developing countries and facilitate free and fair global trade. 
CEN 2015 
Homepage 
 
Standards are documents that set out specifications and other technical information with 
regard to various kinds of products, materials, services and processes.  
Standards provide a basis for mutual understanding among individuals, businesses, public 
authorities and other kinds of organizations. They facilitate communication, commerce, 
measurement and manufacturing.  
European Standards bring benefits to businesses and consumers in terms of reducing 
costs, enhancing performance and improving safety. They also help to ensure the 
compatibility of different components, products and services.  
European Standards can be used to enhance safety and performance, improve energy 
efficiency, and protect consumers, workers and the environment. They complement 
European and national policies, and make it easier for businesses and other actors to 
respect relevant legislation. 
European Standardization is a key instrument for consolidating the Single Market and 
facilitating cross-border trade – within Europe and also with the rest of the world. It is a 
valuable tool for strengthening the competitiveness of European companies, thereby 
creating the conditions for economic growth. 
 
4.33 Standard Operating Procedure (SOP) 
Table 4.33 shows the original definitions of the term 'Standard Operating Procedure 
(SOP)', which have been collected from the literature and used to develop the NANoREG 
Definition. Definitions could found in documents from international organisations such as 
OECD (2005) and FAO (1998), in reports from European national authorities (NILU 
2013), and in documents prepared by US bodies such as US EPA (1992). Accordingly, 
the harmonised definition developed in NANoREG combines elements from each of these 
definitions. 
 
Table 4.33 Literature definitions collected for the key term 'Standard Operating 
Procedure (SOP)' and considered to develop the NANoREG Definition. 
Source Original definition of the term 'Standard Operating Procedure (SOP)' 
INTERNATIONAL BODIES 
OECD 2005 
Validation of new 
and updated test 
methods 
A formal, written procedure that describes in detail how specific routine and test-specific 
laboratory operations should be performed. SOPs are required by Good Laboratory 
Practice.  
FAO 1998 
Guidelines for 
quality 
management in 
soil and plant 
laboratories 
An important aspect of a quality system is to work according to unambiguous Standard 
Operating Procedures (SOPs). A SOP for a laboratory can be defined as follows:  
"A Standard Operating Procedure is a document which describes the regularly recurring 
operations relevant to the quality of the investigation. The purpose of a SOP is to carry 
out the operations correctly and always in the same manner. A SOP should be available at 
the place where the work is done". 
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Table 4.33 (cont.) 
Source Original definition of the term 'Standard Operating Procedure (SOP)' 
 A SOP is a compulsory instruction. If deviations from this instruction are allowed, the 
conditions for these should be documented including who can give permission for this and 
what exactly the complete procedure will be. The original should rest at a secure place 
while working copies should be authenticated with stamps and/or signatures of authorized 
persons. Several categories and types of SOPs can be distinguished. 
EUROPEAN NATIONAL AUTHORITIES 
NILU 2013 
Good laboratory 
practice system  
Standard Operating Procedures means documented procedures, which describe how to 
perform tests or specific activities. 
US BODIES 
US EPA 1992 
Guidelines for 
exposure 
assessment 
Standard operating procedure (SOP) - A procedure adopted for repetitive use when 
performing a specific measurement or sampling operation. 
 
4.34 Substance 
Table 4.34 shows the original definitions of the term 'substance', which have been 
collected from the literature and used to develop the NANoREG Definition. Definitions 
could be retrieved from different pieces of legislation on chemicals including UN Globally 
Harmonised System (UN 2003), European REACH legal text (EP and EC 2006) and CLP 
Regulation (EP and EC 2008), US TSCA (TSCA 2002) and CEPA (1999). Accordingly, the 
harmonised definition developed in NANoREG reflects the definition provided in European 
law such as REACH and CLP Regulation (EP and EC 2006, 2008). The same definition is 
used in the UN Globally Harmonised System (UN 2003). 
 
Table 4.34 Literature definitions collected for the key term 'substance' and considered 
to develop the NANoREG Definition. 
Source Original definition of the term 'substance' 
INTERNATIONAL BODIES 
UN 2003 
Globally 
Harmonised 
System 
Substance means chemical elements and their compounds in the natural state or obtained 
by production process including any additive necessary to preserve the stability of the 
product and any impurities deriving from the process used, but excluding any solvent 
which may be separated without affecting the stability of the substance or changing its 
composition; 
EUROPEAN BODIES 
EP and EC 2008 
CLP Regulation 
‘substance’ means a chemical element and its compounds in the natural state or obtained 
by any manufacturing process, including any additive necessary to preserve its stability 
and any impurity deriving from the process used, but excluding any solvent which may be 
separated without affecting the stability of the substance or changing its composition; 
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Table 4.34 (cont.) 
Source Original definition of the term 'substance' 
EP and EC 2006 
REACH 
Regulation 
[…] means a chemical element and its compounds in the natural state or obtained by any 
manufacturing process, including any additive necessary to preserve its stability and any 
impurity deriving from the process used, but excluding any solvent which may be 
separated without affecting the stability of the substance or changing its composition.  
US BODIES 
TSCA 2002 
US Toxic 
Substances 
Control Act 
[…] the term ‘‘chemical substance’’ means any organic or inorganic substance of a 
particular molecular identity, including— (i) any combination of such substances occurring 
in whole or in part as a result of a chemical reaction or occurring in nature, and (ii) any 
element or uncombined radical. 
(B) Such term does not include— (i) any mixture, (ii) any pesticide (as defined in the 
Federal Insecticide, Fungicide, and Rodenticide Act) when manufactured, processed, or 
distributed in commerce for use as a pesticide, (iii) tobacco or any tobacco product, (iv) 
any source material, special nuclear material, or byproduct material (as such terms are 
defined in the Atomic Energy Act of 1954 and regulations issued under such Act), (v) any 
article the sale of which is subject to the tax imposed by section 4181 of the Internal 
Revenue Code of 1954 (determined without regard to any exemptions from such tax 
provided by section 4182 or 4221 or any other provision of such Code), and (vi) any food, 
food additive, drug, cosmetic, or device (as such terms are defined in section 201 of the 
Federal Food, Drug, and Cosmetic Act) when manufactured, processed, or distributed in 
commerce for use as a food, food additive, drug, cosmetic, or device 
CANADIAN BODIES 
CEPA 1999 
Canadian 
Environmental 
Protection Act 
“substance” means any distinguishable kind of organic or inorganic matter, whether 
animate or inanimate, and includes  
(a) any matter that is capable of being dispersed in the environment or of being 
transformed in the environment into matter that is capable of being so dispersed or that is 
capable of causing such transformations in the environment, 
(b) any element or free radical,  
(c) any combination of elements of a particular molecular identity that occurs in nature or 
as a result of a chemical reaction, and  
(d) complex combinations of different molecules that originate in nature or are the result 
of chemical reactions but that could not practicably be formed by simply combining 
individual constituents,  
and, except for the purposes of sections 66, 80 to 89 and 104 to 115, includes 
(e) any mixture that is a combination of substances and does not itself produce a 
substance that is different from the substances that were combined, 
(f) any manufactured item that is formed into a specific physical shape or design during 
manufacture and has, for its final use, a function or functions dependent in whole or in 
part on its shape or design, and 
(g) any animate matter that is, or any complex mixtures of different molecules that are, 
contained in effluents, emissions or wastes that result from any work, undertaking or 
activity. 
 
4.35 Test method 
Table 4.35 shows the original definitions of the term 'test method', which have been 
collected from the literature and used to develop the NANoREG Definition. One definition 
could be found in a document by OECD (2005). The definitions that are reported in 
OECD official guidance documents are given higher priority as they have regulatory 
relevance and are the result of a broad consultation at international level. Accordingly, 
the harmonised definition adopted in NANoREG reflects the definition provided by OECD.  
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Table 4.35 Literature definitions collected for the key term 'test method' and considered 
to develop the NANoREG Definition. 
Source Original definition of the term 'test method' 
INTERNATIONAL BODIES 
OECD 2005 
Test methods for 
hazard 
assessment 
[…] an experimental system that can be used to obtain a range of information from 
chemical properties through the adverse effects of a substance. The term ‘test method’ 
may be used interchangeably with ‘assay’ for ecotoxicity as well as for human health 
studies. …’. Testing means applying a test method. 
 
4.36 Test method validation 
Table 4.36 shows the original definitions of the term 'test method validation', which have 
been collected from the literature and used to develop the NANoREG Definition. 
Definitions could be found in documents from international organisations such as OECD 
(2005) and in documents prepared by European bodies such as ECHA (2014b). The 
definitions that are reported in OECD official guidance documents are given higher 
priority as they have regulatory relevance and are the result of a broad consultation at 
international level. Accordingly, the harmonised definition adopted in NANoREG reflects 
the definition provided by OECD.  
 
Table 4.36 Literature definitions collected for the key term 'test method validation' and 
considered to develop the NANoREG Definition. 
Source Original definition of the term 'test method validation' 
INTERNATIONAL BODIES 
OECD 2005 
Test methods for 
hazard 
assessment 
Test method validation is a process based on scientifically sound principles by which the 
reliability and relevance of a particular test, approach, method or process are established 
for a specific purpose. Reliability is defined as the extent of reproducibility of results from 
a test within and among laboratories over time, when performed using the same 
standardised protocol. The relevance of a test method describes the relationship between 
the test and the effect in the target species and whether the test method is meaningful 
and useful for a defined purpose, with the limitations identified. In brief, it is the extent to 
which the test method correctly measures or predicts the (biological) effect of interest, as 
appropriate. Regulatory need, usefulness and limitations of the test method are aspects of 
its relevance. New and updated test methods need to be both reliable and relevant i.e. 
validated.  
A validated test method [...] a test method for which validation studies have been 
completed to determine the relevance (including accuracy) and reliability for a specific 
purpose. It is important to note that a validated test method may not have sufficient 
performance in terms of accuracy and reliability to be found acceptable for the proposed 
purpose. 
EUROPEAN BODIES 
ECHA 2014b 
Use of 
alternatives to 
testing on 
animals for 
REACH 
Process by which the reliability and relevance of a test method are evaluated for the 
purpose of supporting a specific use. 
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4.37 Tiered testing strategy 
Table 4.37 shows the original definitions of the term 'tiered testing strategy', which have 
been collected from the literature and used to develop the NANoREG Definition. 
Definitions could be found in documents from international organisations such as OECD 
(2013b) and in peer-reviewed/non peer-reviewed scientific literature (Stone et al 2013, 
Ferrario et al 2014). The definitions that are reported in OECD official guidance 
documents are given higher priority as they have regulatory relevance and are the result 
of a broad consultation at international level. Accordingly, the harmonised definition 
adopted in NANoREG reflects the definition provided by OECD. 
 
Table 4.37 Literature definitions collected for the key term 'tiered testing strategy' and 
considered to develop the NANoREG Definition. 
Source Original definition of the term 'tiered testing strategy' 
INTERNATIONAL BODIES 
OECD 2013b 
Ocular corrosives 
and severe 
irritants 
A stepwise testing strategy where all existing information on a test substance is reviewed, 
in a specified order, using a weight of evidence process at each tier to determine if 
sufficient information is available for a hazard classification decision, prior to progression 
to the next tier. If the irritancy potential of a test substance can be assigned based on the 
existing information, no additional testing is required. If the irritancy potential of a test 
substance cannot be assigned based on the existing information, a step-wise sequential 
animal testing procedure is performed until an unequivocal classification can be made. 
PEER-REVIEWED SCIENTIFIC LITERATURE 
Ferrario et al 
2014 
Glossary of 
reference terms 
Tiered test scheme: Testing approaches based on sequential assessments, where a result 
at one tier is used to determine the next step, if any. It is usually a decision-tree type of 
testing; after each step, the information is assessed to determine whether a prediction for 
the toxicity endpoint can be made or whether further testing/analysis needs to be done. A 
tiered approach usually progresses from a review of existing literature and data to a 
review of data for related chemicals or formulations, to perhaps a SAR/(Q)SAR analysis, 
to simple in vitro screening assays, to the use of more complex in vitro three-dimensional 
models, to testing in lower species, to the traditional animal test. 
Stone et al 2013 
ITS-NANO final 
report 
Sets of a structured approach to assessing the fate and effects of NMs, where test in 
higher tiers may be required depending upon the results of tests at earlier stages (i.e. 
lower tiers). Under a tiered structure, for example, data requirements for effects testing 
might progress from acute to chronic laboratory studies to field studies. 
 
4.38 Tool 
Table 4.38 shows the original definitions of the term 'tool', which have been collected 
from the literature and used to develop the NANoREG Definition. Definitions could be 
retrieved from online dictionaries (Merriam-Webster 2015) and peer-reviewed scientific 
literature (Hristozov et al 2012). The harmonised definition adopted in NANoREG takes 
inspiration from the definition provided by Hristozov et al (2012) but is adapted to the 
context of the project. 
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Table 4.38 Literature definitions collected for the key term 'tool' and considered to 
develop the NANoREG Definition. 
Source Original definition of the term 'tool' 
ONLINE DICTIONARIES 
Merriam-Webster 
2015 
− a handheld device that aids in accomplishing a task; 
− something (as an instrument or apparatus) used in performing an operation or 
necessary in the practice of a vocation or profession; 
− an element of a computer program (as a graphics application) that activates and 
controls a particular function; 
− a means to an end. 
PEER-REVIEWED SCIENTIFIC LITERATURE 
Hristozov et al 
2012 
Risk assessment 
of engineered 
nanomaterials 
A “tool” is a procedure used to generate certain type of output (e.g., data). 
 
4.39 Trend analysis 
Table 4.39 shows the original definitions of the term 'trend analysis', which have been 
collected from the literature and used to develop the NANoREG Definition. Definitions 
could be found in documents from international organisations such as OECD (2014a) and 
in documents prepared by European bodies such as ECHA official guidance for 
implementation of REACH (ECHA 2008a). The definitions that are reported in OECD 
official guidance documents are given higher priority as they have regulatory relevance 
and are the result of a broad consultation at international level. These definitions are 
reflected in ECHA official guidance for implementation of REACH and in principle apply to 
all chemicals including NMs. Accordingly, the harmonised definition adopted in NANoREG 
reflects the definition provided by OECD. 
 
Table 4.39 Literature definitions collected for the key term 'trend analysis' and 
considered to develop the NANoREG Definition. 
Source Original definition of the term 'trend analysis' 
INTERNATIONAL BODIES 
OECD 2014a 
Guidance on 
grouping of 
chemicals 
Trend analysis refers to a data-gap filling method for “quantitative endpoints” (e.g., 96h-
LC50 for fish) if a number of analogues (at least 3) with experimental results are 
identified. 
For a given category endpoint, the category members are related by a trend such that the 
properties of the category members change in a predictable manner and there is a pattern 
in the changing potency of the properties across the category. 
A chemical that identifies a turning point in a trend is called a breakpoint chemical. 
Category members falling at the opposite extremes of a trend and between which 
interpolations are considered reliable are called sentinel or boundary chemicals. 
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Table 4.39 (cont.) 
Source Original definition of the term 'trend analysis' 
EUROPEAN BODIES 
ECHA 2008a 
QSARs and 
grouping of 
chemicals 
For a given category endpoint, the category members are often related by a trend (e.g. 
increasing, decreasing or constant) in an effect, and a trend analysis can be carried out 
using a model based on the data for the members of the category. 
 
4.40 Validation 
Table 4.40 shows the original definitions of the term 'validation', which have been 
collected from the literature and used to develop the NANoREG Definition. Definitions 
could be found in documents from international organisations such as OECD (2005) and 
IPSC (2004), in European bodies' webpages (EURL ECVAM 2015), and in reports from US 
bodies (NIEHS 1997). The definitions that are reported in OECD and IPSC official 
guidance documents are given higher priority as they have regulatory relevance and are 
the result of a broad consultation at international level. Accordingly, the harmonised 
definition adopted in NANoREG reflects the definitions provided by OECD and IPSC. 
 
Table 4.40 Literature definitions collected for the key term 'validation' and considered to 
develop the NANoREG Definition. 
Source Original definition of the term 'validation' 
INTERNATIONAL BODIES 
IPCS 2004 
Risk assessment 
terminology 
Process by which the reliability and relevance of a particular approach, method, process, 
or assessment is established for a defined purpose.  
Different parties define “Reliability” as establishing the reproducibility of the outcome of 
the approach, method, process, or assessment over time. “Relevance” is defined as 
establishing the meaningfulness and usefulness of the approach, method, process, or 
assessment for the defined purpose. 
OECD 2005 
Validation of test 
methods 
The process by which the reliability and relevance of a particular approach, method, 
process, or assessment is established for a defined purpose.  
EUROPEAN BODIES 
EURL ECVAM 
2015 
Glossary 
Validation is the process by which the reliability and relevance of a procedure are 
established for a specific purpose. 
US BODIES 
NIEHS 1997 
Validation and 
regulatory 
acceptance of 
test methods 
Valid method: A method determined to be acceptable for a specific use and application. 
Validated method: A test method for which the reliability and relevance for a specific 
purpose have been established in one or more validation studies. 
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4.41 Value chain 
Table 4.41 shows the original definitions of the term 'value chain', which have been 
collected from the literature and used to develop the NANoREG Definition. Definitions 
could be found in documents from European national authorities (BSR 2010), in reports 
from industry associations (WBCSD 2011), in universities' websites (Duke University 
2015), and in peer-reviewed scientific literature (Kaplinsky and Morris 2001). There is no 
internationally agreed definition of the term 'value chain'. The definition formulated by 
Kaplinsky and Morris (2001) is clear and underlines the importance of considering the 
"full range of activities" in a value chain, from the very beginning of an intellectual 
process to disposal of a product or a service. Accordingly, the harmonised definition 
adopted in NANoREG reflects the definition formulated by Kaplinsky and Morris (2001). 
The NANoREG harmonised definition also explains the difference between the terms 'life 
cycle' and 'value chain' and what is meant by 'safety value chain case study' within the 
project. 
 
Table 4.41 Literature definitions collected for the key term 'value chain' and considered 
to develop the NANoREG Definition. 
Source Original definition of the term 'value chain' 
EUROPEAN NATIONAL AUTHORITIES 
BSR 2010 
Responsible 
supply chain 
management 
A series of activities undertaken by a company that generate and add value to products. 
These activities include inbound logistics, operations, outbound logistics, marketing and 
sales, and services, and they are supported by activities including firm infrastructure, 
human resources management, technology development and procurement. A company's 
value chain is part of a larger value system that includes the value chains of upstream 
suppliers and downstream channels and customers. (See Michael Porter, Competitive 
Advantage: Creating and Sustaining Superior Performance. New York: Free Press, 1980.) 
INDUSTRY ASSOCIATIONS 
WBCSD 2011 
A value chain 
approach 
A value chain refers to the full life cycle of a product or process, including material 
sourcing, production, consumption and disposal/recycling processes. 
PEER-REVIEWED SCIENTIFIC LITERATURE 
Kaplinsky and 
Morris 2001 
A handbook for 
value chain 
research 
The value chain describes the full range of activities which are required to bring a product 
or service from conception, through the different phases of production (involving a 
combination of physical transformation and the input of various producer services), 
delivery to final consumers, and final disposal after use. 
NON PEER-REVIEWED SCIENTIFIC LITERATURE 
Duke University 
2015 
The global value 
chains initiative 
The value chain describes the full range of activities that firms and workers do to bring a 
product from its conception to its end use and beyond. This includes activities such as 
design, production, marketing, distribution and support to the final consumer. The 
activities that comprise a value chain can be contained within a single firm or divided 
among different firms. Value chain activities can produce goods or services, and can be 
contained within a single geographical location or spread over wider areas.” 
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4.42 Waiving 
Table 4.42 shows the original definitions of the term 'waiving', which have been collected 
from the literature and used to develop the NANoREG Definition. Definitions could be 
found in documents from European bodies such as ECHA official guidance for 
implementation of REACH (ECHA 2010c; 2011a). Accordingly, the harmonised definition 
adopted in NANoREG reflects the definition provided by ECHA. See the term 'adaptation'. 
 
Table 4.42 Literature definitions collected for the key term 'waiving' and considered to 
develop the NANoREG Definition. 
Source Original definition of the term 'waiving' 
EUROPEAN BODIES 
ECHA 2010c 
How to report 
data waiving 
[…] waiving of the information requirements for an endpoint means that the submission of 
the standard information for the particular endpoint is not considered necessary in a 
specific case. 
ECHA 2011a 
Adaptations to 
information 
requirements 
The term ‘omission’ (=waiving) is used when on the basis of specific rules in Annex XI, 
section 3, or the sections in column 2 of Annex VII-X testing may be omitted. 
 
4.43 Weight of Evidence (WoE) 
Table 4.43 shows the original definitions of the term 'Weight of Evidence (WoE)', which 
have been collected from the literature and used to develop the NANoREG Definition. 
Definitions could be found in documents from international organisations such as UN 
(2003) and OECD (2012a, 2013b), in documents prepared by European bodies such as 
REACH legal text (EC 2009), ECHA official guidance for implementation of REACH (ECHA 
2010b, 2011c, 2011d), and documents prepared by SCENIHR (2012), in US bodies' 
official guidance documents (US EPA 1998, NRC 2009) and in peer-reviewed scientific 
literature (Weed 2005, Linkov et al 2009, Hope and Clarkson 2013, Ferrario et al 2014, 
Rhomberg 2014). International and European bodies (i.e. OECD, SCENHIR and ECHA) 
tend to use the term WoE in the context of hazard assessment and propose the same 
definition. Accordingly, the harmonised definition adopted in NANoREG reflects this 
definition and integrates it with features specified in other sources. 
 
Table 4.43 Literature definitions collected for the key term 'Weight of Evidence (WoE)' 
and considered to develop the NANoREG Definition. 
Source Original definition of the term 'Weight of Evidence (WoE)' 
INTERNATIONAL BODIES 
UN 2003 
Globally 
Harmonised 
System 
This means that all available information bearing on the determination of toxicity is 
considered together, including the results of valid in vitro tests, relevant animal data, and 
human experience such as epidemiological and clinical studies and well-documented case 
reports and observation.  
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Table 4.43 (cont.) 
Source Original definition of the term 'Weight of Evidence (WoE)' 
OECD 2014a 
Guidance on 
grouping of 
chemicals  
Weight of evidence refers to a positive expert opinion that considers available evidence 
from different independent sources and viewpoints on a particular issue, coming to a 
considered view of the available, oftentimes conflicting, data. It is preferred when every 
source does not provide sufficient information individually. 
OECD 2012a; 
OECD 2013b 
The process of considering the strengths and weaknesses of various pieces of information 
in reaching and supporting a conclusion concerning the hazard potential of a substance. 
EUROPEAN BODIES 
SCENIHR 2012 
Weighing of 
evidence and 
uncertainty 
The process of considering the strengths and weaknesses of various pieces of information 
in reaching and supporting a conclusion concerning the hazard potential of a substance. 
ECHA 2011c 
Hazard 
assessment 
The weight of evidence (WoE) approach is not a scientifically well-defined term or an 
agreed formalised concept. It involves assessing the relevance, reliability and adequacy of 
each piece of available information, holding the various pieces of information up against 
each other and reaching a conclusion on the hazard. This process always involves expert 
judgement. It is important to document and communicate how the evidence-based 
approach was used in a reliable, robust and transparent manner. 
ECHA 2011d 
Evaluation of 
available 
information 
[…] is a component of the decision-making procedure on substance properties and thus an 
important part of the chemical safety assessment. […]  
An evidence based approach involves an assessment of the relative values/weights of 
different pieces of available information that has been retrieved and gathered in previous 
steps. […] 
An evidence based approach may imply formalised decision schemes where explicit rules 
for weighing information elements have been established. After having assessed/ranked 
the quality of the individual components the next step should be the integrating, 
comparing and putting together all information pieces with their relative values or weights 
and drawing a conclusion. This often includes expert judgment. 
ECHA 2010b 
How to report 
weight of 
evidence 
The process of considering the strengths and weaknesses of various pieces of information 
in reaching and supporting a conclusion concerning the hazard potential of a substance. 
EC 2009 
REACH Annex XI 
There may be sufficient weight of evidence from several independent sources of 
information leading to the assumption/conclusion that a substance has or has not a 
particular dangerous property, while the information from each single source alone is 
regarded insufficient to support this notion. 
US BODIES 
NRC 2009 
Science and 
decisions, 
advancing risk 
assessment 
The phrase weight of evidence (WOE) is used by EPA and other scientific bodies to 
describe the strength of the scientific inferences that can be drawn from a given body of 
evidence. In its most common applications in EPA, WOE is used to characterize the 
hazardous (toxic or carcinogenic) properties of chemicals on the basis of an integrated 
analysis of all relevant observational and experimental data. It is increasingly used to 
describe the strength of evidence supporting particular modes of (toxic) action (MOAs) and 
dose-response relationships. Because scientific evidence used in WOE evaluations varies 
greatly among chemicals and other hazardous agents in type, quantity, and quality, it is 
not possible to describe the WOE evaluation in other than relatively general terms. It is 
thus not unexpected that WOE judgments in particular cases can vary among experts and 
that consensus is sometimes difficult to achieve. 
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Table 4.43 (cont.) 
Source Original definition of the term 'Weight of Evidence (WoE)' 
US EPA 1998 
Guidance on 
ecological risk 
assessment 
The development of lines of evidence provides both a process and a framework for 
reaching a conclusion regarding confidence in the risk estimate. It is not the kind of proof 
demanded by experimentalists (Fox, 1991), nor is it a rigorous examination of weights of 
evidence. (Note that the term “weight of evidence” is sometimes used in legal discussions 
or in other documents, e.g., Urban and Cook, 1986; Menzie et al., 1996). The phrase lines 
of evidence is used to de-emphasize the balancing of opposing factors based on 
assignment of quantitative values to reach a conclusion about a “weight” in favor of a 
more inclusive approach, which evaluates all available information, even evidence that 
may be qualitative in nature. It is important that risk assessors provide a thorough 
representation of all lines of evidence developed in the risk assessment rather than simply 
reduce their interpretation and description of the ecological effects that may result from 
exposure to stressors to a system of numeric calculations and results. 
PEER-REVIEWED SCIENTIFIC LITERATURE 
Ferrario et al 
2014 
Glossary 
The process of considering the strengths and weaknesses of various pieces of information 
in reaching and supporting a conclusion concerning the hazard potential of a substance. 
Rhomberg 2014 
Hypothesis-
driven WoE 
“weight-of-evidence” evaluation—the application of professional judgment to consider the 
strengths and weaknesses of individual studies, to compare and contrast their findings, 
and to try and reconcile or explain inconsistencies so as to arrive at a characterization of 
what potential toxicological properties are sufficiently supportable to justify the regulatory 
decisions that will be made. The challenge is for such a process to be sufficiently flexible to 
apply to a wide variety of arrays of data and patterns of agreement and disagreement, 
and at the same time sufficiently prescribed so that the results will not be seen as 
arbitrary, having consistent application of principles and standards of proof from case to 
case, applied in a way that is seen as transparent and objective. 
Hope and 
Clarkson 2013 
WoE methods in 
ecological risk 
assessments 
The term “weight of evidence” (WOE) has been mathematically defined for over a century 
and is used in studies of decision-making in humans and other primates (Good 2003; Gold 
and Shadlen 2007). It has not, however, been practically defined, in terms of tools and 
procedures, for use in predictive risk assessments (Weed 2005). WOE is basically the 
process of considering the strengths and weaknesses of various pieces of information in 
order to inform a decision being made among competing alternatives. An evidence-based 
approach involves an assessment of the relative weights of different pieces of available 
information. To this end, a weight is assigned to each piece of information, in either an 
objective way using a formalized procedure or expert judgment. The weight given to 
available evidence will be influenced by factors such as data quality, consistency of 
results, nature and severity of effects, and relevance of the information to the decision 
context. In the context of an ecological risk assessment (ERA), a WOE approach integrates 
outcomes from two or three lines of evidence (LOEs) to estimate the probability (i.e., 
chance) of an adverse outcome for an assessment endpoint. 
Linkov et al 2009 
Review of WoE 
approaches 
Weight of evidence (WOE) can be defined as a framework for synthesizing individual lines 
of evidence, using methods that are either qualitative (examining distinguishing 
attributes) or quantitative (measuring aspects in terms of magnitude) to develop 
conclusions regarding questions concerned with the degree of impairment or risk. In 
general, qualitative methods include presentation of individual lines of evidence without an 
attempt at integration, or integration through a standardized evaluation of individual lines 
of evidence based on qualitative considerations. Quantitative methods include integration 
of multiple lines of evidence using weighting, ranking, or indexing as well as structured 
decision or statistical models. 
Weed 2005 
WoE: a review of 
concepts and 
methods 
“Weight of evidence” typically refers either to the interpretative methods of risk 
assessment or to claims about risk that emerge from their use. The central role that this 
concept plays in the practice of risk assessment makes it imperative that the many 
stakeholders be clear about its definition, its uses, and its implications. 
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Table 4.43 (cont.) 
Source Original definition of the term 'Weight of Evidence (WoE)' 
 “Weight of evidence” has at least three characteristic uses: metaphorical, methodological 
(with several subcategories), and theoretical, roughly in order of their relative prevalence. 
The most common use of the phrase “weight of evidence” is to refer to a body of scientific 
evidence that has been examined for some purported risk, without reference to any 
interpretative methodology. “Weight of evidence” in this context can therefore be 
considered symbolic or metaphorical; the phrase could be replaced by the words 
“summary interpretation of the evidence” or “synthesis of the evidence.” 
The second category in Table I is methodological. In this literature, the phrase “weight of 
evidence” is sometimes used to refer to a methodological approach with a fairly simple 
premise: that all available evidence should be examined and interpreted. 
 
 
  
 
5. Closing remarks 
The development of the NANoREG harmonised terminology in the field of nanoEHS was a 
very useful initiative in that it facilitated mutual understanding among partners during 
meetings and improved coherence of project documents. The benefit has been 
particularly evident in those activities coordinated by JRC, where partners with very 
different types of expertise worked together aiming at producing multidisciplinary and 
integrated outputs, such as the NANoREG Framework and the associated Toolbox.  
The discussion on the key terms to be considered for the NANoREG Terminology led to 
the selection of 43 key terms. The list includes terms with international regulatory 
relevance such as those defined at OECD level (e.g. Adverse Outcome Pathway, 
alternative test method, grouping, read-across) as well as terms that have a specific 
meaning and use under REACH (e.g. Chemical Safety Assessment, nanoform). They 
represent the main regulatory reference for all project activities and deliverables. Most of 
the selected key terms have been already defined for chemicals. Either they have been 
considered as appropriate for NMs, too, or they have been discussed and slightly 
modified to account for NM specificities. 
The relevant sources for the development of the harmonised definitions were selected 
through an extensive literature search, but based on the expert judgment of the project 
partners. The references do not represent an exhaustive list of sources and hence it 
cannot be excluded that other definitions may be available in other guidance documents, 
legal texts or scientific publications. However, this possible source of uncertainty has 
been considered as minor and acceptable, taking into account the short time schedule 
available to serve the NANoREG project and the available human resources. 
This report is to be considered solely as a project document that does not have any 
regulatory consequences and does not represent the official position of the European 
Commission. 
  
 86 
 
References 
Anastas ND, Warner JC. 2005. The incorporation of hazard reduction as a chemical 
design criterion in green chemistry. Chemical Health & Safety, 12(2):9-13. 
doi:10.1016/j.chs.2004.10.001. 
 
Ankley GT, Bennett RS, Erickson RJ, Hoff DJ, Hornung MW, Johnson RD, Mount DR, 
Nichols JW, Russom CL, Schmieder PK, Serrano JA, Tietge JE, Villeneuve DL. 2010. 
Adverse Outcome Pathways: A Conceptual Framework to Support Ecotoxicology 
Research and Risk Assessment. Environ. Toxicol. Chem., 29:730-741. 
 
Ariëns EJ. 1980. Chapter 1 Design of safer chemicals. In: Medicinal Chemistry: a series 
of monographs. Volume 11-IX. Published by Academic Press Inc., London. Regulatory 
Toxicology and Pharmacology, 70:492–506. 
 
Arts JHE, Hadi M, Keene AM, Kreiling R, Lyon D, Maier M, Michel K, Petry T, Sauer UG, 
Warheit D, Wiench K, Landsiedel R. 2014. A critical appraisal of existing concepts for the 
grouping of nanomaterials. Regulatory Toxicology and Pharmacology, 70(2):492–506. 
 
Behm M. 2005. Linking construction fatalities to the design for construction safety 
concept. Vol. 43(8):589-611. 
 
Brouwer DH. 2012. Control Banding Approaches for Nanomaterials. Commentary. Ann. 
Occup. Hyg., 56(5):506-514. 
 
BSR 2010. Supply chains and the OECD Guidelines for multinational enterprises. BSR 
discussion paper on responsible supply chain management. 10th OECD roundtable on 
corporate responsibility. Launching an update of the OECD Guidelines for Multinational 
Enterprises 30 June – 1 July 2010, OECD Conference Centre, Paris, France. Prepared by 
Cody Sisco, Blythe Chorn, Peder Michael Pruzan-Jorgensen, Jeremy Prepscius, and 
Veronica Booth from Business for Social Responsibility (BSR). 
 
Burello E, Worth A. 2015. A rule for designing safer nanomaterials: do not interfere with 
the cellular redox equilibrium. Nanotoxicology, 9:sup1:116-117. 
 
CEFIC-LRI 2012. Workshop Report. Experts Workshop on Read-Across Assessment. 
Organised by ECHA with the active support from Cefic-LRI. (October 3, 2012). Use of 
"read-across" for Chemical Safety Assessment under REACH. 
 
CEN 2015. Homepage. Link (accessed in August 2015):  
Link: https://www.cen.eu/ 
 
CEPA 1999. Canadian Environmental Protection Act (S.C. 1999, c. 33).  
Link: http://laws-lois.justice.gc.ca/eng/acts/C-15.31/ 
 
Cronin MTD. 2013. An Introduction to Chemical Grouping, Categories and Read-Across to 
Predict Toxicity. In: Cronin MTD, Madden JC, Enoch SJ, Roberts DW (Ed.). Chemical 
Toxicity Prediction: Category Formation and Read-Across. Issues in Toxicology N° 17. 
Published by the Royal Society of Chemistry. 
 
Danish EPA 2013. Information requirements for nanomaterials – IRNANO. The Danish 
Environmental Protection Agency, Copenhagen. ISBN No: 978-87-92903-51-8. 
 
Duffus JH, Nordberg M, Templeton DM. 2007. Glossary of terms used in toxicology, 2nd 
edition (IUPAC recommendations 2007). International Union of Pure and Applied 
Chemistry and Human Health Division. Pure Appl. Chem., 79(7):1153-1344. 
doi:10.1351/pac200779071153. 
 87 
 
Duke University 2015. Global Value Chains Initiative. Link (accessed in September 
2015): https://globalvaluechains.org/concept-tools  
 
EC 2008a. Commission Staff Working Document. Accompanying document to the 
Communication from the Commission to the European Parliament, the Council and the 
European Economic and Social Committee. Regulatory Aspects of Nanomaterials. 
Summary of legislation in relation to health, safety and environment aspects of 
nanomaterials, regulatory research needs and related measures. COM(2008) 366 final. 
Brussels, 17.6.2008, SEC(2008) 2036. 
 
EC 2008b. Council Regulation (EC) N° 440/2008 of 30 May 2008 laying down test 
methods pursuant to Regulation (EC) No 1907/2006 of the European Parliament and of 
the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals 
(REACH). 31.5.2008. Official Journal of the European Union, L 142/1. 
 
EC 2009. Commission Regulation (EC) N° 134/2009 of 16 February 2009 amending 
Regulation (EC) N° 1907/2006 of the European Parliament and of the Council on the 
Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) as regards 
Annex XI. 17.2.2009. Official Journal of the European Union, L 46/3. 
 
EC 2011. Commission Recommendation of 18 October 2011 on the definition of 
nanomaterial (2011/696/EU). 20.10.2011. Official Journal of the European Union, L 
275/38. 
 
ECETOC 2007. Intelligent testing strategies in ecotoxicology: mode of action approach 
for specifically acting chemicals. Technical Report N° 102. European Centre for 
Ecotoxicology and Toxicology of Chemicals, Brussels. 
 
ECETOC 2010. Guidance on Assessment Factors to Derive a DNEL. Technical Report N° 
110. Brussels, October 2010.  
 
ECETOC 2012. Category approaches, Read-across, (Q)SAR. Technical Report N° 116. 
European Centre for Ecotoxicology and Toxicology of Chemicals, Brussels. 
 
ECHA 2008a. Guidance on information requirements and chemical safety assessment. 
Chapter R.6: QSARs and grouping of chemicals. May 2008. European Chemicals Agency, 
Helsinki. 
 
ECHA 2008b. Guidance on information requirements and chemical safety assessment. 
Chapter R.10: Characterisation of dose [concentration]-response for environment. May 
2008. European Chemicals Agency, Helsinki. 
 
ECHA 2009. Guidance in a Nutshell. Chemical Safety Assessment. European Chemicals 
Agency, Helsinki. 
 
ECHA 2010a. Guidance on information requirements and chemical safety assessment 
Chapter R.12: Use descriptor system. Version 2.0. March 2010 (under review). European 
Chemicals Agency, Helsinki. 
 
ECHA 2010b. Practical guide 2: How to report weight of evidence. European Chemicals 
Agency, Helsinki. Link: 
http://echa.europa.eu/documents/10162/13655/pg_report_weight_of_evidence_en.pdf 
 
ECHA 2010c. Practical guide 4: How to report data waiving. European Chemicals Agency, 
Helsinki. 
Link: http://echa.europa.eu/documents/10162/13655/pg_report_data_waiving_en.pdf  
 
 88 
 
ECHA 2011a. Guidance on information requirements and chemical safety assessment. 
Chapter R.5: Adaptation of information requirements. Version 2.1. December 2011. 
European Chemicals Agency, Helsinki. 
 
ECHA 2011b. Guidance on information requirements and chemical safety assessment. 
Part A: Introduction to the Guidance Document. Version 1.1. December 2011. European 
Chemicals Agency, Helsinki. 
 
ECHA 2011c. Guidance on information requirements and chemical safety assessment. 
Part B: Hazard assessment. Version 2.1. December 2011. European Chemicals Agency, 
Helsinki. 
 
ECHA 2011d. Guidance on information requirements and chemical safety assessment. 
Chapter R.4: Evaluation of available information. Version 1.1. December 2011. European 
Chemicals Agency, Helsinki. 
 
ECHA 2012a. Best practices on physicochemical and substance identity information for 
nanomaterials. First GAARN meeting. Helsinki, 29 May 2012. European Chemicals 
Agency, Helsinki. 
 
ECHA 2012b. Guidance on information requirements and chemical safety assessment. 
Chapter R.8: Characterisation of dose [concentration]-response for human health. 
Version 2.1. November 2012. European Chemicals Agency, Helsinki. 
 
ECHA 2012c. Background paper. An Introduction to the Assessment of Read-Across in 
ECHA. Experts Workshop on Read-Across Assessment with the active support of Cefic 
LRI. 2-3 October 2012. ECHA's Conference Centre, Guido Sacconi Room, Annankatu 18, 
Helsinki. 
 
ECHA 2012d. Expert Workshop “Dealing with Uncertainty of Non-Test Methods under 
REACH”. Background Document. 23-24 September 2010, ECHA Conference centre, 
Annankatu 18, Helsinki. European Chemicals Agency, Helsinki. 
 
ECHA 2013a. Assessing human health and environmental hazards of nanomaterials - 
Best practice for REACH Registrants. Second GAARN meeting. Helsinki, 21-22 January 
2013. European Chemicals Agency, Helsinki. 
 
ECHA 2013b. Grouping of substances and read-across approach. Part I: Introductory 
note. European Chemicals Agency, Helsinki. 
 
ECHA 2014a. Human health and environmental exposure assessment and risk 
characterisation of nanomaterials. Best practice for REACH registrants. Third GAARN 
meeting. Helsinki, 30 September 2013. European Chemicals Agency, Helsinki. 
 
ECHA 2014b. The Use of Alternatives to Testing on Animals for the REACH Regulation. 
Second report under Article 117(3) of the REACH Regulation. European Chemicals 
Agency, Helsinki. 
 
ECHA 2014c. Summary of Workshop on the Read-Across Assessment Framework 
(RAAF). 2-3 October 2014. European Chemicals Agency, Helsinki. 
 
ECHA 2015a. Read-Across Assessment Framework (RAAF). European Chemicals Agency, 
Helsinki. 
 
ECHA 2015b. Topical Scientific Workshop Regulatory Challenges in the Risk Assessment 
of Nanomaterials. Proceedings. 23-24 October 2014, Helsinki, Finland. European 
Chemicals Agency, Helsinki. 
 89 
 
EP and EC 2006. Regulation (EC) N° 1907/2006 of the European Parliament and of the 
Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and 
Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending 
Directive 1999/45/EC and repealing Council Regulation (EEC) N° 793/93 and 
Commission Regulation (EC) N° 1488/94 as well as Council Directive 76/769/EEC and 
Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC. 
30.12.2006. Official Journal of the European Union, L 396/1. 
 
EP and EC 2008. Regulation (EC) N° 1272/2008 of the European Parliament and of the 
Council of 16 December 2008 on classification, labelling and packaging of substances 
and mixtures, amending and repealing Directives 67/548/EEC and 1999/45/EC, and 
amending Regulation (EC) N° 1907/2006. 1.12.2008. Official Journal of the European 
Union, L 353/1. 
 
EP and EC 2009. Regulation (EC) N° 1223/2009 of the European Parliament and of the 
Council of 30 November 2009 on cosmetic products. 22.12.2009. Official Journal of the 
European Union, L 342/59. 
 
EP and EC 2010. Directive 2010/63/EU of the European Parliament and of the Council of 
22 September 2010 on the protection of animals used for scientific purposes. 
20.10.2010. Official Journal of the European Union, L 276/33. 
 
ETUC 2010. ETUC Concept of a regulatory definition of a substance in the nanoform. 
European Trade Union Confederation, Brussels (Belgium).  
Link: 
https://www.etuc.org/sites/www.etuc.org/files/REACH_nanosubstance_definition_ETUC_
concept.pdf 
 
EURL ECVAM 2015. Glossary. European Union Reference Laboratory for Alternatives to 
Animal Testing. Link (accessed in August 2015): 
Link: https://eurl-ecvam.jrc.ec.europa.eu/glossary 
 
FAO 1998. Guidelines for Quality Management in Soil and Plant Laboratories. (FAO Soils 
Bulletin - 74). Food and Agriculture Organization of the United Nations. 
 
Ferrario D, Brustio R and Hartung T. 2014. Glossary of Reference Terms for Alternative 
Test Methods and their Validation - t4 Report*. Transatlantic think tank of toxicology. 
Link: http://www.altex.ch/All-issues/Issue.50.html?iid=150&aid=6. 
 
Gebel T, Foth H, Damm G, Freyberger A, Kramer PJ, Lilienblum W, Röhl C, Schupp T, 
Weiss C, Wollin KM, Hengstler JG. 2014. Manufactured nanomaterials: categorization 
and approaches to hazard assessment. Arch Toxicol, 88(12):2191-211. doi: 
10.1007/s00204-014-1383-7. 
 
Godwin H, Nameth C, Avery D, Bergeson LL, Bernard D, Beryt E, Boyes W, Brown S, 
Clippinger AJ, Cohen Y, Doa M, Hendren CO, Holden P, Houck K, Kane BK, Klaessig F, 
Kodas T, Landsiedel R, Lynch I, Malloy T, Miller MB, Muller J, Oberdoster G, Petersen EJ, 
Pleus RC, Sayre P, Stone V, Sullivan KM, Tentschert J, Wallis P, Nel AE. 2015. 
Nanomaterial Categorization for Assessing Risk Potential To Facilitate Regulatory 
Decision-Making. ACSNano, 9(4):3409-3417. 
 
Hoehener K, Hoeck J. 2013. Deliverable D2.6 Draft (M30) Consolidated Framework for 
EHS of Manufactured Nanomaterials. ERA-NET SIINN Safe Implementation of Innovative 
Nanoscience and Nanotechnology. 
 
 90 
 
Hope BK, Clarkson JRR. 2013. A Strategy for Using Weight-of-Evidence Methods in 
Ecological Risk Assessments. Human and Ecological Risk Assessment: An International 
Journal. doi:10.1080/10807039.2013.781849. 
 
Hristozov DR, Gottardo S, Critto A, Marcomini A. Risk assessment of engineered 
nanomaterials: a review of available data and approaches from a regulatory perspective. 
Nanotoxicology 6:880-98. doi: 10.3109/17435390.2011.626534. 
 
Igarashi T. 2014. OECD member countries' approaches to develop or use concepts of 
grouping, equivalence and read-across based on physical-chemical properties (GERA-PC) 
of nanomaterials for their hazard assessment in regulatory regimes. Platform 
presentation at OECD Expert Meeting on Categorization of Manufactured Nanomaterials, 
17-19 September 2014, Washington DC. 
 
IPSC 2004. IPCS Risk Assessment Terminology. Part 1: IPCS/OECD Key Generic Terms 
used in Chemical Hazard/Risk Assessment. Part 2: IPCS Glossary of Key Exposure 
Assessment Terminology. International Programme on Chemical Safety. World Health 
Organization, Geneva.  
Link: http://www.inchem.org/documents/harmproj/harmproj/harmproj1.pdf 
 
ISO 2006. ISO (UNI EN) 14040. Environmental Management-Life Cycle Assessment 
(LCA)-Principles and Framework. International Organization for Standardization, Geneve. 
 
ISO 2012. ISO/TS 12901-1:2012. Nanotechnologies — Occupational risk management 
applied to engineered nanomaterials — Part 1: Principles and approaches. International 
Organization for Standardization, Geneve. 
 
ISO 2014. ISO/TS 12901-2:2014. Nanotechnologies - Occupational risk management 
applied to engineered nanomaterials – Part 2: Use of the control banding approach. 
International Organization for Standardization, Geneve. 
 
ISO 2015a. Glossary. Link (accessed in August 2015): 
Link: http://www.iso.org/sites/ConsumersStandards/5_glossary.html 
 
ISO 2015b. Homepage. Link (accessed in August 2015): 
Link: http://www.iso.org/ 
 
JRC 2005. Chemical Categories and Read Across. Report prepared by Patlewicz G. Joint 
Research Centre, Ispra. 
 
JRC 2010. ILCD handbook. International Reference Life Cycle Data System. General 
guide for Life Cycle Assessment - Detailed guidance. First edition. Joint Research Centre, 
Ispra. 
 
JRC and ECHA 2012. NANO SUPPORT Project. Scientific technical support on assessment 
of nanomaterials in REACH registration dossiers and adequacy of available information. 
AA 07.0307/2010/581080/AA/D3 between DG Environment (DG ENV) and the Joint 
Research Centre (JRC). Final Report on analysis and assessment (Task I, step 3&4&5) 
and options for adapting REACH (Task II, step 1). 12 March 2012. 
 
Kaplinsky R, Morris M. 2001. A Handbook for Value Chain Research. Prepared for the 
International Development Research Centre (IDRC), p.4-6. 
 
Kelty CM. 2009. Beyond Implications and Applications: the Story of ‘Safety by Design’. 
Nanoethics, 3:79-96. 
 
 91 
 
Linkov I, Loney D, Cormier S, Satterstrom K, Bridges T. 2009. Weight-of-evidence 
evaluation in environmental assessment: Review of qualitative and quantitative 
approaches. Science of the Total Environment, 407(5):199–5205. 
 
Lynch I, Weiss C, Valsami-Jonesa E. 2014. A strategy for grouping of nanomaterials 
based on key physico-chemical descriptors as a basis for safer-by-design NMs. Nano 
Today, 9:266-270. 
 
Merriam-Webster 2015. Link (accessed in August 2015): 
Link: http://www.merriam-webster.com/dictionary/framework 
 
Movia D, Gerard V, Manus Maguire C, Jain N, Bell AP, Nicolosi V, O’Neill T, Scholz D, 
Gun’ko Y, Volkov Y, Prina-Mello A. 2014. Safe-by-design approach to the development of 
gold nanoboxes as carriers for internalization into cancer cells. Biomaterials, 35:2543-
2557. 
 
NIEHS 1997. Validation and Regulatory Acceptance of Toxicological Test Methods: A 
Report of the ad hoc Interagency Coordinating Committee on the Validation of 
Alternative Methods. NIH Publication No. 97-3981. National Institute of Environmental 
Health Sciences, Research Triangle Park, North Carolina, USA. 
 
NILU 2013. Good Laboratory Practice System. HEL11P002 Definition of terms. Norwegian 
Institute for Air Research. 
 
NIOSH 2009. Qualitative Risk Characterization and Management of Occupational 
Hazards: Control Banding (CB). A Critical Review and Literature Analysis. Department of 
Health and Human Services, Centers for Disease Control and Prevention, National 
Institute for Occupational Safety and Health. 
 
NRC 2009. Science and Decisions. Advancing Risk Assessment. Committee on Improving 
Risk Analysis Approaches. Used by the U.S. EPA Board on Environmental Studies and 
Toxicology Division on Earth and Life Studies. National Research Council. The National 
Academies Press, Washington. 
 
OECD 2003. Descriptions of selected key generic terms used in chemical hazard/risk 
assessment OECD Series on Testing and Assessment. Organization for Economic Co-
operation and Development, Environment Directorate, Joint Meeting of the Chemical 
Committee and the Working Party on Chemicals, Pesticides and Biotechnology, Paris. 
ENV/JM/MONO(2003)15. Unclassified. 30-Oct-2003. 
 
OECD 2005. Guidance document on the validation and international acceptance of new 
or updated test methods for hazard assessment. Series on Testing and Assessment, N° 
34. Organization for Economic Co-operation and Development, Environment Directorate, 
Joint Meeting of the Chemical Committee and the Working Party on Chemicals, Pesticides 
and Biotechnology, Paris. ENV/JM/MONO(2005)14. Unclassified. 18-Aug-2005. 
 
OECD 2007. Guidance Document on the Validation of (Quantitative) Structure-Activity 
Relationships [(Q)SAR] models. Organization for Economic Co-operation and 
Development, Environment Directorate, Joint Meeting of the Chemical Committee and 
the Working Party on Chemicals, Pesticides and Biotechnology, Paris. 
ENV/JM/MONO(2007)2. Unclassified. 30-March-2007. 
 
OECD 2011. Report of the Workshop on Using Mechanistic Information in Forming 
Chemical Categories. Series on Testing and Assessment, N° 138. 8-10 December 2010, 
Crystal City VA, USA. Organisation for Economic Co-operation and Development, 
Environment Directorate, Joint Meeting of the Chemical Committee and the Working 
 92 
 
Party on Chemicals, Pesticides and Biotechnology, Paris. ENV/JM/MONO(2011)8. 
Unclassified. 18-May-2011. 
 
OECD 2012a. Fluorescein Leakage Test Method for Identifying Ocular Corrosives and 
Severe Irritants. TG 460.  
Link: http://ntp.niehs.nih.gov/iccvam/suppdocs/feddocs/oecd/oecd-tg460-508.pdf 
 
OECD 2012b. Appendix I Collection of working definitions. Organisation for Economic Co-
operation and Development.  
Link: http://www.oecd.org/chemicalsafety/testing/49963576.pdf 
 
OECD 2013a. Guidance document on developing and assessing Adverse Outcome 
Pathways. Series on Testing and Assessment N° 184. Organisation for Economic Co-
operation and Development, Environment Directorate, Joint Meeting of the Chemicals 
Committee and the Working Party on Chemicals, Pesticides and Biotechnology. 
ENV/JM/MONO(2013)6. Unclassified. 17-April-2013. 
 
OECD 2013b. Bovine Corneal Opacity and Permeability Test Method for Identifying 
Ocular Corrosives and Severe Irritants.TG 437. Adopted: 26 July 2013. Link: 
http://ntp.niehs.nih.gov/iccvam/suppdocs/feddocs/oecd/oecd-tg437-2013-508.pdf 
 
OECD 2014a. Guidance on grouping of chemicals. Second edition. Series on Testing and 
Assessment N° 194. Organisation for Economic Co-operation and Development, 
Environment Directorate, Joint Meeting of the Chemical Committee and the Working 
Party on Chemicals, Pesticides and Biotechnology, Paris. ENV/JM/MONO(2014)4. 
Unclassified. 14-April-2014. 
 
OECD 2014b. OECD Working Party on Manufactured Nanomaterials. OECD Expert 
Meeting on Categorization of Manufactured Nanomaterials, Washington (USA), 17-19 
September 2014. Background Document. Organisation for Economic Co-operation and 
Development, Paris. 
 
OECD 2015. Testing of chemicals. Link (accessed in August 2015): 
Link: http://www.oecd.org/chemicalsafety/testing/ 
 
Patlewicz G, Ball N, Becker RA, Booth ED, Cronin MTD, Kroese D, Steup D, van 
Ravenzwaay B, Hartung T. 2014. Food for Thought … Read-Across Approaches – 
Misconceptions, Promises and Challenges Ahead. ALTEX, 31(4):387-396.  
Link: http://dx.doi.org/10.14573/altex.1410071 
 
Raunio H. 2011. In silico toxicology–non-testing methods. Perspective Article. Frontiers 
in Pharmacology, 2. doi: 10.3389/fphar.2011.00033. 
 
RCC 2013. Work Element 2, Priority Setting: Development of a Joint Nanomaterials 
Classification Scheme. Final Report. Regulatory Cooperation Council (RCC) 
Nanotechnology Initiative.  
 
Rhomberg. 2014. Hypothesis-Based Weight of Evidence: An Approach to Assessing 
Causation and its Application to Regulatory Toxicology. Risk Analysis. doi: 
10.1111/risa.12206. 
 
RIVM 2015. Grouping nanomaterials: A strategy towards grouping and read-across. 
RIVM Report 2015-0061. Prepared by: Sellers K, Deleebeeck NME, Messiean M, Jackson 
M, Bleeker EAJ, Sijm DTHM, van Broekhuizen FA. National Institute for Public Health and 
the Environment (RIVM), Bilthoven (The Netherlands). 
 
 93 
 
Roebben G, Rasmussen K, Kestens V, Linsinger TPJ, Rauscher H, Emons H, Stamm H. 
2013. Reference materials and representative test materials: the nanotechnology case. J 
Nanopart Res, 15:1455. doi: 10.1007/s11051-013-1455-2. 
 
SCCS 2015. Factsheet: Is it safe to use cosmetics containing silica in nanoform? 
Factsheet based on the opinion of the independent Scientific Committee on Consumer 
Safety (SCCS): "Silica, Hydrated Silica and Silica Surface Modified with Alkyl Silylates 
(nano form)". 
Available at: Link: 
http://ec.europa.eu/health/scientific_committees/docs/citizens_nanosilica_en.pdf 
 
SCCS 2012. Guidance on the Safety Assessment of Nanomaterials in Cosmetics. 
Scientific Committee on Consumer Safety. SCCS/1484/12. 
 
SCCS 2013. Opinion on Carbon Black (nano-form). SCCS/1515/13. Revision of 27 March 
2014. Scientific Committee on Consumer Safety. 
 
SCENIHR 2012. Memorandum on the use of the scientific literature for human health risk 
assessment purposes – weighing of evidence and expression of uncertainty. Scientific 
Committee on Emerging and Newly Identified Health Risks. Adopted on 19 March 2012. 
Link: 
http://ec.europa.eu/health/scientific_committees/emerging/docs/scenihr_s_001.pdf 
 
Schultz TW. 2010. Adverse outcome pathways: A way of linking chemical structure to in 
vivo toxicological hazards. In: Cronin MTD, Madden JC (Ed.). In Silico Toxicology: 
Principles and Applications. The Royal Society of Chemistry, Cambridge, UK, pp. 346-
371. 
 
Schultz TW, Amcoff P, Berggren E, Gautier F, Klaric M, Knight DJ, Mahony C, Scwarz M, 
White A, Cronin MTD. 2015. A strategy for structuring and reporting a read-across 
prediction of toxicity. Regulatory Toxicology and Pharmacology, 72:586-601. 
 
Sealy C. 2011. ‘Safe-by-design’ nanoparticles show reduced toxicity. Nano Today. 
doi:10.1016/j.nantod.2011.02.010. 
 
SETAC (Society of Environmental Toxicology and Chemistry). 1993. Guidelines for Life-
Cycle Assessment: A “Code of Practice”. Boca Raton,Lewis. 
 
Sips AJAM, Noorlander C, Groenewold M, Salverda J, Oomen AG. 2013. Safe(r) by 
design: An adequate way of keeping Pace with Innovation? Platform presentation at 
NanotechItaly 2013. 
 
Som C, Berges M, Chaudhry Q, Dusinska M, Fernandes TF, Olsen S, Nowack B. 2010. 
The Importance of Life Cycle Concepts for the Development of Safe Nanoproducts. J 
Toxicology, 269(2-3):160-169. 
 
Stone V, S. Pozzi-Mucelli, L. Tran, K. Aschberger, S. Sabella, U.B. Vogel, C. Poland, D. 
Balharry, T. Fernandes, S. Gottardo, S. Hankin, M. Hartl, N. Hartmann, D. Hristozov, K. 
Hund-Rinke, H. Johnston, A. Marcomini, O. Panzer, D. Roncato, A.T. Saber, H. Wallin 
and J.J. Scott-Fordsmand. 2013. Research prioritisation to deliver an intelligent testing 
strategy for the human and environmental safety of nanomaterials. ITS NANO. 
 
TSCA 2002. Toxic Substances Control Act [As Amended Through P.L. 107–377, 
December 31, 2002].  
Link: http://www2.epa.gov/laws-regulations/summary-toxic-substances-control-act 
 
 94 
 
 
UN 2003. Globally Harmonised System of Classification and Labelling of Chemicals 
(GHS). United Nations, New York and Geneva. 
Link: http://www.unece.org/trans/danger/publi/ghs/ghs_welcome_e.html 
 
US EPA 1992. Guidelines for Exposure Assessment. Risk Assessment Forum. United 
States Environmental Protection Agency, Washington, DC. 
 
US EPA 1998. Guidelines for Ecological Risk Assessment. Risk Assessment Forum. U.S. 
Environmental Protection Agency, Washington, DC. 
 
US EPA 1999. Development of Chemical Categories in the HPV Challenge Program. 
United States Environmental Protection Agency, Office of Pollution Prevention and 
Toxics, Washington. 
 
US EPA 2002. A review of the reference dose and reference concentration processes. 
Final Report. EPA/630/P-02/002F, December 2002. Prepared for the Risk Assessment 
Forum. United States Environmental Protection Agency, Washington, DC. 
 
US EPA 2010. TSCA New Chemicals Program (NCP) Chemical Categories. Last revised: 
August, 2010. Office of Pollution Prevention and Toxics, United States Environmental 
Protection Agency, Washington, DC. 
 
US EPA 2014a. Assessment and management of nanomaterials under the Toxic 
Substances Control Act. Platform presentation by Jim Alwood at 'ECHA Topical Scientific 
Workshop: Regulatory Challenges in Risk Assessment of Nanomaterials', Helsinki, 23 
October 2014. 
 
US EPA 2014b. Guidance for Applying Quantitative Data to Develop Data-Derived 
Extrapolation Factors for Interspecies and Intraspecies Extrapolation. EPA/R-14/002F, 
September 2014. United States Environmental Protection Agency, Office of the Science 
Advisor, Risk Assessment Forum, Washington, DC. 
 
US EPA 2015. Glossary. Link (accessed in August 2015): 
Link: http://www.epa.gov/opp00001/science/comptox-glossary.html#r  
 
van Leeuwen CJ,Patlewicz GY, Worth AP. 2007. 11. Intelligent Testing Strategies. In: 
van Leeuwen CJ & Vermeire TG (Editors). Risk Assessment of Chemicals: An 
Introduction. 2nd Edition. Springer. 
 
van Leeuwen K, Schultz TW, Henry T, Diderich B, Veith GD. 2009. Using chemical 
categories to fill data gaps in hazard assessment. SAR and QSAR in Environmental 
Research, 20(3-4):207-220. 
 
Villeneuve DL, Garcia-Reyero N. 2011. A vision and strategy for predictive ecotoxicology 
testing in the 21st century. Environ. Toxicol. Chem., 30:1–8. 
 
Walser T, Studer C. 2015. Sameness: The regulatory crux with nanomaterial identity and 
grouping schemes for hazard assessment. Regul Toxicol Pharmacol, 72(3):569-71. doi: 
10.1016/j.yrtph.2015.05.031. 
 
Watanabe, KH, Andersen, ME, Basu N, Carvan III MJ, Crofton KM, King KA, Suňol C, 
Tiffany-Castiglioni E, Schultz IR. 2011. Defining and modelling known adverse outcome 
pathways: domoic acid and neuronal signalling as a case study. Environ. Toxicol. Chem., 
30:9-21. 
 
 95 
 
WBCSD 2011. Collaboration, innovation, transformation: Ideas and inspiration to 
accelerate sustainable growth - A value chain approach. World Business Council for 
Sustainable Development, p.3 & 5. 
 
Weed DL. 2005. Weight of Evidence: A Review of Concept and Methods. Risk Analysis, 
25(6). doi: 10.1111/j.1539-6924.2005.00699.x 
 
Zimmerman JB, Anastas PT. 2015. Toward designing safer chemicals. Editorial. Science, 
347(6219). Link: http://pubs.acs.org/doi/abs/10.1021/es5040969. 
 
  
 96 
 
List of abbreviations and definitions  
ADI Acceptable Daily Intake 
AF Assessment Factor 
AIT Austrian Institute of Technology 
AOP Adverse Outcome Pathway 
ATS Alternative Testing Strategy 
BMD Benchmark Dose 
CB Control Banding 
CEFIC-LRI European Chemical Industry Council-Long-range Research Initiative 
CEN European Committee for Standardisation 
CEPA Canadian Environmental Protection Act 
CLP Classification Labelling Packaging 
CNTs Carbon Nanotubes 
CSA Chemical Safety Assessment 
CSR Chemical Safety Report 
DDEF Data-Derived Extrapolation Factor 
DG ENV Directorate-General for the Environment 
DMEL Derived Minimal Effect Level 
DNEL Derived No Effect Level 
EC European Council 
EC10 Effect Concentration 10% 
EC50 Effect Concentration 50% 
ECETOC European Centre for Ecotoxicology and Toxicology of Chemicals 
ECHA European Chemicals Agency 
EHS Environmental Health and Safety 
ENEA National Agency for New Technologies, Energy and Sustainable 
Economic Development 
ENM Engineered Nanomaterial 
EP European Parliament 
EPA Environmental Protection Agency 
ERA Ecological Risk Assessment 
ES Exposure Scenario 
EU European Union 
EURL ECVAM European Union Reference Laboratory for alternatives to animal 
testing 
FAO Food and Agriculture Organization of the United Nations 
GAARN Group Assessing Already Registered Nanomaterials 
GLP Good Laboratory Practice 
IPSC International Programme on Chemical Safety 
ISO International Standardisation Organisation 
ISQ Institute for Soldering and Quality 
IUPAC International Union of Pure and Applied Chemistry 
JRC Joint Research Centre 
KI Karolinska Institute 
LCA Life Cycle Assessment 
LOAEL Lowest Observed Adverse Effect Level 
LoE Line of Evidence 
MAD Mutual Acceptance of Data 
MF Modifying Factor 
MIE Molecular Initiating Event 
MOA Mode of Action 
NANoREG A common European approach to the regulatory testing of 
nanomaterials 
NIEHS National Institute of Environmental Health Sciences 
NILU Norwegian Institute for Air Research 
NM Nanomaterial 
 97 
 
NOAEL No Observed Adverse Effect Level 
NOEC No Observed Effect Concentration 
NRCWE National Research Centre for the Working Environment 
OECD Organisation for Economic Cooperation and Development 
OEL Occupational Exposure Limit 
PBT Persistent Bioaccumulative Toxic 
PNEC Predicted No Effect Concentration 
QNAR Quantitative Nanostructure-Activity Relationship 
(Q)SAR (Quantitative) Structure-Activity Relationship 
RAAF Read-Across Assessment Framework 
RCC Regulatory Cooperation Council 
REACH Registration, Evaluation, Authorisation and Restriction of Chemicals 
RfC Reference Concentration 
RfD Reference Dose 
RIVM National Institute for Public Health and the Environment 
SAR Structure-Activity Relationship 
SCCS Scientific Committee on Cosmetics Safety 
SCENHIR Scientific Committee on Emerging and Newly Identified Health Risks 
SOP Standard Operating Procedure 
TDI Tolerable Daily Intake 
TGD Technical Guidance Document 
TNO Netherlands Organization for applied scientific research 
TSCA Toxic Substances Control Act 
UF Uncertainty Factor 
UN United Nations 
US EPA United States Environmental Protection Agency 
US United States 
vPvB very Persistent very Bioaccumulative 
WoE Weight of Evidence 
  
 98 
 
List of tables  
Table 3.1 NANoREG Harmonised Terminology and Definitions in the field of 
environmental health and safety assessment of nanomaterials with focus on the 
European REACH regulatory context. 
Table 4.1 Literature definitions collected for the key term 'adaptation' and considered 
to develop the NANoREG Definition. 
Table 4.2 Literature definitions collected for the key term 'adaptation based on 
exposure' and considered to develop the NANoREG Definition. 
Table 4.3 Literature definitions collected for the key term 'Adverse Outcome Pathway 
(AOP)' and considered to develop the NANoREG Definition. 
Table 4.4 Literature definitions collected for the key term 'alternative test method' and 
considered to develop the NANoREG Definition. 
Table 4.5 Literature definitions collected for the key term 'analogue(s)' and considered 
to develop the NANoREG Definition. 
Table 4.6 Literature definitions collected for the key term 'Assessment Factor (AF)' 
and considered to develop the NANoREG Definition. 
Table 4.7 Literature definitions collected for the key term 'categorisation' and 
considered to develop the NANoREG Definition. 
Table 4.8 Literature definitions collected for the key term 'chemical category' and 
considered to develop the NANoREG Definition. 
Table 4.9 Literature definitions collected for the key term 'Chemical Safety 
Assessment (CSA)' and considered to develop the NANoREG Definition. 
Table 4.10 Literature definitions collected for the key term 'class of substances' and 
considered to develop the NANoREG Definition. 
Table 4.11 Literature definitions collected for the key term 'Control Banding (CB)' and 
considered to develop the NANoREG Definition. 
Table 4.12 Literature definitions that have been collected for the key term 'data gap' 
and have been considered to develop the NANoREG Definition. 
Table 4.13 Literature definitions collected for the key term 'data gap filling' and 
considered to develop the NANoREG Definition. 
Table 4.14 Literature definitions collected for the key term 'endpoint' and considered to 
develop the NANoREG Definition. 
Table 4.15 Literature definitions collected for the key term 'Exposure Scenario (ES)' 
and considered to develop the NANoREG Definition. 
Table 4.16 Literature definitions collected for the key term 'extrapolation' and 
considered to develop the NANoREG Definition. 
Table 4.17 Literature definitions collected for the key term 'framework' and considered 
to develop the NANoREG Definition. 
Table 4.18 Literature definitions collected for the key term 'grouping' and considered to 
develop the NANoREG Definition. 
Table 4.19 Literature definitions collected for the key term 'harmonisation' and 
considered to develop the NANoREG Definition. 
Table 4.20 Literature definitions collected for the key term 'information requirement' 
and considered to develop the NANoREG Definition. 
Table 4.21 Literature definitions collected for the key term 'interpolation' and 
considered to develop the NANoREG Definition. 
 99 
 
Table 4.22 Literature definitions collected for the key term 'life cycle' and considered to 
develop the NANoREG Definition. 
Table 4.23 Literature definitions collected for the key term 'Life Cycle Assessment 
(LCA)' and considered to develop the NANoREG Definition. 
Table 4.24 Literature definitions collected for the key term 'mode of action' and 
considered to develop the NANoREG Definition. 
Table 4.25 Literature definitions collected for the key term 'nanoform' and considered 
to develop the NANoREG Definition. 
Table 4.26 Literature definitions collected for the key term '(Quantitative) Structure-
Activity Relationship ((Q)SAR)' and considered to develop the NANoREG Definition. 
Table 4.27 Literature definitions collected for the key term '(Quantitative) Structure-
Activity Relationship ((Q)SAR) model validation' and considered to develop the NANoREG 
Definition. 
Table 4.28 Literature definitions collected for the key term 'read-across' and considered 
to develop the NANoREG Definition. 
Table 4.29 Literature definitions collected for the key term 'Read-Across Assessment 
Framework (RAAF)' and considered to develop the NANoREG Definition. 
Table 4.30 Literature definitions collected for the key term 'regulatory acceptance' and 
considered to develop the NANoREG Definition. 
Table 4.31 Literature definitions collected for the key term 'safe-by-design' and 
considered to develop the NANoREG Definition. 
Table 4.32 Literature definitions collected for the key term 'standardisation' and 
considered to develop the NANoREG Definition. 
Table 4.33 Literature definitions collected for the key term 'Standard Operating 
Procedure (SOP)' and considered to develop the NANoREG Definition. 
Table 4.34 Literature definitions collected for the key term 'substance' and considered 
to develop the NANoREG Definition. 
Table 4.35 Literature definitions collected for the key term 'test method' and 
considered to develop the NANoREG Definition. 
Table 4.36 Literature definitions collected for the key term 'test method validation' and 
considered to develop the NANoREG Definition. 
Table 4.37 Literature definitions collected for the key term 'tiered testing strategy' and 
considered to develop the NANoREG Definition. 
Table 4.38 Literature definitions collected for the key term 'trend analysis' and 
considered to develop the NANoREG Definition. 
Table 4.39 Literature definitions collected for the key term 'tool' and considered to 
develop the NANoREG Definition. 
Table 4.40 Literature definitions collected for the key term 'validation' and considered 
to develop the NANoREG Definition. 
Table 4.41 Literature definitions collected for the key term 'value chain' and considered 
to develop the NANoREG Definition. 
Table 4.42 Literature definitions collected for the key term 'waiving' and considered to 
develop the NANoREG Definition. 
Table 4.43 Literature definitions collected for the key term 'Weight of Evidence (WoE)' 
and considered to develop the NANoREG Definition. 
  
 100 
 
 
  
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
How to obtain EU publications 
 
Our publications are available from EU Bookshop (http://bookshop.europa.eu), 
where you can place an order with the sales agent of your choice. 
 
The Publications Office has a worldwide network of sales agents. 
You can obtain their contact details by sending a fax to (352) 29 29-42758. 
Europe Direct is a service to help you find answers to your questions about the European Union 
Free phone number (*): 00 800 6 7 8 9 10 11 
(*) Certain mobile telephone operators do not allow access to 00 800 numbers or these calls may be billed. 
 
A great deal of additional information on the European Union is available on the Internet. 
It can be accessed through the Europa server http://europa.eu 
 102 
 
 
doi: 10.2788/71213 
ISBN 978-92-79-57545-7 
L
B
-N
A
-2
7
8
0
8
-E
N
-N
 
JRC Mission 
 
As the Commission’s  
in-house science service,  
the Joint Research Centre’s  
mission is to provide EU  
policies with independent,  
evidence-based scientific  
and technical support  
throughout the whole  
policy cycle. 
 
Working in close  
cooperation with policy  
Directorates-General,  
the JRC addresses key  
societal challenges while  
stimulating innovation  
through developing  
new methods, tools  
and standards, and sharing  
its know-how with  
the Member States,  
the scientific community  
and international partners. 
 
Serving society  
Stimulating innovation  
Supporting legislation 
 
